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ABSTRACT
ADHERENCE, INTRACELLULAR REPLICATION AND THE HOST 
CYTOKINE RESPONSE DURING LEGIONELLA PNEUMOPHILA 
INFECTION BOTH IN  VITRO  A N D  IN  VIVO
by
Corinna M. Krinos 
University of New Hampshire, May, 1999
Legionnaires' disease is an acute lobar pneum onia caused, primarily by 
the intracellular pathogen Legionella pneumophila. This organism when 
inhaled by humans descends into the lower respiratory tract and parasitizes 
alveolar macrophages. L. pneumophila adhered to U-937 cells, A549 cells and 
peritoneal macrophages from A /J mice in an opsonin-independent fashion. 
Following attachment, the organism penetrated the cell membrane, replicated 
within these cells eventually inducing lysis. To better define the adhesion of 
L. pneumophila to host cells, an E. coli clone (LP 116), expressing the 25 kDa 
major outer membrane protein (MOMP) of L. pneumophila was used in 
binding studies. This MOMP-expressing clone showed a 5-fold increase in 
opsonin-independent binding to U-937 cells as compared to the parent E. coli 
strain and suggests that the 25 kDa MOMP of L. pneumophila functions as an 
adhesin.
A major thrust of this study was to better define the cytokine response of 
the host during L. pneumophila infection. Challenge of macrophage-like
xv
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U-937 cells with live, killed o r fixed L. pneumophila elicited the secretion of 
some cytokines while downregulating others, suggesting that L. pneumophila 
modulates cytokine production in vitro. To develop a better understanding 
of the complexity of the imm une response to L. pneumophila infection, an 
experimental model of Legionnaires7 disease in A /J mice was developed. A/J 
mice were challenged intratracheally with a sublethal dose of L. pneumophila 
to investigate bacterial replication and to characterize the progression of 
pneumonic disease. Challenge of mice with L. pneumophila resulted in an 
8-fold increase in the numbers of L. pneumophila in the lungs within 24 h 
followed by gradual clearing of the organism. During infection with L. 
pneumophila, gross and histopathological evaluation indicated pneumonic 
infection. In addition, infection with L. pneumophila produced both 
proinflammatory and immunoregulating cytokines as assayed from 
bronchoalveolar lavage fluids, lung homogenates and sera. This biphasic 
approach demonstrated that L. pneumophila elicits the expression of some 
cytokines while modifying the levels of others produced by macrophages. 
Furthermore, L. pneumophila induced a specific cytokine response in A/J 
mice following lung infection.
xvi
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CHAPTER I
H istory o f Legionella and Legionnaires' D isease
1.1 Historical Perspective
Legionella pneumophila gained notoriety in July of 1976 at an 
American Legion Convention held in Philadelphia Pennsylvania at the 
Bellevue-Stratford hotel during the Bicentennial celebration of the 
Declaration of Independence. A total of 221 individuals subsequently 
developed an acute respiratory disease and 34 died (131). Of the 221 identified 
cases of disease, 182 were members of the Pennsylvania branch of the 
American Legion and 29 died after returning home from the convention.
The 39 additional non-legionnaires who were either in or passed by the hotel 
also developed what was subsequently termed Broad Street pneumonia and 
of these 5 died (131). The source of the disease although never proven, was 
suspected to be a contaminated ventilation system. There followed a medical 
media event that played out as the weeks passed. The news media turned its 
attention to the mysterious disease identifying each new case and publishing 
hundreds of articles in newspapers and weekly magazines. Epidemiological 
and microbiological studies continued for 6 months. It was believed by many 
that the cause of the disease was chemical, viral or toxin related but a bacterial
1
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etiology was not suspected as pathogenic bacteria were not isolated from the 
victims. It was not until January of 1977 that Dr. Joseph McDade at the 
Centers for Disease Control and Prevention (CDC) identified the causative 
agent using rickettsial methodology (233). The agent was named Legionella 
pneumophila from the disease it caused (Legionnaires' disease) and from the 
pneumonic symptoms of those affected. Failure to initially isolate or identify 
the agent was caused due to a lack of staining with the typical Gram stain 
procedure which uses safranin, nor did it grow on traditional bacteriological 
media (233). That specimens had been tested for rickettsiae by inoculation 
into guinea pigs was fortuitous and lead to the isolation and identification of 
the bacterium.
Guinea pigs inoculated with lung tissue of infected individuals became 
ill, however, there was no transmission of disease from guinea pig to guinea 
pig and organisms were not isolated when subcultured on routine agar. 
Embryonate hens' eggs were used in an attempt to isolate pathogens; 
however, this technique used for the isolation of rickettsiae proved 
unsuccessful, probably because of the use of penicillin and streptomycin to 
suppress contaminants. Omitting the antibiotics and using the Giemenez 
stain, which was developed for Rickettsia and contains carbol fuchsin, gram 
negative bacilli were seen (233). In this way an entirely new family of 
pathogenic bacteria was identified. Retrospective studies have shown that the 
disease, although unrecognized, has occurred in epidemics since the 1940's
2
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(260,333,338).
In addition to Legionnaires' disease, the pathogen causes another, albeit 
milder, non-pneumonic condition that, like the pneumonic form, had 
occurred in explosive outbreaks in the past but had gone undiagnosed until 
1978. One such unsolved episode was an acute respiratory condition that 
afflicted 144 employees and visitors at the Oakland County Health 
Department in Pontiac Michigan in 1968 (156, 198). This form of the disease 
was named Pontiac Fever and differed from the Philadelphia outbreak in key 
properties (Table 1). Legionnaires' disease is a potentially fatal multifocal 
necrotizing pneumonia while Pontiac Fever presents as a self-limiting 
flu-like illness. Although there were no fatalities in Pontiac, the attack rate 
was 95% (156). No definitive explanation has been offered for these two 
disparate disease conditions collectively referred to as legionellosis; indeed, 
both are caused by apparently identical genotypic and phenotypic organisms.
In this respect, the role of the immune system in the host is a key factor in 
disease expression.
The first agar medium reported by Feeley et al. (116) to support sparse 
growth of L. pneumophila was Mueller-Hinton agar supplemented with 1% 
hemoglobin and 1% Iso Vitale XR. Dumoff used chocolate agar to isolate L. 
pneumophila from lung tissue and pleural fluid from a patient who died 
from a pneumonia of previously unknown etiology (97). Feeley et al. (116) 
identified the essential growth factor present in Iso Vitale XR as L-cysteine
3
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.





Named for: Philadelphia outbreak, 1976 Pontiac outbreak, 1968
Attack rate (%):
Incubation period (days): 
Clinical syndrom:
Symptoms common to both:









Fever, cough, headache, confusion, chest 
pains, nausea, malaise, diarrhea and 
vomiting
Dyspnoea, haemoptysis, Pleuritic pain 
upper respiratory tract infection, 
abdominal pain, non-purulent 
sputum production 
Central nervous system, 
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which, together w ith ferric ions in hemoglobin, were required for successful 
isolation of the pathogen. Substituting yeast extract for casein hydrolysate,
and adding activated charcoal (115), a-ketoglutarate (99) and ACES (N-2- 
acetamido-2-aminoethanesulfonic add) buffer (265) improved organism 
growth on solid media logarithmically. This medium, buffered charcoal yeast 
extract (BCYE-a) agar is the mainstay of the bacteriology, clinical and research
laboratory for growing this organism and substantial growth appears within 
24 to 48 h  incubation at 37#C in a humid atmosphere. L. pneumophila has a 
specific requirement for iron which is met by the addition of ferric
pyrophosphate to BCYE-a (275). A broth medium formulated from the same 
components as BCYE, but lacking the agar and charcoal and which is filtered, 
also supports the growth of legionellae (279).
Legionella species are environmental organisms and are ubiquitous in 
fresh water environments. Legionellae have been isolated from lakes, rivers, 
mud samples, thermal lagoons and potable water supplies (130, 245, 319, 240, 
127). In the environment these organisms multiply within a variety of 
protozoa (296, 295,18). Legionellae parasitize and replicate within these cells 
and are then released into the environment from where they enter 
man-made water supplies. Human infection typically occurs when 
contaminated aerosolized water droplets are inhaled and the organisms 
descend into the lower respiratory tree where they primarily infect alveolar
5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
macrophages (180). Legionellae are not primary human disease agents, but 
rather are opportunistic pathogens which, after gaining entry into the host, 
cause severe disease.
Several investigators have studied the pathogenesis of L. pneumophila 
using in vitro and in vivo models of infection. There are a variety of human 
and an im al cells that support the intracellular replication of L. pneumophila. 
Alveolar macrophages are the primary cells infected in humans; however, 
peripheral blood monocytes also support the intracellular replication of the 
organism (188). A variety of animal models have been investigated to study 
L. pneumophila infection and these include guinea pigs, rats, mice, monkeys 
and hamsters (132, 315, 263, 55). However, each animal system provides 
advantages and disadvantages for delineating the pathogenesis of L. 
pneumophila.
1.2 The Organism
1.2.1 Taxonomy and nomenclature. In 1979 Brenner et al. (54) using 
deoxyribonucleic ad d  (DNA) homology established that this newly identified 
organism represented not only a new genus but a new family of bacteria, the 
Legionellaceae, comprised of a single genus. Since the initial identification of 
L. pneumophila, num erous additional species have been added to the genus, 
which currently consists of 39 spedes and 3 subspedes and numerous 
serogroups (Table 2). Two additional genera were proposed, Tatlockia and
6
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Table 2: Taxonomy and classification of the legionellae*
Species Serogroups Source f}—lac Ox Hip G1 BP AF M
L. pneumophilab 14 H/E + V + + + - +
L. adelaidensis 1 E - - - + - - +
L. anisa 1 H/E + + - + + BW(V) +
L. birminghamensis 1 H + V - + - YG +
L. bozemanifc 2 H/E V V - + + B W +
L. brunensis 1 E + - - + +e - +
L. cincinnatiensis 1 H - + - + + - +
L. cherrii 1 E + + - + + B W +
L. dumojfiic 1 H/E + - - + V B W +
L. erytkra 2 E + + - + + R +
L. fairfieldensis 1 E - +e - - - - -
L. feelii 2 H/E - - V - +e - +
L. geestiana 1 E - - +e + +e - +
L. gormaniic 1 H/E + - - + + B W +
L. gratiana 1 E + + - + - - +
L. hackeliae 2 H + + - + + - +
L. israelensis 1 H/E + - - +e + - +
L. james town iens is 1 E + - - + + - +
L. jordanis 1 H/E + + - + + - +
L. lansinsensis 1 H - + - - - - +
L. londiniensis 1 E + - _ /+ e + + - -
L. longbeachae 2 H V + - + + - +
L. maceachemii 1 H/E - + - + + - +
L. micdadeid 1 H/E - + - - - - +
L. moravica 1 E + +e - + +e - +
L. nautarum 1 E + + - - - - -
L. oakridgensis 1 H/E +e - - + + - -
L. parisiensis 1 E + + - + + B W +
L. quarteirensis 1 E + - - + + - +
L. quinlivanii 2 E - - - + + - +
L. rubrilucens 1 E + - - + + R +
L. sainthelensi 2 H/E + + - + + - +
L. santicrucis 1 E + + + + + - +
L. shakespearei 1 E - +e - + - - +
L. spiritensis 2 E + + +e + + - +
L. steigerwaltii 1 E + - - + + B W +
L. tucsonensis 1 H + - - + - B W +
L. wadsworthii 1 H + - - + - - +
L. worsleiensis 1 E + - - + + - +
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Table adapted from Rodgers and Pasculle (1991)
aAll strains are catalase positive (L. hackliae, L. londinensis and L.
worsleiensis are weakly positive) and all foil to reduce nitrate.
bL. pneumophila contains three subspecies: L. pneumophila subspecies
pneumophila, subspecies pascullei and subspecies fraseri.
cAlternate genus name : Fluoribacter
^Alternate genus name: Tatlockia
eSome strains are weakly positive only
+ = positive reaction; - = negative reaction; V = variable results
p-lac = p-lactamase; Ox = oxidase; Hip = hipurate; G1 = gelatin liquification; BP 
= brown pigment; AF = autofluorescence; BW = blue/w hite fluorescence; YG 
= yellow/green fluorescence; R = red fluorescence; M= motility
8
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Fluoribacter, to encompass L. micdadei and the autofluorescent species L. 
bozemanii, L. dumoffii and L. gormanii respectively (146). However, there 
has not been universal acceptance of this nomenclature system. Serological 
reactions, determination of cellular fatty acids, and isoprenoid quinone 
analysis are useful for classification; however, these do not differentiate all 
species, thus DNA relatedness remains the mainstay of classification (51). 
Presumptive identification of Legionellae is accomplished by growth on 
BCYE-a with L-cysteine and a-ketoglutarate and the absence of growth on
blood agar or BCYE-a w ithout L-cysteine with subsequent confirmation using 
a variety of bacteriological and molecular techniques (51).
1.2.2 Physico-chemical properties. L. pneumophila organisms grow 
optimally on complex bacteriological media at tem peratures between 35-37°C 
and at an optimum pH  of 6.9 with a narrow range between 6.85-6.95 for 
clinical isolates. The use of potassium buffers rather than those that contain 
sodium are preferable as sodium ions can restrict or inhibit Legionella growth
(116). It has been suggested that the purpose of charcoal and a-ketoglutarate 
in the medium is to detoxify BCYE-a by neutralizing the toxic activity of free
fatty adds such as, oleic ad d  produced in the media during autoclave 
sterilization. Alternatively, charcoal may scavage toxic oxygen radicals 
released from the yeast extract present in the medium  especially after
9
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exposure to bright light (176). In the environment, Legionella has been 
isolated from thermal lagoons and cooling towers at temperatures in excess of 
60°C and generally grow well over a wide temperature range (127).
1.2.3 Cultural and morphological characteristics. Although legionellae 
are facultative intracellular organisms they are readily cultured on 
bacteriological media and colonies appear in 1-3 days. Typically, colonies are 
opalescent, resemble cut glass and have a stringy consistency. During early 
growth, colonies show a pink or blue-green iridescence which disappears with 
prolonged incubation at which time large and small colony variants develop. 
These appear grey-white in color, losing their characteristic appearance as they 
become more opaque resembling other bacteria. Some Legionella species 
autofluoresce brilliant blue-white whereas L. pneumophila does not (54, 213). 
Yet others autofluoresce either yellow-green or red (Table 2) (116, 234).
The morphological characteristics of L. pneumophila are shown in 
Table 3. L. pneumophila is a gram negative, fastidious, pleiomorphic rod 
ranging in size from 0.3 to 0.9 |im in w idth by 2 to 20 pm or more in length 
(289, 283, 68, 51). When grown on bacteriological media L.pneumophila 
appear as elongated or filamentous rods up  to 50 pm in length with tapered 
ends; however, when viewed from autopsied lung, rods are seen as short 
coccobadlli (68, 283, 290). L. pneumophila is a motile, non-sporeforming, 
aerobic, non-acid fast, non-encapsulated bacterium. Legionellae exhibit
10
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Table 3: Morphological characteristics of L. pneumophila
• Slender gram negative rods (in vivo forms are short 0.5 x 1-2 pm)
(from bacteriological media 0.4 x 2-3 |im)
• Pleiomorphic (long froms can reach 20 fim in length in vivo and > 50 Jim
in length in vitro)
• Divide by non-septate, pinching, binary fission
• Non-parallel sides with tapered ends
• Internal PHB storage granules
• Vacuolated surfaces, convoluted or smooth surfaces
• Possess lipopolysaccharide (F-l antigen) on bacterial surface
• Motile by polar or sub-polar flagella
• Fimbriae present
• No evidence of acid mucopolysaccharide capsule
• Blebs on outer membrane surface
• Outer membrane and cytoplasmic membrane each 10 nm thick
separated by a thin peptidoglycan layer
• Ribosomes 25 nm in diameter
11
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cellular architecture typical of gram-negative bacteria when examined by 
electron microscopy (289, 283). The double layer cell envelope of the 
organism is approximately 25 nm thick and comprises the periplasm located 
between the outer and cytoplasmic membranes each measuring 
approximately 10 nm in width (289, 283,284). Peptidoglycan and 
diaminopimelic add , a component of peptidoglycan as well as 
2-keto-3-deoxyoctonate (KDO), a component of lipopolysaccharide (LPS), have 
been identified in L. pneumophila (126, 283, 284). The LPS of legionellae is 
smooth and the spedes and serologic differences in composition allow for 
serogroup differentiation (142, 166, 254). L. pneumophila LPS consists of a 
membrane-assodated lipid portion that is rich in branched-chain fatty acids 
and is tightly assodated with the major outer membrane protein (MOMP). In 
addition, L. pneumophila, possesses a polysaccharide complex comprised of 
glucose, rhamnose, mannose, quinovosamine, KDO and glucosamine. The 
O-antigenic side chain is responsible for the characteristic ladder-like banding 
appearance in sodium  dodecyi sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) gels as well as for the serogroup specificity detected in sera (167, 
318). Patients elid t strong antigenic responses to the LPS of the organism. 
Poly-P-hydrohybutyrate (PHB) storage granules have been identified as 
electron-lucent vacuoles measuring 30 to 200 nm (33). However, larger forms 
up to 0.5 |im have been identified by negative stain, thin section and 
freeze-fracture electron microscopy (289, 283, 284,281). James et. al. (193) has
12
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recently described that L. pneumophila accumulate intracellular reserves of 
PHB, which support its long-term survival in a culturable state under 
starvation conditions. It was suggested that this endogenous energy reserve is 
likely to play an important role in promoting the persistence of legionellae in 
stressful low-nutrient environments outside the amoebal host. The majority 
of species, except for L. oakridgensis, L. nautarum and L. londiniensis are 
motile by means of polar o r sub-polar flagella (284, 287) (Table 2) and these are 
unsheathed measuring 14-20 nm  in diameter and up  to 8  nm in length (287, 
288). The individual monomeric flagellin proteins have a molecular mass of 
47 kDa, as determined by SDS-PAGE (262). The expression of flagella is 
nutrient and temperature dependent (262). In addition, the legionellae were 
shown by electron microscopy to possess pili (287) and this finding has 
recently been confirmed by genetic techniques. Ribosomes measuring 25 nm 
in diameter are found in the cytoplasm along w ith the fine skein of nuclear 
material typical of gram-negative bacteria (289, 283, 287).
1.2.4 Biochemical properties. L. pneumophila possesses the enzymes 
catalase, peroxidase, gelatinase, phospholipase and p-lactamase; they are 
oxidase variable and have the ability to hydrolyze hippurate (Table 2 ) (339, 54, 
80,168). Under longwave ultraviolet light (366 nm) some species display 
blue-white or red fluorescence that may assist in species identification (54, 80). 
They contain high levels of branched chain fatty acids in their cell wall (51);
13
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however, the presence of an extracellular a d d  polysaccharide layer detectable 
by ruthenium red staining has remained in doubt (169, 283). The organisms 
are nutritionally fastidious, utilizing amino ad d s  such as arginine, threonine, 
methionine, serine, valine, and cysteine as energy sources rather than 
carbohydrates (355, 268, 334, 337, 335,150). The organism in particular has an 
unusually high requirement for L-cysteine (116, 268). The organic acids; 
lactate, pyruvate, acetate, malate, fumarate, and oxaloacetate serve to 
stimulate oxygen consumption by these bacteria.
Even though L. pneumophila can hydrolyze starch and oxidize certain 
sugars, its energy metabolism is based on oxidation-dependent rather than 
fermentative pathways (116, 268, 355). L. pneumophila primarily derives its 
energy from the oxidation of amino adds by utilizing the Krebs cycle and a 
complex electron transport chain, that is expressed in these organisms (150, 
337). Hoffman and Pine (175) have detected the presence of cytochromes of 
the c, b, a, and d types. The slow metabolism of glucose by L. pneumophila is 
used for biosynthesis rather than as an energy source (356, 337). Most of the 
glucose that is consumed by the organism is metabolized and broken down by 
the Entner-Doudoroff and pentose phosphate pathway, presumably to 
provide pentoses for nucleic ad d  synthesis and NADPH for the reducing 
power that the organism needs for various biosynthetic pathways, such as 
fatty add  biosynthesis (337). The Embden-Meyerhof pathway does not 
function in glucose catabolism, however, the gluconeogenic anabolic
14
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enzymes of this pathway are responsible for sugar synthesis (150,175, 356).
Most branched chain fatty adds are synthesized by L. pneumophila, the 
predominant one being isopalmitate, a saturated, branched, 16-carbon fatty 
add (244). L. pneumophila also contains hydroxy fatty adds, such as 
P-hydroxyisomyristic add , P-hydroxyarachidic ad d  which are mostly confined 
to cell wall structures (232). The major phospholipids of L. pneumophila are 
phosphatidylcholine, cardiolipin (diphosphatidylglycerol), 
phosphatidylethanolamine, phosphatidylglycerol and 
phosphatidyldimethylethanolamine (124).
When examined, the strains of L. pneumophila all produced
extracellular protease, phosphatase, lipase, DNase, RNase, and p-lactamase
activity. They did not however, produce elastase, collagenase, hyaluronidase, 
chondroitinase, neuraminidase, urease or coagulase (340).
Important ions for Legionella cultivation, include calcium, cobalt, 
copper, magnesium, manganese, molybdenum, nickel, potassium, vanadium 
and zinc (275, 336). Legionellae show a requirement for iron and although 
the organism will grow at iron concentrations of 0.5 pm, excess amounts are 
usually needed for optimal growth of the organism and for the efficient 
operation of bacterial enzymes, ferredoxins and cytochromes. Iron is also 
involved in the bacterial process of electron transport, regulation of gene 
expression and oxygen metabolism.
15
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1.2.5 Environm ental aspects. The Legionellaceae are environmental 
organisms that are ubiquitous in fresh water environments. Legionellae 
have been isolated from a wide range of fresh water habitats, and in particular 
those that have been thermally polluted, including lakes, rivers, ground 
water, thermal lagoons and potable water supplies (130, 245, 45, 49). Isolates 
have also been obtained from moist potting soils, mud, river banks and rain 
water run-off (319). The association of L. pneumophila with blue-green algae 
and fresh water amoebae in the aquatic environment is well documented 
(341, 28, 296, 18). The organism multiplies intracellularly in a variety of 
protozoa belonging to the genera Hartmanella (121, 56), Acanthamoeba (6 , 
316), Naegleria (252), Echinamoeba, Tetrahymena (122) and Cyclidium (49, 18, 
344) (Table 4). Legionella parasitize and replicate within these protozoa and 
are then released into the environment. It is from these sources that 
legionellae gain entry into man-made water supplies such as water systems of 
large buildings, evaporative condensers and cooling towers (4, 79, 92,138, 145). 
L. pneumophila have been isolated from aerosols created by many sources 
such as evaporative air conditioners, decorative fountains (117), whirlpool 
baths, showers (45, 49), humidifiers (221), supermarket vegetable water 
misting systems (219) and respiratory care equipment (13, 229). When L. 
pneumophila comes into contact with humans infection typically occurs 
provided the organisms are presented in proper fashion. As aerosolized 
water droplets of approximately 5-15 |im in diameter are inhaled,
16
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the organisms evade the constitutive barriers of the upper respiratory tract by 
virtue of the droplet size and descend into the lower respiratory tree where 
they primarily infect alveolar macrophages eventually leading to the disease 
state. It has been suggested that the presence of cyanobacteria, flavobacteria, 
secretions of certain aquatic plants, algae and free-living amoebae may serve 
to either stabilize and protect the organisms in aerosols or to actively 
stimulate their growth (353, 352, 351, 320). Cirillo et al. (76) demonstrated that 
L. pneumophila grown in Acanthamoeba castellanii were more invasive for 
epithelial cells and  macrophages than were L. pneumophila grown on agar. 
Replication of L. pneumophila in protozoans present in domestic water 
supplies may be necessary to produce bacteria that are competent to enter 
mammalian cells and produce hum an disease. Invasion and intracellular 
replication within protozoa are thought to be major factors in the 
transmission of Legionnaires' disease. Legionellae are protected within 
protozoal cysts which show increased resistance to drying and to water 
treatment processes such as chlorination and heating. Furthermore, bacterial 
load may be increased in aerosols containing these protozoa (341, 351). Thus, 
Legionella is delivered in an amplified and protected manner to the human 
host. It is possible that the mechanisms involved in the recognition, survival 
and replication of the pathogen within protozoa may be reflected in the target 
cell during Legionnaires7 disease; namely the human alveolar macrophage. 
Similar interaction phenomena occur in both cell types in which Legionella
18
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are taken-up, replicate intracellularly within similar endocytic compartments 
and are released (2). Recently a model for attachment and entry of L. 
pneumophila into Hartmanella vermiformis has been proposed (348, 347). 
Venkataraman et al. (348,347 reported the identification of a 170-kD 
galactose/N- acetyl-D-galactosamine (Gal/GalNAc) lectin in the protozoan 
host, H. vermiformis, as a potential receptor for attachment and invasion by 
L. pneumophila . It was demonstrated that attachment of L. pneumophila to 
the H. vermiformis 170-kD lectin was required for invasion and was 
associated with tyrosine dephosphorylation of the Gal/GalNAc lectin in 
addition to other host proteins (348). However, Hard et al. (162) provided 
biochemical and genetic evidence that the mechanisms of attachment and 
subsequent uptake of L. pneumophila by H. vermiformis and Acanthamoeba 
polyphaga were, in part, different, yet invasion and subsequent killing of the 
host cell was followed by similar intracellular replication within a rough 
endoplasmic reticulum-surrounded phagosome (162). Many of the
mechanisms utilized by L. pneumophila to parasitize mammalian and 
protozoan cells are suggested to be similar, however, Gao et al. (144) using 
transposon insertion mutagenesis of L. pneumophila to detect mutants that 
exhibited defective phenotypes of cytopathogenidty and intracellular 
replication within macrophage-like U937 cells but not within A. polyphaga 
demonstrated that there were unique mechanisms utilized by L. 
pneumophila to survive and replicate within macrophages but not protozoa.
19
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In addition, unique genetic lod  were required for L. pneumophila to 
parasitize mammalian but not protozoan cells. These data suggested that L. 
pneumophila has evolved as a protozoan parasite in the environm ent but 
has acquired loci specific for intracellular replication within macrophages. 
Alternatively, ecological coevolution w ith protozoa has allowed L. 
pneumophila to possess multiple redundant mechanisms to parasitize 
protozoa and that some of these mechanisms do not function within 
macrophages (144). It has been suggested that Legionella may recognize a 
highly conserved structure on the surface of the alveolar macrophage which 
structurally mimics a similar molecule on amoebae, however, this hypothesis 
has not been confirmed. Legionellae are important medical pathogens, yet, 
the human host is a dead end infection as there is no mechanism for return 
to the environment or to another suitable host. Human to human spread of 
the disease has never been documented.
1 .2 .6  Genetics. The legionellae possess a genome size of 2.5xl09 daltons 
and a guanine plus cytosine (G + C) content in their DNA of 38-52 mol % (54, 
104). DNA homology studies were used to determine that the organism 
constituted not only a new genus, but also a new bacterial family (54). Based 
on DNA homology and 16S ribosomal studies, the legionellae are 
distinguishable from and unrelated to other bacterial genera (139, 302). DNA- 
hybridization assay remains the recognized method for species identification.
20
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Commercial DNA probes have been developed to identify Legionella species 
and strains in diagnostic and environmental settings (99, 98, 319, 342). DNA 
relatedness is high (up to 99 %) between strains and serogroups for individual 
species, but ranges from 1 to 67 % between different species within the genus 
(52). L. pneumophila was divided into three subspecies, (pneumophila, 
pascullei and fraseri), based on a much reduced DNA homology of two of the 
new subspecies to the type strain Philadelphia 1 (53, 308). In addition to 
divergence in DNA homology, differences in enzyme profiles and amino acid 
requirements were reported for these subspecies.
Plasmids ranging in size from 21 to 85 MDa have been reported from 
both clinical and environmental strains and serogroups (60, 83, 204, 220, 235, 
255). The presence of such plasmids has not been associated with either 
enhanced or reduced virulence. The presence or absence of plasmids do not 
modify antimicrobial resistance patterns nor change expression of virulence 
traits. The detection of plasmids has proved useful for the molecular 
differentiation of isolates for epidemiological purposes. The introduction of 
DNA into L. pneumophila has been achieved by a variety of methods which 
include transformation using electroporation, conjugation and transduction 
(70, 95, 107, 225, 349). Cloning genes for L. pneumophila antigens into 
Escherichia coli has been successful and valuable for characterizing virulence 
genes. Through such genetic manipulation, the mip gene encoding the 24 
kDa macrophage infectivity potentiator (Mip) protein was identified as a
21
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virulence factor (109, 108). Mip is a surface protein of L. pneumophila and 
other Legionella species essential for intracellular infection (74, 73). Other 
genes have also been successfully cloned and expressed in E.coli and these 
include the gene responsible for the major outer membrane protein (MOMP) 
(170), a 38 kDa zinc metalloprotease (272) and a 19 kDa outer membrane 
peptidoglycan-assodated protein (171, 218). Several highly conserved genes 
have also been cloned into E. coli including the recA gene, involved in repair 
of DNA (94, 374) and the groEL gene, responsible for production of a 60 kDa 
heat-shock protein (174). Other genes that have been identified include the 
proA (273) and fly genes (365) responsible for the expression of the bacterial 38 
kDa protease and 39 kDa hemolysin and their possible role in virulence has 
been suggested. The sequences of several Legionella genes have been 
reported. In some cases, the sequences showed significant homology to 
cognate genes from other bacteria. For example, the Legionella recA gene was 
found to be approximately 70 and 75 % similar to the E. coli and 
Pseudomonas aeruginosa genes, respectively (374). In addition, the sequence 
of the L. pneumophila protease revealed that the enzyme was more than 70 
% homologous with Pseudomonas elastase (32). The specific mutation of a 
designated gene in its native background is the most direct and definitive 
approach to address the role of any specific gene in pathogenesis. To date, 
only three specific genetic loci have been identified in this fashion and these 
include the efa, mip and msp loci. An insertion in efa, a locus of unknown
22
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function, demonstrated that the methods for insertion mutagenesis per se do 
not cause a defect in cellular infection (72). However, a mutation in mip 
resulted in attenuated virulence in macrophages and in guinea pigs (74, 73). 
Interestingly, a mutation in the gene encoding the extracellular protease 
(msp) suggested that the protease has no necessary function in pathogenesis 
(330, 44). New genetic approaches are being implemented to discover new 
genes that may be important for virulence. One such method involves 
transfer of a genomic library to a nonreverting, avirulent L. pneumophila 
mutant. Host cells are then infected in order to select an isolate carrying a 
cosmid (or plasmid) that complements the mutation. A mutation that fails to 
evade phagosome-lysosome fusion was complemented by using this 
approach (222). Another approach is to focus on those genes that are 
expressed in the intracellular environment but not in bacteriological 
medium-grown bacteria. Finally, alkaline phosphatase gene fusions are being 
used to identify insertion mutations in genes expressing secreted proteins by 
using the procedure known as shuttle mutagenesis in which the 
transposition step is performed in the more permissive E. coli background 
(107).
As L. pneumophila is an intracellular pathogen able to grow within 
alveolar macrophages residing in a phagosome that does not fuse with 
lysosomes, much research has centered on defining those genes and gene 
products responsible for limiting interactions between the phagosomal
23
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compartment and lysosomes in addition to those genes necessary for 
intracellular survival of L. pneumophila. A large number of L. 
pneumophila genes, called dot (defect in organelle trafficking) and icm 
(intracellular multiplication), have been identified that are required for 
intracellular growth within human macrophages (48, 223, 271). This gene 
family is implicated in several aspects of virulence and appears to constitute 
components of a conjugal transfer system that has been adopted to prevent 
phagosome-lysosome fusion in the host cell and to mediate host cytotoxicity 
by pore formation (306). It has recently been shown that the dot /icm  genes 
code for a large putative membrane complex that forms a type IV secretion 
system used to alter the endocytic pathway (350). The dot A  locus from L. 
pneumophila has been identified as an essential gene for intracellular growth 
(29). Phagosomes formed by dotA mutants do not mature into a replicative 
vacuole and eventually fuse with lysosomes (29). Genetic and biochemical 
data have demonstrated that DotA is an integral inner membrane protein. 
Recently Roy et al. (297) have demonstrated that the dotA product is required 
to regulate trafficking of the L. pneumophila phagosome. In addition, the 
icm-dependent conjugal ability of L. pneumophila and its relationship to 
intracellular multiplication and host cell killing have been investigated. L. 
pneumophila has been shown to mediate plasmid DNA transfer and this 
process is dependent on several icm genes. L. pneumophila contain a 
functional icm complex that can mediate conjugal DNA transfer and is
24
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necessary for intracellular replication of the organism (307).
1.3 Clinical and epidemiological findings
1.3.1 Clinical presentation. Two clinical syndromes have been 
associated with infection by L. pneumophila; Legionnaires' disease, an acute 
febrile pneum onia and Pontiac fever, a non-pneumonic, influenza-like 
illness, collectively referred to as legionellosis (Table 1). The organisms 
responsible for Legionnaires' disease and Pontiac fever are phenotypically and 
genotypically indistinguishable and it is believed that the status of the host's 
immune system at the time of infection is crucial to the establishment and 
progression of the two disease states. Unlike Pontiac fever, Legionnaires' 
disease, afflicts those w ith underlying disease such as lymphoma, pulmonary 
distress, congestive heart failure and acquired im m une deficiency syndrome 
(AIDS) (17). Legionnaires' disease is a multifocal necrotizing pneumonia 
with multisystem involvement (113). The incubation period is 2-10 days and 
the prodromal symptom s include acute fever, chills, headache, anorexia, 
rigors, myalgia and malaise (131). As infection proceeds respiratory 
manifestations include dyspnea, bradycardia, rales and a non-productive 
cough with little or no sputum production (16, 131, 333). If sputum is 
produced it is typically non-purulent. Absence of sputum  or its lack of 
purulence has been suggested to be characteristic of Legionnaires' disease.
The acute nature of the illness results in the need for hospitalization. As
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disease progresses lung examination reveals abnormalities w ith rales and 
very often lung consolidation being evident as lung function becomes 
compromised. Lung infection may be rapid and may be responsible for 
increasing dyspnea and acute respiratory failure. Major systematic changes 
also ensue including abnormal liver function tests, including elevations in 
creatine levels, blood gas and electrolyte imbalances as well as hyponatremia, 
hematuria, proteinuria and pancytopenia (85,131, 201, 237). Extrapulmonary 
symptoms are common including disorientation and confusion out of 
proportion to the degree of fever. Central nervous system dysfunction, 
involvement of the heart, spleen, bone marrow, brain and lymph nodes as 
well as cellulitis have been documented (12, 354). In addition, gastrointestinal 
complaints of nausea and diarrhea occur in many patients. Acute renal 
failure, disseminated intravascular coagulation, shock, respiratory 
insufficiency, coma and circulatory collapse are the major factors leading to 
death (259). Bacteremia has been documented and may explain the 
extrapulmonary manifestations of Legionnaires' disease that include cerebral 
microglial granuloma, cutaneous and hepatic abscess formation, endocarditis, 
pericarditis and pyelonephritis (278, 280, 324).
1.3.2 Pathology. Radiological findings indicate that the pneumonia is 
lobar in nature, initially limited to one or several foci, especially in 
immunocompromised patients (364). The pneumonia is bilateral in 60 % of
26
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the cases and as the infiltrates extend into adjacent and non-adjacent areas, 
consolidation is evident in one or more lobes of the lung (110, 200). Pleural 
effusions can be detected in 25 % to 50 % of cases, however, these are usually 
small and may be due to underlying cardiac failure (200). Radiological 
changes may be extensive and slow to resolve even following recovery (35). 
During severe disease, diffuse multilobar involvement of the lung occurs 
with focal or lobar consolidation evident as either red or grey hepatization. 
Distinct macroscopic lesions are produced by L. pneumophila and are similar 
for all pathogenic species of Legionella (36, 364). These lesions may be 
difficult to distinguish from classical pneumococcal pneumonia. Tissue 
damage in the lungs is exacerbated by the production of numerous potent 
exotoxins and enzymes and these facilitate coagulative necrosis, congestion, 
hemorrhage and abscess formation and also act to suppress phagocytosis and 
interfere with host cell oxidative metabolism. Abscesses are rarely seen by 
radiologic examination, however, abscess formation has frequently been seen 
in tissue specimens of lungs from fatal cases of Legionnaires' disease (5, 364).
Pathological examination of infected lung tissues exhibit a severe 
inflammatory response indicative of acute fibrino-purulent pneumonia. 
During microscopic evaluation, alveoli and terminal bronchioles are 
distended and contain proteinaceous fibrin-rich debris in which macrophages 
and neutrophil polymorphonuclear leukocytes are present in varying 
number and proportions. The proximal bronchioles and bronchi are not
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usually involved. Alveolar damage with hyaline membranes and 
desquamation of lining cells has been observed in lung biopsies (256, 362).
13.3 Pathogenesis and virulence factors. L. pneumophila is a 
facultative intracellular bacterium that replicates within alveolar 
macrophages during hum an disease (250). Establishment of disease during 
infection with L. pneumophila depends on ill-defined virulence factors, the 
dose of infecting organisms and the status of the host's immune system. The 
precise mechanisms by which L. pneumophila infects host cells thus leading 
to human disease are not well understood. In 1978, Rodgers et al. (289) first 
demonstrated the presence of L. pneumophila w ithin lung cells by electron 
microscopy. To better elucidate the infectious process, particularly at the 
cellular level, various prim ary and transformed cells in addition to several 
animal models have been developed (267, 363, 370). Those host cells that 
have been used in pathogenesis studies include transformed and primary 
cells of epithelial, fibroblast, polymorphonuclear and mononuclear lineage 
from both human and animal origin (Table 5) (155,188, 224, 258, 286). As 
alveolar macrophages are the primary cell infected in disease, these form the 
most appropriate cell type for studying cellular infection. However, these 
cells are not readily available therefore, macrophages or macrophage-like cells 
have been used to study adherence, intracellular replication and lysis of L. 
pneumophila. Among these, the most frequently used include human
28
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Table 5: Cells supporting L. pneumophila replication
• Alveolar macrophages
(human and rodent)
• Human peripheral blood monocytes
• MRC-5 cells (human embryonic lung fibroblasts)
• Hep-2 (human epithelial laryngeal carcinoma)
• HeLa (human cervical carcinoma)
• HL-60 (human leukemia)
• Vero (african green monkey kidney)
• U-937 (human histiocytic lymphoma)
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peripheral blood monocytes and the U-937 and HL-60 cell lines. The U-937 
cell has been extensively used in studies of attachment and intracellular 
replication of Legionella (153,188, 224, 267, 286). These cells possess Fc and 
complement receptors at levels consistent w ith human alveolar macrophages 
(294). In addition, the intracellular replication kinetics of L. pneumophila 
within U-937 cells is similar to that in alveolar macrophages, thus making 
this cell line an appropriate model for cellular infection (267). L. 
pneumophila is taken up by polymorphonuclear leukocytes (PMNLs); 
however, these cells do not support replication of the organism (186). 
Epithelial and fibroblast cells which do not possess the same membrane 
receptors as those found on macrophages also support the cellular infectious 
cycle of the organism, indicating that alternative mechanisms of cellular 
infection exist. There are four stages of cellular infection common to 
intracellular pathogens; attachment of the organism to host cells, uptake by 
the cell and, once inside, intracellular replication begins with the terminal 
event being lysis of the host cell with subsequent release of the organism to 
allow the cycle to begin once again. Adherence of L. pneumophila to host 
cells followed by phagocytic uptake and intracellular replication are central to 
establishment of disease. Adherence is a necessary prelude to infection (24) 
and two mechanisms of attachment have been demonstrated for L. 
pneumophila; opsonin-dependent and opsonin-independent systems and 
each have been shown to be important in cellular infection in vitro (155, 186).
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In the complement-mediated system, complement receptors CR1 (CD35) and 
CR3 (CDllb and CD18) on human phagocytes which recognize complement 
fragments C3b and C3bi respectively, mediate phagocytosis of L. pneumophila 
(26). The major outer membrane protein (MOMP) on  the surface of 
Legionella fixes C3 exclusively via the alternative pathway of complement 
activation (26). The MOMP/C3bi complex binds to CR3 on human 
phagocytes. The opsonin-independent mechanism of uptake occurs in an 
environment devoid of complement or specific antibody (155, 286). This 
mechanism has been shown to produce a normal bacterial replicative cycle in 
U-937 cells as well as in MRC-5, HEp-2 and Vero cells (Table 5).
Uptake during complement-dependent processes is often mediated by 
coiling phagocytosis in which long phagocyte pseudopods coil around the 
organism as it is internalized (182). Once phagocytosed L. pneumophila 
induce the formation of a unique phagosome that is studded with host cell 
ribosomes (179, 258). Formation of the vacuole entails a complex sequence of 
cytoplasmic events that take place during the first 4-8 h after infection and 
involve host cell smooth vesicles, mitochondria and ribosomes. The 
significance of these observations has not been delineated, however, these 
processes may be important for the survival of the organism within host 
cells. A variety of mechanisms have been implicated in the intracellular 
survival of different bacteria, including extraphagosomal location, resistance 
to oxidative and nonoxidative killing mechanisms, inhibition of
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phagosome-lysosome fusion, and interruption of phagocyte activation and 
the subsequent production of bactericidal oxygen metabolites (123)(317). The 
initial investigations of phagocytes that ingest Legionella species did not 
detect any of the variety of mechanisms used by other organisms to evade 
intracellular destruction. It had been demonstrated that L. pneumophila and 
L. micdadei were phagocytozed and remained within the phagosome. In 
addition, both species were susceptible to killing in vitro by and other
bactericidal oxygen metabolites produced by phagocytic cells. L. pneumophila 
internalization by macrophages does result in an oxidative burst, however, 
following ingestion of the organism, the phagosome does not fuse with host 
cell lysosomes, thus, the bacteria-containing phagosome does not become 
acidified to the low pH levels characteristic of phagosome-lysosome fusion 
events and which are necessary for bacterial killing (181,185). The 
mechanism by which L. pneumophila inhibits phagosome-lysosome fusion is 
not well understood. Recently, Vogel et al. (350) have shown that the 
dot/icm  genes code for a large putative membrane complex that forms a type 
IV secretion system used to alter the endocytic pathway and is required for L. 
pneumophila intracellular survival. Thus, L. pneumophila is able to 
circumvent the normal destructive processes of the macrophages and not 
only survive bu t replicate within these very cells "designed" by evolution to 
destroy foreign antigens descending into the lungs. Following unabated 
intracellular replication, L. pneumophila is released from the confinements
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of the macrophage phagosome and escapes into the extracellular milieu 
where progeny organisms infect other cells in the surrounding tissues thereby 
facilitating the continuation of disease. The mechanisms by which L. 
pneumophila is released from the phagosome and the host cell cytoplasmic 
membrane is not defined. However, recent evidence indicates that the 
release of the organism may be preceded by macrophage apoptosis (143, 246). 
The major secretory protein of Legionella, a zinc metalloprotease with 
cytotoxic properties may play a role in this process; however, this protease is 
not essential for intracellular growth or cell killing (330) and is not a required 
virulence factor in a guinea pig model of Legionnaires' disease (44).
Virulence in the legionellae appears to be a multifactorial process and 
several potential virulence factors have been described for L. pneumophila 
(Table 6 ) that may promote cell invasion or intracellular survival and 
multiplication. Mip, a 24 kDa, cell surface protein is necessary for the efficient 
invasion of macrophages and for full virulence in a guinea pig model of 
legionellosis (74, 73). L. pneumophila mip (Mip*) mutants are defective in 
their ability to infect macrophages and to parasitize amoebae, ciliates and lung 
epithelial cells (74, 75). Furthermore, the phenotype of the mip mutant 
within macrophages and protozoa suggests that Mip is involved in bacterial 
resistance to intracellular killing (75). The role of other bacterial products in 
virulence is less clear. It has been demonstrated that L. pneumophila 
responds during infection of macrophages by alteration of gene expression.
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Table 6: Virulence factors from L.pneumophila
Virulence factor Molecular mass (kDa) Gene Function
Macrophage infectivity 24 m ip Macrophage
potentiator (Mip) internalization protein; 
inhibits protein kinase C
Major cytoplasmic membrane 58 htpAB Genus common;
protein heat-shock protein; 
illicits humoral 
response
Major outer membrane 24-29 ompM Genus and species
protein (MOMP) specific epitope; involved 
in phagocytosis; binds 
complement C3; 
associated with LPS; 
porin; putative adhesin
Zinc metalloprotease (MSP) 38 proA Tissue and cell damaging 
protein
Flagella (flagellin) 47 f laA Motility; common to 
serogroups 1-3
Hemolysin/ legiolysin 39 tty Hemolysis
Peptidoglycan-assodated 19 pal Immunogenic
Lipoprotein (PAL) (plpAB) ND*
Phospholipase C 50-54 ND* Hydrolyses
phosphotidylcholine
Lipopolysaccharide (LPS) ND* ND* Activates complement 
cascade; immunogenic; 
weak endotoxin
*ND = Not determined
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Upon infection of macrophages, the expression of at least 70 proteins was 
shown to be induced, 39 of which were not detected in organisms grown in 
defined bacteriological media (210). The expression of these newly 
synthesized proteins may be required for the survival of L. pneumophila in 
host cells. The response of the organisms to the intracellular environment is 
complex and may involve multiple regulons. Similar gene regulation events 
have been observed in other intracellular pathogens, such as Salmonella 
Typhimurium, which responds to the intracellular environment of 
macrophages by inducing the synthesis of 136 de novo proteins, some of 
which are well-established virulence factors (61). The mechanisms used by 
pathogenic bacteria to cause infection and disease usually include an 
interactive group of virulence determinants, sometimes coregulated, which 
are suited for the interaction of a particular microorganism with a specific 
host. Because pathogens must overcome similar host barriers, common 
themes in microbial pathogenesis have evolved. It may be that some of these 
induced proteins of legionellae and salmonellae have similar functions that 
allow these organisms to survive in the macrophage environment.
Extracellular enzymes, such as proteases and hemolysins have been 
suggested as factors that may be responsible for some of the pulmonary and 
extrapulmonary manifestations of legionellosis. L. pneumophila has been 
shown to produce various toxins, including legiolysin (a hemolysin), 
endotoxin (LPS) and a tissue destructive protease (23, 78,142, 365).
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L. pneumophila produces a 6 8  kDa phosphatase which has been 
implicated in modulating the respiratory burst of phagocytes by inhibiting 
superoxide production by human PMNLs (340). However, the phosphatase 
does not fully account for the capacity of the bacterium to block the respiratory 
burst of phagocytic cells following stimulation. The phosphatase is heat 
sensitive and loses both phosphatase activity and its inhibitory effect on 
stimulated neutrophil 0 2' production after heating; however, ingestion of
heated L. micdadei inhibits subsequent neutrophil and monocyte activation.
Baine et al. (15) identified that L. pneumophila possess a phospholipase 
C that is released into the medium in which the organisms are grown and 
hydrolyses phosphatidylcholine to produce diacylglycerol and 
phosphorylcholine. These investigators suggested a possible 
pathophysiological implication of the phospholipase C in that 
phosphatidylcholine is a major component of pulmonary surfactant and its 
destruction could impair pulmonary gas exchange. Supporting this are the 
alveolar hyaline membranes that have been described in Legionella 
pneumonia (362). In addition, since phosphatidylcholine is an important 
constituent of eukaryotic membranes, the cytolytic action of the 
phospholipase C might injure both inflammatory cells and lung tissue cells. 
There is, however, no direct evidence that the Legionella phospholipase C is 
cytolytic or affects eukaryotic cell membranes.
Legionellae posses a number of proteolytic enzymes and
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aminopeptidases, some of which remain bound to the organism and some of 
which are secreted into the extracellular culture medium (27). The major 
secretory protein of L. pneumophila, a zinc metalloprotease of 38 to 42 kDa, 
has tissue-destructive and cytotoxic properties, inhibits hum an phagocyte 
function, is an immunostimulatory molecule and can degrade proteins that 
may be significant to host defense mechanisms (23, 96, 42, 41, 272). L. 
pneumophila possesses both caseinase and gelatinase activities and has 
extensive amino a d d  identity and shares a similar molecular mechanism of 
proteolysis with the Pseudomonas aeruginosa elastase (32). However, its 
precise role in pathogenesis during Legionnaires' disease has not been 
eluddated. Studies using a protease-defident mutant of L. pneumophila 
have suggested that the protease is not necessary for virulence. Despite this 
evidence it has been suggested that since the mutant does produce small 
quantities of the protease, it is possible that enough enzyme is produced in 
vivo to account for the pathology seen during disease (330). Furthermore, the 
mutant and its parent strain require large aerosol doses to cause death, thus, 
the lung damage observed may be caused by other factors that may not be 
significant following challenge with lower doses of bacteria more typical of 
experimental Legionnaires' disease (42).
L. pneumophila produces LPS which has been shown to activate the 
classical complement cascade and possesses endotoxic activity; however, there 
is contradictory evidence as to the precise role of LPS in virulence. LPS is the
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major immunogenic structure on the surface of L. pneumophila and greater 
than 98% of antibody produced by patients with Legionnaires' disease is 
directed towards the LPS (142). LPS is also an activator of immune
modulating molecules such as interleukin-1(5 (IL-IP), IL-2, interferon-7  
(IFN-y) and tum or necrosis factor-a (TNF-a) from mouse spleen cultures (39,
38). The presence of these cytokine molecules are important for the duration 
and regulation of the immune system.
All Legionella species and serogroups examined express a 58 to 60 kDa 
heat shock protein (Hsp60) which contains a genus-specific epitope recognized 
by monoclonal antibodies, as well as epitopes which are cross-reactive with 
many species of gram-negative bacteria. The gene encoding this protein has 
been cloned in E. coli and its complete nucleotide sequence determined (299). 
The protein demonstrates considerable homology to the Mycobacterium 
tuberculosis 65 kDa heat-shock protein, the GroEL protein of E. coli, and 
Coxiella burnetii HtbB (211, 299). The protein is highly immunogenic and is 
the predom inant Legionella protein reactive with human convalescent-phase 
serum from patients with confirmed cases of legionellosis (40). Hoffman et 
al. (177) demonstrated that virulent, but not avirulent, strains of L. 
pneumophila respond to environmental changes associated with becoming 
intracellular. The response is characterized by a rapid increase in the 
synthesis of Hsp60 and a concomitant shift in location of Hsp60 from the 
cytoplasm and periplasm to the cell surface. Since Hsp60 is a molecular
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chaperone, it was suggested that it may interfere with phagosome membrane 
proteins involved in initiating phagolysosomal fusion (177). Although there 
is no evidence establishing the Legionella heat-shock protein as a direct 
virulence factor, it has been suggested that this protein may be important 
during the unfavorable environment inside the phagosome.
Outer membrane proteins are of interest as they come into primary 
contact with the inflammatory cells and immune system of the host. The 
major outer membrane protein (MOMP) of L. pneumophila is tightly 
associated with the LPS of L. pneumophila and shows a molecular mass 
between 24 to 29 kDa depending on the procedure used for isolation (63,172). 
The MOMP protein aggregates through the formation of interchain disulfide 
bridges (63). Gabay et al. (141) demonstrated that the MOMP of L. 
pneumophila is a cation-selective porin. Porins are a class of bacterial 
proteins capable of inserting themselves into membranes, including those of 
host cells, and opening up channels through which ions can pass. Horwitz et 
al. (182) has speculated that one mechanism by which L. pneumophila might 
inhibit acidification of the monocyte phagosome is by insertion of a proton 
ionophore, namely, the cation-selective MOMP porin, into the monocyte 
membrane. Butler et al. (63) has suggested that the MOMP in its native and 
functional form when embedded into the membrane exists as a 95 kDa 
tetrameric complex. The MOMP selectively fixes complement component C3; 
however, the precise role of the MOMP in the pathogenesis of L.
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pneumophila remains unresolved to date, however, work perform ed by 
High, Torosian and Rodgers (170), demonstrated that when a 750 base pair 
DNA fragment from the virulent L. pneumophila strain w as transformed 
into E. coli, the resulting clones expressed the Legionella MOMP and had 
increased virulence in chicken embryos compared with the parent E. coli 
strain. Further study elucidating the function in pathogenesis of the MOMP 
is of paramount importance since C3 is the major opsonin for the 
phagocytosis of L. pneumophila and modification of the MOMP might lead to 
decreased internalization of the bacterium and subsequent failure to establish 
disease.
The intracellular multiplication of L. pneumophila is iron-dependent, 
thus it requires between 3 to 13 pmoles of iron for minimal growth and up to 
20 fimoles for maximum growth compared to 0.3 to 1.6 nmoles for other 
organisms. Legionellae do not possess siderophores (276). L. pneumophila 
acquires iron from the host cell where it is derived from iron-transferrin via 
transferrin receptors, iron-lactoferrin via lactoferrin receptors and the iron 
storage protein ferritin (65, 6 6 , 64). Proteins on the organism bind lactoferrin 
and transferrin and reduce the iron stores of ferritin from Fe+++ to Fe++ by 
utilizing an iron reductase (195). The iron incorporated into L. pneumophila 
is found in seven major iron-containing proteins, one of which is an iron 
superoxide dismutase. The major iron-containing protein has an apparent 
molecular mass of 85 to 90 kDa under denaturing conditions and 210 kDa in a
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nondenaturing environment (236). Inhibition of iron by three different 
sources have been demonstrated and this effect inhibits L. pneumophila 
intracellular replication. First, the nonphysiologic and physiologic iron 
chelators, deferoxamine and apolactoferrin (65,66). Second, the weak bases 
chloroquine and ammonium chloride reduce the iron pool by blocking the 
pH-dependent release of iron from endocytized iron-transferrin and the 
pH-dependent proteolysis and release of iron from iron-lactoferrin and 
ferritin (64). Third, EFN-y reduces iron availability by down-regulating 
transferrin receptor expression and intracellular ferritin concentration (65).
1.3.4 Epidem iology. L. pneumophila and other members of the 
Legionellaceae are nearly ubiquitous in fresh water environments including 
lakes and ponds. However, in these natural water sources, legionellae are 
present in low concentrations. Amoebae appear to play a critical role in the 
amplification process of L. pneumophila (18, 119, 296). Biofilms, common in 
plumbing systems, also contribute in supporting the growth of many bacteria 
including L. pneumophila (291). Aquatic biofilms, which are widespread not 
only in nature but also in medical and dental devices, can be the source of 
serious nosocomial infections. Barbeau et al. (19) demonstrated that in these 
microbial communities, pathogens such as nontuberculous mycobacteria, 
Pseudomonas aeruginosa and L. pneumophila not only survive but 
proliferate in  biofilms. The mode of transmission of legionellosis is
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inhalation of Legionella-contzuninated aerosolized water droplets of 
respirable size (5-15 (im). From an epidemiological perspective, the major 
sources of Legionella contamination include air-conditioning evaporative 
condensers, cooling towers, humidifiers, nebulizers, showerheads, whirlpool 
spas, decorative fountains and vegetable misting machines (4, 45, 49,117, 79, 
92,138,145).
Males between the ages of 40-70 are more likely to acquire Legionnaires' 
disease than are females while infections in children are rare. Predisposing 
factors for disease include increased age, heavy smoking, previous lung 
disorders, high alcohol intake and diabetes. Individuals who are 
immunocompromised due to chemotherapy or chronic illness such as 
lymphomas, leukemia and AIDS are also at greater risk (33, 90, 226).
Legionella species cause 1 to 5 % of all cases of diagnosed pneumonia, 
although rates as high as 30 % have been reported (113). Data from a large, 
ongoing, population-based study of community-acquired pneumonia 
requiring hospitalization indicate that the annual rate of non­
outbreak-related, community-acquired Legionella infection is 6.1/100,000 
population per year (227). Extrapolation of the rate from this study conducted 
in Ohio to the adult population in the United States is problematic as the 
incidence of infection may vary by region. However, the rate translates to an 
estimated 11,000 cases of community-acquired Legionella-associated 
pneumonia requiring hospitalization yearly in the United States (227). This
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figure is an underestimate of the actual incidence of legionellosis as a 
substantial proportion of patients may not be hospitalized; indeed, some 
patients infected with Legionella species may not have pneumonia and 
serology, urinary antigen detection and culture are not 1 0 0  % sensitive.
Legionnaires' disease shows a world-wide incidence and can occur as 
epidemics, sporadic cases and nosocomial infections. Epidemic legionellosis 
has been reported in many countries including the United States, Great 
Britain, Spain, Australia, The Netherlands, Germany, Sweden, France, 
Canada and Italy. The incidence of disease is higher in the summer months 
of July, August and September. The incidence of Pontiac fever is poorly 
understood and difficult to assess as it presents as a self-limiting influenza­
like illness and usually goes undiagnosed. Each year 1000-1300 cases of 
Legionnaires' disease are reported to the CDC in the United States (Figures 1.1 
and 2.1). This however, may reflect a major underestimate in the incidence 
of disease. Although the organism was identified in 1977, many cases go 
unrecognized because Legionella is only detectable on special media that are 
not regularly used for the screening and diagnosis of pneumonia agents. 
Estimates of the incidence of legionellosis have ranged from 10,000 to 100,000 
cases annually in the United States (184). L. pneumophila serogroup 1 is 
responsible for 85 % of all reported cases of community-acquired legionellosis 
while L. micdadei causes approximately 6  % (362).
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Figure 1.1: Total number of cases of legionellosis as reported by the Centers 
for Disease Control and Prevention (CDC) Atlanta, GA.. Adapted from C.D.C. 
Morbidity and Mortality Weekly Reports, Summary of Notifiable Diseases, 
United States 1997.
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Figure 1.2: Total number of cases of legionellosis per 100,000 as reported by 
each state as documented by Centers for Disease Control and Prevention 
(CDC) Atlanta, GA.. Adapted from C.D.C. Morbidity and Mortality Weekly 
Reports, Summary of Notifiable Diseases, United States 1997.
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1.3.5 D iagnosis. L. pneumophila is a pneumonic pathogen exhibiting 
clinical symptoms similar to other pneumonic agents, thus making clinical 
diagnosis difficult. Failure to stain with traditional gram stain techniques and 
difficulties in growing the organism pose a problem for proper diagnosis of 
Legionella pneumonia. The mainstay of diagnosis in determining the
presence of Legionella, is culture in that organisms grown on BCYE-a agar 
supplemented with L-cysteine but not on unsupplemented blood agar are 
presumptive for legionellae. Sensitivity of culture is between 50-80% but the 
specificity is 100 % (99, 360, 375). Selective media have been developed for the 
cultivation of Legionella organisms from clinical specimens that are likely to
contain other microorganisms. These include BCYE-a agar with added 
cefamandole, polymyxin B and anisomydn (99) or alternatively glycine, 
vancomycin, polymyxin B and anisomycin (351). These media reduce the 
numbers of contaminants that would otherwise quickly overgrow the slow 
growing legionellae. Infection can be diagnosed by serologic means using 
both direct or indirect immunofluorescence to detect antibody in patient sera 
(100,114, 237). Immunoassays use a specific monoclonal or polyclonal 
antibody to probe for the presence of bacterial soluble antigens in specimens. 
Legionella soluble antigens present in respiratory tract secretions, sputum, 
serum and especially in urine have been detected by enzyme-linked 
immunoassays, radioimmunoassays and latex agglutination and 
microagglutination tests (207, 206, 2 1 2 , 301, 300, 357). Commercially available
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urinary antigen kits as both enzyme and radioimmunoassays exist (160). 
Nuclei ad d  probes have been developed to detect L. pneumophila in clinical 
and environmental samples (300). A 125I- labelled cDNA probe is 
commercially available and hybridizes with the highly conserved 16S rRNA 
from Legionella and the resultant RNA-DNA duplexes are assessed by a
y-counter. The polymerase chain reaction has been used for the detection of
Legionella antigens by adding the mip gene and the gene encoding 5S rRNA 
to Legionella DNA probes to improve their sensitivity (25)(219).
1.3.6 Treatm ent. As legionellae are facultative intracellular pathogens 
the effectiveness of antibiotics relies on the membrane transportability of the 
antibiotic in question. Only those antibiotics that possess high lipid solubility 
and are able to penetrate host cell membranes to gain access to the pathogen 
within the cytoplasm of infected target cells are effective. For this reason, 
macrolides have proven the most efficacious in treating Legionnaires' 
disease. The most widely used macrolide is erythromycin (106, 163).
However, this antibiotic is not well tolerated by many individuals and results 
in peripheral phlebitis and intestinal distress. Recently, novel macrolide 
compounds in the ketolide class (semisynthetic derivatives of erythromycin) 
have been show n to be effective against L. pneumophila both in vitro and in 
vivo (103). O ther clinically effective antibiotics include rifampin, doxycycline, 
co-trimoxazole and members of the 5 -fluoroquinolones, such as ciprofloxacin
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(217, 290). Tzianabos and Rodgers (345) have extensively investigated the in 
vitro effects o f ciprofloxacin and demonstrated that this antibiotic was 
effective against intracellular bacteria. In contrast, many microbial agents, 
including the p-lactams and aminoglycosides have no role in the treatment of
Legionella infections (14, 201). In the absence of effective antimicrobial 
therapy, prognosis is poor. Contrary to in vivo situations, Legionella isolates 
are susceptible to a plethora of antibiotics in vitro (101, 228, 285).
1.3.7 Im m unity and the imm une response. Legionnaires' disease is 
more common and  more severe when cell-mediated immunity is impaired, 
particularly in the setting of corticosteroid therapy and in individuals who 
either have an immunodeficiency or are immunocompromised due to drugs 
used for transplants or because of other co-existing conditions that affect the 
immune system such as that associated with AIDS (33, 90, 157, 226). During 
the last decade there has been considerable research defining some of the 
underlying mechanisms involved in the immune response to L. 
pneumophila. Cell-mediated immunity rather than humoral immunity is 
suggested to play a central role in host defense mechanisms against L. 
pneumophila as is the case with other facultative intracellular organisms 
such as Mycobacteria, Leishmania and Listeria (135, 178, 362). The 
development of a cell-mediated immune response leads to activation of 
macrophages to resist intracellular pathogens and is likely an essential host
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response to these organisms. Although the effector mechanisms of 
cell-mediated im m unity to L. pneumophila in the lung have not been 
established, in vitro studies have shown that lymphokine-activated 
monocytes and macrophages inhibit the intracellular growth of L. 
pneumophila (31, 194, 250, 249). It has been suggested that T cell-mediated 
immunity begins to operate early during L. pneumophila infection in guinea 
pigs and that protective immune responses to L. pneumophila involve T cell- 
mediated delayed-type immune responses (50, 253). Cell-mediated immunity 
based on lymphocytes reacting with the organisms and cytokines produced by 
such lymphocytes are important in resistance. Vaccines prepared from killed 
Legionella or their components readily induce cell-mediated immunity (137). 
However, patients who recover from Legionella infections do develop 
antibody of both the IgG and IgM class. Antibody titers increase rapidly after 
exposure of individuals to these bacteria either by infection or immunization 
(137). Antibody promotes the phagocytosis of the bacteria by monocytes, 
alveolar macrophages and PMNLs, but does not promote complement- 
mediated killing of L. pneumophila in vitro (136). Thus, antibody produced 
against Legionella may not be protective and the net result is more bacteria 
gain access to the intracellular environment in which they multiply. 
Antibody-coated bacteria multiply at the same rate as bacteria phagocytosed in 
the absence of antibody.
To investigate the role of cell-mediated immunity in host defense
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against L. pneumophila, Horwitz et al. (178) demonstrated that human 
monocytes activated by incubation w ith concanavalin A and human 
lymphocytes inhibited the intracellular multiplication of L. pneumophila. In 
addition, monocytes activated by incubation with cell-free filtered 
supernatant from concanavalin A-sensitized mononuclear cell cultures also 
inhibited the intracellular growth of L. pneumophila (178). This inhibition 
occurred in two ways, first, the monocytes phagocytozed fewer bacteria and 
they slowed the rate of intracellular multiplication of bacteria that were 
internalized. These findings demonstrated that human monocytes could be 
activated to inhibit the replication of L. pneumophila. Thus, inhibition of L. 
pneumophila was accomplished by activating the monocytes and not by 
coating the bacteria with antibody and complement.
Lymphocyte sensitization to L. pneumophila antigen has been 
demonstrated in humans and laboratory animals recovering from 
legionellosis, and lymphokine-activated mononuclear phagocytes inhibit the 
replication of L. pneumophila in vitro. Several lymphokines are able to 
activate macrophages such that they exert an enhanced antimicrobial effect. 
IFN-y is one of the major macrophage activating factors produced by 
lymphocytes for induction of anti-Legionella activity (38, 203, 249, 369). In 
addition, TNF-a has been shown to promote the anti-Legionella activity of 
neutrophils (38). It has been shown that IFN-y treatment of murine
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macrophages collected after infection w ith the protozoa Leishmania (164, 165), 
Trypanosoma (147), Toxoplasma (148, 158) and Schistosoma (148) as well as 
the bacteria, Listeria (251)and Mycobacteria (373), enhances antimicrobial 
activities for these pathogens. These cytokines and others play a crucial role 
in modulating the immune response of m any facultative intracellular 
bacteria, including M. tuberculosis, L. monocytogenes, Brucella abortus and S. 
Typhimurium (373,197,238, 251,343,196, 251).
In light of the high mortality rate associated with Legionnaires' disease, 
especially in immunocompromised individuals and the shortcoming of 
antibiotic therapy, alternative therapeutic strategies are being sought. Such 
alternates includes vaccination, immunotherapy and cytokine therapy to 
augment the current antimicrobial treatments available. One such avenue 
involves the use of naturally occurring host molecules or response systems, 
specifically cytokines, to amplify the crucial host response to combat this 
disease. Cytokines are a class of soluble low molecular weight glycoproteins 
that possess a number of properties including mediating cell-to-cell 
communication during an immune response. Membrane-bound forms have 
also been described for many cytokines (81, 111). Cytokines are comprised of 
several groups of molecules including interleukins, lymphokines, 
monokines, interferons, colony-stimulating factors and a variety of other 
proteins (9, 81). Initially it was thought that these molecules were produced 
exclusively by leukocytes, lymphocytes, and monocytes; however, epithelial
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and endothelial cells secrete some as well (81, 216). Cytokines exhibit 
synergistic, antagonistic, redundant and pleiotropic properties (9, 216). 
Through these attributes this diverse group of molecules mediates, 
m a in ta in s , regulates and dictates the intensity and duration of the immune 
response in a coordinated, interactive way by modulating the activity of 
immune effector cells. The effects of cytokines on target cells are exerted by 
binding to specific membrane bound cytokine receptors which function as 
ligand binding and signal transduction moieties (81,112, 111, 216, 239). The 
cellular consequences of ligand binding are diverse and involve the 
induction of gene transcription of cytokine encoding genes, as well as a 
diverse set of responses associated with cellular proliferation and 
differentiation (9). It has been suggested that the sharing of receptor subunits 
may in part reflect the redundant functions of cytokines (81, 1 1 1 ).
Functions of immune cells are finely coordinated to ensure an 
adequate response to an antigenic stimulus, and part of this coordination is 
mediated by secreted cytokines. Cytokines regulate the immune response by 
stimulating or alternatively inhibiting the proliferation of various cells or the 
secretion of antibodies or other cytokines. The development of an effective 
immune response involves lymphoid and inflammatory cells and other 
hematopoietic cells (134). Cytokines are secreted by various cells in the 
immune response such as T cells.
T cells can be subdivided based on their expression of CD4 or CD8
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membrane molecules. The CD4+ T cells recognize antigen in association with 
major histocompatibility class II molecules (MHC) and largely function as 
helper cells, whereas CD8 + T cells recognize antigen in association with MHC 
class I molecules and largely function as cytotoxic cells (241). CD4+ helper T 
cells exist as two types in the mouse and are referred to as Thl and Th2 cells 
(241). Thl and Th2 cells show distinct patterns of cytokine production and
effector function. Thl cells secrete IL-2, TNF-6 , and IFN-y and are the 
principal effectors of cell-mediated immunity against obligate or facultative 
intracellular pathogens and of delayed type hypersensitivity reactions (242, 
243). Murine Thl cells can also stimulate production of antibodies of the 
IgG2a class, which are effective at activating complement and opsonizing 
antibodies for phagocytosis. Th2 cells on the other hand produce IL-4 which 
stimulates IgE and IgGl antibody production, IL-5, IL-10 and IL-13, which 
together with IL-4 downregulate macrophage functions (242). Th2 cell 
responses are associated with humoral immunity. Both classes of Th cell 
clones produce TNF-a, IL-3 and granulocyte macrophage colony stimulating
factor (GM-CSF). In addition to Thl and Th2 cells, CD4+ Th cell subsets with a 
less differentiated cytokine profile than Thl and Th2 cells, designated ThO 
usually arise in the absence of clearly polarizing signals (325). It has been 
proposed that ThO cells likely dominate the earliest stages of some responses 
and mediate intermediate effector functions, depending upon the spectrum
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and concentrations of cytokines produced and the nature of the responding
cells. ThO cells produce IL-2 , IL-3, IL-4, IL-5, IFN-y, TNF-a and GM-CSF (325).
There is increasing data to support the view that these subpopulations also 
exist in humans (8 8 , 298). Human Thl and Th2 cells produce similar patterns 
as seen in the mouse, although synthesis of IL-2, IL-6 , IL-10 and IL-13 is not as 
tightly restricted to a single subset as in murine T cells (243). The secreted 
cytokines of Thl and Th2 cell types can mutually regulate and inhibit each
other's functions. For example IFN-y selectively inhibits proliferation of Th2 
cells and IL-10 inhibits cytokine synthesis by Thl cells (125, 242). It has been 
suggested that this cross regulation may partly explain the strong biases 
towards Thl or Th2 responses during many infections in mice and humans. 
Therefore, the fine balance between the secreted cytokines is important for the 
resulting nature of host resistance against pathogens.
Thl and Th2 patterns of cytokine secretion correspond to activated 
effector phenotypes generated during an immune response. They do not exist 
among naive T cells. When first stimulated by antigen on antigen presenting 
cells, naive CD4+ T cells principally or entirely produce IL-2 and then 
differentiate into phenotypes that secrete other cytokines (328). Seder et al. 
(305) demonstrated that Thl and Th2 cells can both be derived from a single 
precursor cell. IL-4 stimulates differentiation into Th2 cells, whereas IL-12
and IFN-y enhance Thl development (328). The factors that play a role in
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driving naive CD4+ T cells toward Thl or Th2-dominated populations 
include the type of antigen-presenting cells, the nature and am ount of 
antigen, and other microenvironmental factors, such as hormones and 
cytokines (305,189). In addition, the co-stimulatory proteins B7-1 and B7-2, 
located on the antigen-presenting cell, play important roles in initiating 
Thl/Th2 determination; however, their actions are more permissive than 
direct. For example, by initiating IL-4 production, B7-2 can have an effect that 
leads to Th2 cell development. Since B7-1 does not elicit IL-4 production, it 
leaves the cell open to other influences, such as IL-12 produced by 
macrophages. Kuchroo et al. (209) showed that anti-B7-l added to an in vitro 
assay of mouse T cell differentiation led to increased production of IL-4 while
anti-B7-2 led to greater IFN-y production. Using human cells, Freeman et al. 
(133) also showed non-identical co-stimulatory signals from B7-1 and B7-2. 
Development of the appropriate Th subset during an immune response 
against offending agents is important because certain pathogens are more 
effectively controlled by either a predominantly Thl or Th2 type immune 
response.
To date a detailed understanding of the host immune response to L. 
pneumophila has been ham pered due to the lack of relevant systems to study 
infection. Several investigators have used in vitro systems to begin to 
elucidate the production of cytokines elicited by L. pneumophila or its 
antigens during infection of cells in vitro. Studies have demonstrated the
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importance of the macrophage-L. pneumophila interaction to allow L. 
pneumophila to persist in the lung (55, 57, 250). Furthermore, it is widely 
accepted that a cell-mediated host response is crucial to resolution of 
Legionnaires' disease (178, 369). Investigators have used a variety of in vitro 
models to study cellular infection by L. pneumophila and these include cells 
of human and non-human origin (224,153, 187, 267, 368). Based on the 
nature of the disease process and the fact that L. pneumophila is a facultative 
intracellular pathogen, recent investigations have focused on understanding 
the interactions of L. pneumophila with the host's immune system.
L. pneumophila attachment to murine peritoneal macrophages has 
been shown to increase certain cytokine and chemokine mRNA levels (371). 
Legionella as well as purified antigens from this organism induce secretion of
specific proinflammatory and immunoregulatory cytokines, such as IL-1|3 and
IFN-y respectively from a variety of cells including murine peritoneal, splenic 
and pulmonary macrophages as well as human peripheral blood monocytes 
and lymphocytes (203).
It is proposed that the resolution of Legionella infection is facilitated by 
activation of macrophages which subsequently resist Legionella infection. 
IFN-y is a major macrophage activating factor and has been shown to activate 
human and rodent alveolar macrophages and monocytes to inhibit the 
growth of L. pneumophila in vitro but does exhibit bactericidal activity
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against L. pneumophila (65, 31,149,194, 249, 313, 314). In addition to IFN-y, 
proinflammatory cytokines have been shown to play a role in infectious 
diseases. TNF-a participates in the cytokine cascade during the immune
response, acting synergistically with IFN-y. In addition, TNF-a has been 
shown to activate mononuclear phagocytes and rodent macrophages to 
inhibit intracellular parasites and to potentiate the antimicrobial action of 
IFN-y (197, 314). L. pneumophila induces secretion of TNF-a in vitro and L.
pneumophila infection leads to in vivo production of TNF-a, suggesting a
potential role for this cytokine in host resistance to legionellosis (11, 37, 38). 
In contrast to activated monocytes and alveolar macrophages, PMNLs
activated by IFN-y and TNF-a have been shown to have an enhanced ability
to kill L. pneumophila (38).
In addition to protective cytokines, such as IFN-y and TNF-a
immunosuppressive cytokines such as IL-10 are able to downregulate IFN-y
and TNF-a production which leads to exacerbated infection in many diseases
(164,173, 261, 293, 309). This effect has been seen with M. leprae, in which IL- 
1 0  is triggered in lepromatous patients with ineffective immune responses 
but not in tuberculoid leprosy patients that have an effective immune 
response (183). Thus, host resistance depends on the ability of the immune 
system to m ount the appropriate cell response to the intracellular bacteria.
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Indeed, a cell-mediated immune response with a predominantly Thl type 
cytokine pattern is crucial to recovery. Inhibitory cytokines have been shown 
to exhibit important deactivating effects on macrophages in murine models 
of infections due to Leishmania (22) Trypanosoma (310) Toxoplasma and 
Schistosoma (148) as well as, Listeria (343) and Mycobacteria (21, 20, 327) 
infections. Furthermore, IL-10 exacerbates L. pneumophila infection within 
resident alveolar macrophages and monocytes (264).
These data accumulated to date for cytokine production following 
Legionella infections has been obtained primarily using in vitro 
experimentation. The use of single cell systems provide limited insight into 
the complex interactions involved during infection of an animal host. 
Modulation of the immune system with cytokines requires a fine balance and 
specific interplay between cytokines and host cells in the immune response 
that cannot be accounted for by using single-cell systems. Animal models 
provide a means of testing theories of the pathogenesis of diseases such as L. 
pneumophila pneumonia as well as the potential value of therapeutic 
interventions.
Historically, guinea pig (132), rat (315) and hamster (263) models have 
been used to study the progression of Legionnaires' disease, but have not been 
useful for studying the host immune response to L. pneumophila infection, 
in part, due to a lack of specific immunologic reagents for these animal 
species. The use of animal models, primarily the guinea pig, have yielded
58
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
insight into the underlying processes that occur following inhalation of L. 
pneumophila into the respiratory tract and have confirmed the host cellular 
responses to L. pneumophila challenge. Yamamoto et al. (370) established 
that peritoneal macrophages of A /J mice supported L. pneumophila 
replication, whereas peritoneal macrophages from other mouse strains 
including BALB/c, BDF1, C3H/HeN, C57BL/6 and DBA/2 were resistant to 
Legionella replication. Prior to these studies it was believed that mice were 
uniformly resistant to L. pneumophila infection and thus represented a poor 
model for studying Legionnaires7 disease.
In recent years there has been an upsurge in interest to better 
understanding the host immune response, particularly the role that cytokines 
play, in regulating systemic infection. To date there is limited information 
regarding the production of cytokines during L. pneumophila infection in 
animal models. Brieland et al. (55) developed a surgical model of 
Legionnaires7 disease pneumonia using the A /J mouse which has been 
shown in many ways to closely mimic the development of human disease. 
Furthermore, the abundance of immunologic reagents for the mouse has 
allowed subsequent study at the molecular level of the host7s immune 
response in the lung following L. pneumophila infection.
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CHAPTER n
ADHERENCE OF LEGIONELLA PNEUMOPHILA TO HOST CELLS AND THE 
ROLE OF THE 25 kDa MAJOR OUTER MEMBRANE PROTEIN OF L.
PNEUMOPHILA IN  ATTACHMENT TO U-937 CELLS.
(A portion of the work outlined in this section has been published as: Krinos, 
C., A. S. High and F. G. Rodgers. 1999. "Role of the 25 kDa major outer 
membrane protein of Legionella pneumophila in attachment to U-937 cells 
and its potential as a virulence factor for chick embryos". /. Applied 
Microbiol. 86:237-344.
2.1 Abstract
Adherence of Legionella pneumophila to alveolar macrophages is a 
necessary prelude to infection in the lung. The attachment of the organism to 
U-937 cells, A549 cells and primary explants of thioglycollate-elicited 
peritoneal macrophages from A /J mice was investigated in a opsonin- 
independent system. Bacterial attachment to host cells was determined by 
viable bacterial cell colony (VBCC) counts and indirect immunofluorescence 
assay (IFA) methods. L. pneumophila attached to the three cell types 
investigated in the absence of opsonins and maximum binding occurred at a 
multiplicity of infection (MOI) of 100. Following these initial adherence
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studies, U-937 cells were used further to investigate the role of the 25 kDa 
major outer membrane protein (MOMP) present on the surface of L. 
pneumophila as an adhesin for the organism. The gene encoding the 25 kDa 
MOMP of L. pneumophila was previously transformed into Escherichia coli 
JM 83 and the resultant £. coli LP 116 clone was shown to express the 
Legionella-MOMP. Compared with the parent £. coli JM 83 strain, the £. coli- 
LegioneZZa-MOMP-containing clone showed a 5-fold increase in opsonin- 
independent binding to U-937 cells as assayed by both VBCC counts and IFA 
techniques. In addition, the clone showed enhanced virulence for chick 
embryos. These studies suggest that the 25 kDa MOMP of L. pneumophila 
functions as an adhesive molecule for host cells and serves as a virulence 
factor for the organism.
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2J2 Introduction
Legionella pneumophila is a gram-negative, facultative intracellular 
pathogen responsible for a necrotizing, lobar pneumonia known as 
Legionnaires' disease. The bacterium is capable of replicating in a variety of 
cell types, yet primarily parasitizes alveolar macrophages during human 
disease (250).
Attachment of bacteria to host cells is usually quite specific and is 
determined by the presence of specific ligand or adhesin molecules on the 
surface of the microorganism that recognize receptors on host cells (24). As 
such, binding is regarded as a prerequisite for tissue invasion and infection 
and this initial interaction has been the subject of numerous reports 
including those on Neisseria spp., Escherichia coli, Vibrio cholerae, 
Pseudomonas aeruginosa and Streptococcus spp. (91, 123, 257, 270, 366). In 
these investigations some of the factors responsible for disease initiation have 
been defined. Many pathogens possess pili, fimbriae, capsular 
mucopolysaccharide, flagella, lectin-like molecules, and OMPs all of which 
have been implicated in bacterial attachment to host cells (91,123, 287, 317). 
Several factors contribute to the attachment process, including availability of 
appropriate receptors, attractive and repulsive forces (van der Waals forces), 
pH and the hydrophobicity of the interacting membranes (24, 104). Binding 
can be divided into a two step process in which a preliminary or weak binding 
event is followed by a firm highly specific attachment process. Several
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pathogenic bacteria use a group of highly conserved immune system-specific 
receptors known as integrins, specifically those of the (31 and (32 subsets, to
gain entry into various cells (8 , 26, 82,192, 274, 303). The (31 integrins are used
by organisms that either possess invasin on their surface while the (32 group, 
which includes complement receptor type 3 (CR3) are used by organisms that 
directly bind to these cells in the presence or absence of complement or 
immune modulators (8 , 26, 93,155,192, 286, 303).
Two mechanisms of attachment have been proposed for L. 
pneumophila; opsonin-dependent (26, 266) and opsonin-independent 
systems (154, 286). Opsonins are molecules that enhance phagocytosis and 
include antibody and complement which facilitate antigen clearance. Thus, 
in a complement-mediated system, antibody and complement bind to 
bacterial surfaces increasing the engulfment of the antigen by macrophages.
In the complement-mediated system, complement receptors CR1 and CR3 on 
human professional phagocytes that recognize complement fragments C3b 
and C3bi respectively mediate phagocytosis of L. pneumophila (26, 266). The 
mechanism of direct recognition of bacteria by macrophages in the absence of 
opsonic components is not well defined. However, given the low opsonic 
components present in the lung, an opsonin-independent mechanism of 
attachment may be critical for disease establishment (277). It has been 
hypothesized that organisms which enter host cells via this system are able to
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survive the antimicrobial processes induced in the cell by the 
opsonin-mediated event and that these continue to grow and cause severe 
disease. This non-opsonic, direct binding type of recognition has been 
established for many pathogens, such as M. tuberculosis , group B streptococci 
and Yersinia pseudotuberculosis and may represent a crucial mechanism for 
disease establishment (8 , 82,191). Indeed, there is evidence that the 
intracellular fate of pathogens is dictated by the initial mode of attachment 
(82,346,359,366).
The outer membrane content of Legionella has been explored to 
determine if a single factor is responsible for uptake and intracellular 
survival of the organism and several genes have been identified that are 
responsible for intracellular survival, evasion of endocytic pathways and 
killing of host cells (48, 74, 271, 350). Although reports have varied as to the 
commonality of various proteins across strains of L. pneumophila and 
Legionella species, some L. pneumophila serogroups do contain a single 
MOMP that ranges in mass between 24 to 29 kDa (63, 170, 172). Butler and 
Hoffman (62) have also reported the presence of 28 and 31 kDa outer 
membrane proteins (OMP) in L. pneumophila.
In the complement-mediated system, the MOMP of L. pneumophila 
has been shown to selectively fix the complement component C3 and this 
facilitates uptake by complement-mediated phagocytosis (26). Gibson et al. 
(154) showed that treatment of host cells with monoclonal antibodies (MAb)
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specific for CR1 (CD35), CR3 (CD llb + CD18) and CR4 (CD llc + CD18) to block 
these receptors or their sub-units did not interrupt bacterial attachment or 
intracellular replication. The target cell for L. pneumophila infection during 
human disease is the alveolar macrophage, thus, this cell is ideal for studying 
Legionella-host interactions; however, obtaining these cells is extremely 
difficult. A wide variety of eukaryotic cells have been shown to support L. 
pneumophila replication in vitro (188, 202, 224, 250, 286) Pearlman et al. (267) 
demonstrated that the transformed macrophage-like U-937 cell, established 
from a human histiocytic lymphoma, supported the intracellular survival of 
L. pneumophila. L. pneumophila possess pili, fimbriae and flagella and as 
suggested by Rodgers (287), these may potentiate binding by overcoming the 
gap between the negatively charged surfaces of the invading pathogen and the 
host cells. In addition, Oldham and Rodgers (258) have investigated L. 
pneumophila interaction w ith HEp-2 cells, Vero cells and MRC-5 cells, the 
later being of human embryonic lung origin. It was demonstrated that L. 
pneumophila attachment to cells resulted in thickening of eukaryotic cell 
membranes and proliferation of microvilli leading to bacterial endocytosis, 
referred to as "bacteriopexis".
In the present study, the first objective was to investigate opsonin- 
independent adherence of L. pneumophila using two hum an transformed 
cell lines (U-937 and A549) and a primary murine cell (A /J peritoneal 
macrophages) as a potentiator for infection. U-937 cells are transformed
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macrophage-like cells, established from a human histiocytic lymphoma (326) 
and A549 cells are human transformed cells derived from explant cultures of 
lung carcinomatous tissue (151) and have been characterized as type II 
pneumocytes (215). Following these experiments the role of the MOMP of L. 
pneumophila as a direct adhesin to U-937 cells was investigated using a 
recombinant clone which expresses the MOMP. Adherence assays were 
evaluated by both VBCC counts and IF A assays and the ability and number of 
bound organisms following adherence was determined. Studies to elucidate 
the bacterial adhesin of L. pneumophila may serve to assist in development 
of novel strategies for the prevention and control of Legionnaires' disease, 
especially in high risk groups. Anti-adherence vaccines and purified 
adherence molecules used in a competitive fashion were evaluated by 
Beachey (24) and yielded promising results.
2.3 Materials and Methods
Reagent formulations and preparation along with detailed procedures are 
given in Appendix 1.
2.3.1 Organism Cultivation:
Legionella pneumophila. L. pneumophila serogroup 1 , strain 
Nottingham 7 is a highly virulent clinical isolate from a fatal case of 
Legionnaires' disease. The organism was initially isolated from sputum  on
66
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
low sodium, enriched blood agar. Colonies were sub-cultured once on 
buffered charcoal yeast extract agar supplemented w ith L-cysteine, ferric
pyrophosphate and a-ketoglutarate (BCYE-a) and stored as stock cultures 
frozen at -70°C in 1 % serum sorbitol (Appendix 1). Thawed aliquots were 
inoculated onto BCYE-a and incubated for 72 h at 37°C. Colonies were 
harvested, placed into buffered yeast extract broth supplemented with L- 
cysteine, ferric pyrophosphate and a-ketoglutarate (BYE-a) at a density of 
IxlO6 CFU (colony forming units)/m l and bacteria were grown for 24 h at 
37°C with shaking, yielding approximately IxlO10 C FU /m l as determined by 
VBCC counts. L. pneumophila were harvested from broth by centrifugation 
at 6,000 x g in a Beckman Microfuge 12 (Beckman Instruments, Palo Alto,
CA.), washed three times with Hanks Balanced Salt Solution (HBSS) (Cellgro, 
Hemdon, VA.) and adjusted to 5xl09 CFU/ml. Serial 10-fold dilutions were 
made from 5xl09 to 5x10s in order to yield the various bacteria to host cell 
ratios. For subsequent adherence assays bacteria were adjusted to 5xl07 
CFU/ml. The ratio of bacteria to cells was approximately 100:1 for all cell lines 
used in these experiments. A MOI of 100 was chosen because bacterial 
binding experiments using U-937 cells confirmed previously established data 
conducted in our laboratory that an MOI of 100 reached near maximal binding 
capacity to host cells. In addition, bacterial binding experiments were 
performed using A549 and murine peritoneal macrophages with similar
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results.
Escherichia coli TM 83 and E. coli IM  83 LP done 116. E. coli JM 83 (JM 
83) is a laboratory strain with the ability to express doned fragments and 
supports the multiplication of extra-chromosomal elements. £. coli JM 83 LP 
done 116 (LP 116) is a genetically mutated derivative of E. coli JM 83 generated 
in our laboratory by High et al. (170) using pUC 19 as a vector. This strain has 
been shown to express the MOMP of L. pneumophila and is resistant to 
ampidllin. The clone was grown on nutrient agar or in nutrient broth 
containing 50 jig /m l ampidllin (Appendix 1). All strains were stored frozen 
at -70°C in serum sorbitol. JM 83 or LP 116 were thawed and inoculated onto 
nutrient agar and allowed to grow for 24 h  at 37°C. A 100 (il aliquot of 
nutrient broth suspension of JM 83 (62 Klett units) or LP 116 (60 Klett units) 
was added to 5 ml sterile nutrient broth (5x10s CFU/ml). These suspensions 
were incubated in a shaking incubator for 6  h  (JM 83) or 8  h (LP 116) at 37°C 
and adjusted to give approximately 5xl07 CFU/m l prior to adherence assays.
2.3.2 Eukaryotic Cell Growth and Maintenance:
U937 cells. U-937 cells (ATCC, Rockville, MD) express macrophage-like 
characteristics w hen treated with phorbol esters (267). The cells were 
maintained as replicative, non-adherent monocyte-like cells grown in 
RPMI-1640 (Cellgro) supplemented with 10 % heat-inactivated fetal bovine 
serum (FBS) (Sigma, St. Louis, MO.) and 3 mM L-glutamine (Sigma)
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(Appendix 1). For adherence assays, cells were grown to l-2xl06 cells/m l in 
T-75 cm2 flasks (Costar, Cambridge, MA.) and harvested by centrifugation at 
250 x g for 10 min at 4°C. Cells were then resuspended in 1 ml fresh medium 
and counted using trypan blue vital stain (0.04 %). Cells were then adjusted 
to IxlO7 cells/m l in fresh medium, treated with phorbol 12-myristate 
13-acetate (PMA) (Sigma) (final concentration of 10'8 M) and cultured for 24 h 
at 37°C with 5 % COz in T-75 cm2 flasks. Adherent cells were washed three
times with HBSS, physically removed from the culture flasks by gentle 
scraping with a silicon rubber-coated glass rod and resuspended in fresh 
medium to 5x10s cells/m l for VBCC counts. A 1 ml aliquot of this 
suspension was placed into each well of 24-well cell culture plates (Costar) 
and allowed to re-adhere for 24 h. For IFA assays, U-937 cells were adjusted to 
IxlO6 cell/ml and 2 ml of the suspension was placed into 6-well plates 
containing 484 square mm glass coverslips and were allowed to readhere for 
24 h at 37°C with 5 % COr
A549 cells. A549 cells, an epithelial, adherent cell line characterized as 
human type II pneumocytes, were obtained from ATCC and maintained in 
HAM's FK12 m edium supplemented with 10 % FBS and 3 mM L-glutamine 
(Appendix 1) in T-75 cm2 flasks. For bacterial attachment assays, adherent 
cells were washed three times with HBSS without Ca++ or Mg++ and treated 
with trypsin-EDTA (Cellgro) solution for 1 minute. Fresh medium was added
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and cells were collected and centrifuged at 250 x g for 10 min at 4°C, 
resuspended in 1 ml fresh medium and counted using trypan blue vital stain. 
Cells were distributed into 24-well cell culture plates at 5x10s cells/ml and 
allowed to re-adhere for 2 h  at 37°C with 5 % CC>2. For IFA assays, 2 ml of a
IxlO6 cell/ml suspension was placed into 6-well cell culture plates containing 
484 square mm glass coverslips and cells were allowed to re-adhere for 2 h.
A/T mice peritoneal macrophages. A colony of A /J mice was 
established at the University of New Hampshire animal facility by breeding 
siblings from the same liter Jackson Laboratories, Bar Harbor, Maine). Mice 
received food and water ad libitum and were housed, cared for and bread in 
accordance with NEH and University of New Hampshire animal care and use 
committee guidelines under ACUC protocol # 960905. Mice 6-8 weeks old 
were injected intraperitoneally with 2 ml of a 3 % Brewer's thioglycollate 
solution 3 days prior to harvesting macrophages. Mice were humanely 
euthanized by C 02 asphyxiation, and peritoneal macrophages were collected
by injecting 10 ml of HBSS without Ca++ and Mg++ into the peritoneal cavity 
using a 26-gauge needle. Fluid was retrieved from the peritoneal cavity using 
an 18-gauge needle and all fluids were pooled into a 50 ml conical tube and 
centrifuged at 250 x g for 10 min at 4°C. Cells were washed three times with 
HBSS, resuspended in RPMI-1640 supplemented with 10 % heat-inactivated 
FBS and 3 mM L-glutamine. Cell suspensions were counted and cells were
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distributed into either 24-well or 6-well cell culture plates at 5x10s cells/ml or 
IxlO6 cell/ml respectively and allowed to re-adhere for 2 h at 37°C with 5 %
2.3.3 Adherence Assays:
L. pneumophila was grown in BYE-a broth for 24 h as described in
section 2.3.1. Following washing steps w ith HBSS, for eukaryotic cells and 
bacteria, bacteria w ere diluted in serum-free HBSS corresponding to MOI's of 
1, 10,100,1000 or 10,000 to determine the maximum bacterial binding capacity 
for all cell types. In addition, to evaluate the role of the MOMP as an adhesin 
for L. pneumophila, bacterial cultures (L. pneumophila , £. coli JM 83 and 
clone LP 116) were centrifuged at 6,000 x g, washed three times with HBSS and 
resuspended in 1 ml fresh HBSS. Each cell type was treated with cytochalasin 
D at 1 jig/m l in HBSS for 1 h at 37°C with 5 % C 0 2 to inhibit bacterial uptake.
Cells were washed three times with HBSS to remove cytochalasin and each 
MOI was added to 24-well or 6-well cell culture plates containing either U-937, 
A549 or thioglycollate-elidted A /J peritoneal macrophages for 1 h. For 
MOMP studies, organisms were added to U-937 cells at a MOI of 100 bacteria 
per host cell and incubated for 1 h at 37°C in 5 % C 02. Cells were washed
three times with HBSS to remove unbound bacteria and assayed by VBCC 
counts or IF A.
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2.3.4 V iab le bacterial cell colony (VBCC) counts. Eukaryotic cells 
cultured with viable L. pneumophila were subsequently assayed for numbers 
of bound bacteria by adding 1 ml of sterile water to each well followed by 
incubation at room temperature for 20 min. Cells were disrupted with 
vigorous aspiration and expulsion through a sterile pasteur pipet. A 100 fil 
aliquot of each suspension was serially 10-fold diluted in 1 % (w /v) peptone 
and duplicate 25 jil samples of each dilution were plated onto BCYE-a. 
Legionella colonies were enumerated after 72 h and the number of bacteria 
bound to each cell type was determined by dividing the average lysate values 
for each well by the number of eukaryotic cells seeded per well. Three 
separate assays were performed with each MOI in triplicate. Following 
evaluation of binding data, adherence assays were repeated three times using 
an MOI of 100 for all cell types. For MOMP studies, duplicate 25 jj.1 samples of
each dilution were plated on either BCYE-a (L. pneumophila), nutrient agar 
(JM 83) or nutrient agar supplemented with 50 (ig/ml ampicillin (LP 116). 
Organisms were enumerated by counting bacterial colonies.
The num ber of virulent L. pneumophila organisms binding to the U- 
937 rplls was defined as the 100 % adherence value and the binding potential 
of all other strains to host cells was compared to this. In this fashion, 
variations in attachment capabilities between strains were determined and 
increases or decreases greater than 50 % were considered significant. Results 
were expressed as the average of three separate trials each conducted in
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triplicate.
2.3.5 Im m unofluorescence (IFA) assay. Prior to addition of eukaryotic 
cells to the 6-well cell culture plates, 484 square mm sterile glass coverslips 
were added to each well and the cells were allowed to adhere to the 
coverslips. Monolayers were cytochalasin D treated, washed and inoculated 
with L. pneumophila, E. coli JM 83 or E. coli LP 116 as described for VBCC 
counts. Cells were washed three times with PBS and treated with a 1:500 
dilution of rabbit polyclonal anti-L. pneumophila N7 or anti-E. coli JM 83 
serum (Appendix 1) for 1 h  at 37°C. After 1 h of incubation, host cells were 
washed three times to remove non-adherent bacteria and fixed in 10 % 
formalin in phosphate-buffered saline, pH 7.2 (PBS) for 1 h at 25°C. Cells were 
washed three times to remove unbound globulin and treated with a 1:500 
dilution of goat anti-rabbit fluorescein isothiocyanate-conjugated (FITC) 
antibody for 1 h at 37°C. Cells were washed with PBS and stained with 0.01 % 
propidium iodide (Sigma) in PBS for 20 min. Glass coverslips were mounted 
on glass slides in glycerin containing 1 % (w/v) 1,4-diazobicyclo (2.2.2.) octane 
(DABCO) (Sigma) and viewed with an Olympus BH-2 epifluorescence 
microscope using an excitation filter emitting a wavelength of 490 nm and a 
barrier filter blocking wavelengths above 515 nm. IFA results were averages 
of three separate trials each conducted in duplicate enumerating the number 
of adherent bacteria on the first 200 cells per trial counted and expressed as 
adherent organism s/host cell.
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2.4 Results
Adherence of L. pneumophila to U-937. A549 and A/T peritoneal 
macrophages. L. pneumophila attachment to U-937 cells, A549 cells and A/J 
murine peritoneal macrophages was investigated at various MOI's by both 
VBCC counts and IFA methods. Bacterial binding to U-937, A549 and A /J 
peritoneal macrophages is shown by IFA in Plate 2.1. Maximum bacterial 
binding occurred at an MOI of 1000 (5x10s CFU/ml) for U-937 cells (Figure 2.1 
and 2.2), A549 cells (Figure 2.3 and 2.4) and A /J peritoneal macrophages 
(Figure 2.5 and 2.6) as assayed by both VBCC counts and IFA. Maximum 
binding corresponded to an average CFU/cell ratio of 1.97, 3.04, and 1.15 for U- 
937 (Figure 2.1), A549 (Figure 2.3) and A /J peritoneal macrophages (Figure 2.5) 
respectively as assayed by VBCC counts. IFA equivalent ratios were 2.92, 2.7, 
and 1.4 for U-937 (Figure 2.2), A549 (Figure 2.4) and A /J peritoneal 
macrophages (Figure 2.6). There was a high level of non-specific binding to 
the plastic culture ware and glass coverslips with an MOI of 1000 (5xl08 
CFU/ml), however, when 10-fold fewer organisms were used, corresponding 
to an MOI of 100 (5xl07 CFU/ml), the level of non-specific binding was 
reduced to acceptable levels. Bacterial binding at an MOI of 100 approached 
maximum binding levels for all cell types and was subsequently used for all 
additional assays.
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Plate 2.1: L. pneumophila binding to eukaryotic cells in an indirect 
immunofluorescence assay. Bacteria were labelled with FITC (green) while 
eukaryotic cells were counterstained with propidium iodide (orange).
A) L. pneumophila binding to U-937 cells. B) L. pneumophila binding to 
A549 cells. C) L. pneumophila binding to thioglycollate-elicited peritoneal 
macrophages from A /J mice.
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Figure 2.1: Binding of L. pneumophila to U-937 cells as measured by VBCC 
counts. U-937 cells were seeded at 5x105 cells/well and increasing 10-fold 
multiplicities of infection of bacteria were added to the cells. An inoculum of 
5xl07 CFU/ml approached maximum binding of L. pneumophila 
corresponding to 1.12 bacteria per U-937 cell. Results are expressed as means ± 
standard deviations from three separate experiments each of which were 
conducted in triplicate (i.e. 9 data points per column).
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Figure 2.2: Binding of L. pneumophila to U-937 cells as measured by IFA. U- 
937 cells were seeded at 2x106 cells/well and increasing 10-fold multiplicities 
of infection of bacteria were added to the cells. An inoculum of 2xl08 
CFU/ml approached maximum binding of L. pneumophila corresponding to 
2.34 bacteria per U-937 cell. Results are expressed as means ± standard 
deviations from three separate experiments each of which were conducted in 
triplicate enum erating the total number of fluorescent bacteria bound to 200 
host cells (i.e. 9 data points per column).
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Figure 2.3: Binding of L. pneumophila to A549 cells as measured by VBCC 
counts. A549 cells were seeded at 5xl05 cells/well and increasing 10-fold 
multiplicities of infection were added to the cells. An inoculum of 5x107 
CFU/ml approached maximum binding of L. pneumophila corresponding 
1.6 bacteria per A549 cell. Results are expressed as means ± standard 
deviations from three separate experiments each of which were conducted 
triplicate (i.e. 9 data points per column).
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Figure 2.4: Binding of L. pneumophila to A549 cells as measured by IFA.
A549 cells were seeded at 2x106 cells/well and increasing 10-fold multiplicities 
of infection of bacteria were added to the cells. An inoculum of 2x108 
CFU/ml approached maximum binding of L. pneumophila corresponding to
2.3 bacteria per A549 cell. Results are expressed as means ± standard 
deviations from three separate experiments each of which were conducted in 
triplicate enumerating the total number of fluorescent bacteria bound to 200 
host cells (i.e. 9 data points per column).
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Figure 2.5: Binding of L. pneumophila to thioglycollate-elicited peritoneal 
macrophages from A /J mice cells as measured by VBCC counts. Macrophages 
were seeded at 5x10s cells/well and increasing 10-fold multiplicities of 
infection were added to the cells. An inoculum of 5x107 CFU/ml approached 
maximum binding of L. pneumophila corresponding to 0.77 bacteria per A/J 
macrophage. Results are expressed as means ± standard deviations from 
three separate experiments each of which were conducted in triplicate (i.e. 9 
data points per column).
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Figure 2.6: Binding of L. pneumophila to thioglycollate-elicited peritoneal 
macrophages from A /J mice as measured by IF A. Macrophages were seeded 
at 2xl06 cells/well and increasing 10-fold multiplicities of infection of bacteria 
were added to the cells. An inoculum of 2xl08 CFU/m l approached 
maximum binding of L. pneumophila corresponding to 0.98 bacteria per 
macrophage. Results are expressed as means ± standard deviations from 
three separate experiments each of which were conducted in triplicate 
enumerating the total number of fluorescent bacteria bound to 200 host cells 
(i.e. 9 data points per column).
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Figure 2.7: Adherence of L. pneumophila strain N7, Escherichia coli strain JM 
83 and the £. coli clone LP 116 to U-937 cells assayed by IFA and VBCC counts. 
Data have been normalized to L. pneumophila which received a 100 % 
adherence value. E. coli clone LP 116 was 4.8 and 5.1 times more adherent 
than the parent E. coli JM 83 strain as assayed by IFA or VBCC counts 
respectively. Each bar represents the average of three trials. *p < 0.0004, **p < 
0.0001.
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The role of the MOMP as an adhesin in the binding of L. pneumophila to 
macrophage-like U-937 cells in an opsonin-independent environment was 
assessed. This was accomplished by comparing the attachment of the parent 
E. coli JM 83, and the genetically mutated E. coli JM 83 clone LP 116 which 
expresses the MOMP gene of virulent L. pneumophila. Comparison of E. coli 
JM 83 and LP 116 showed that the presence of the MOMP gene facilitated 
organism binding in the absence of opsonins. LP 116 was 5 times more 
adherent than the parent strain by both VBCC (p < 0.0001) counts and IFA {p < 
0.0004) (Figure 2.7).
2.5 Discussion
Attachment of bacteria to its host cell is a necessary event for the 
disease process to occur (24). Several adherence mechanisms and bacterial 
components, including pili, fimbriae, flagella and outer membrane proteins 
have been shown to mediate the specific binding event (24, 47, 323, 269). 
However, other processes may be involved in the initial stages of 
bacteria-host cell interaction, such as electrostatic, van der Waals and 
hydrophobic interactions which are followed by stronger binding events. 
Several transformed cells have been proposed as potential cell models for L. 
pneumophila infection (155, 224, 258, 267). To evaluate attachment of L. 
pneumophila to eukaryotic cells in an opsonin-independent environment, 
three cell types were used in the adherence assays, the U-937 cell, the A549 cell
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and A /J thioglycollate-elidted peritoneal macrophages. Each cell was chosen 
to serve a particular purpose. The U-937 cell is a human histiocytic 
lymphoma cell line which expresses either monocyte or macrophage-like cell 
surface markers (326) and has been used frequently as a model to represent 
Legionella-host cell interactions (155, 154, 267, 286). U-937 cells are 
maintained as non-adherent monocyte-like cells, however, they can be 
differentiated into macrophage-like cells when stimulated with various
agents, such as phorbol myristate acetate (PMA), interferon-y (IFN-y), 1-
a-dihdroxyvitamin D3, human recombinant interleukin-6 or retinoic acid.
When differentiated, these cells possess receptors analogous to macrophages, 
adhere to culture vessels, and are incapable of cell replication. These cells 
express both high and low IgG binding receptors as well as complement 
receptor type 3 (CR3) and complement receptor type 4 (CR4) at levels similar 
to alveolar macrophages. Thus, this cell is considered a versatile and 
appropriate cell model for many pathogens, including L. pneumophila and 
thus it was chosen to further investigate the role of the 25 kDa MOMP of L. 
pneumophila.
The A549 cell is a human, epithelial, transformed cell characterized as a 
type II pneumocyte (151, 215). Type II pneumocytes line the alveolus in the 
lung and may serve to perpetuate disease by supporting L. pneumophila 
binding and subsequent intracellular replication. In addition L. pneumophila 
may interact with these cells stimulating them to produce immune
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modulating molecules, such as cytokines that may either exacerbate or 
suppress disease.
Transformed cells are of crucial importance for studying the 
pathogenesis, microbiology and immunology of bacteria-host interactions. 
However, these cells do not directly mimic cells that are found in vivo in an 
unaltered state. Therefore, peritoneal cells from the susceptible A /J mouse 
strain, were used to represent a macrophage cell found in its natural state in 
vivo. Yamamoto et al. (370) demonstrated that thioglycollate-elicited 
peritoneal macrophages from various mouse strains were not susceptible to 
L. pneumophila infection with the exception of the A /J strain.
During the adherence assays, cytochalasin D was used to inhibit the 
internalization of L. pneumophila. The cytochalasins have been used to 
determine if pathogens enter host cells by means of active invasion or 
phagocytosis (105). It has been demonstrated that L. pneumophila do not 
actively penetrate cytochalasin-treated guinea pig alveolar macrophages in 
vitro without affecting attachment to host cell membranes (105). In addition 
to adhering to phagocytic-type cells, such as U-937 cells and A /J peritoneal 
macrophages, L. pneumophila were able to adhere to A549 cells, indicating 
that this organism adheres to cells that do not possess complement and Fc 
receptors normally found on the surface of mononuclear cells; thus, an 
alternative mechanism may be responsible for bacterial binding to these cells.
As a facultative intracellular pathogen, L. pneumophila interacts with
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the cell membranes of alveolar macrophages prior to phagocytosis and, as a 
result, surface-located antigens are crucial to disease induction. The MOMP of 
L. pneumophila is known to be tightly associated with LPS and resists 
complete dissociation in SDS at 100’C (141,172). As a consequence of 
difficulties associated w ith separating the MOMP completely from LPS, 
recombinant DNA techniques were used to obtain Legionella surface 
expressed antigens. High et al. (170) constructed a recombinant plasmid 
containing an 810 base pair DNA fragment from the low-passage, fully 
virulent L. pneumophila N7 strain. The plasmid, pLP 116, was shown to 
express the 25 kDa L. pneumophila MOMP in £. coli by both Western blot and 
immunofluorescence analysis using an anti-Legionella MOMP-specific MAb. 
The genetically altered E. coli clone, LP 116, was used to assess the role of this 
25 kDa protein in the pathogen-host cell adherence phenomenon. It was 
demonstrated that the presence of the 25 kDa MOMP enhanced the ability of 
the organism to attach to host cells. The 5-fold increase in binding to U-937 
cells observed for the clone as compared to the parent E. coli suggested that 
the MOMP was, in part, responsible for this opsonin-independent 
attachment. It is possible that the high expression pUC 19 vector used in 
these studies resulted in an increase in the am ount of MOMP on the surface 
of LP 116 organisms and that this expression was responsible for the greater 
than two-fold increased binding of the clone to U-937 cells as compared to the 
virulent L. pneumophila N 7 strain. Alternatively, the attachment potential
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of the clone may have been influenced by conformational changes in the 
expression of the MOMP in the E. coli clone. Furthermore, it is possible that 
the MOMP of L. pneumophila is not associated with LPS in the clone; thus, 
steric factors may have contributed to the observed increase in adherence. 
Further studies on these strains will yield information on the nature of the 
MOMP adhesin-host cell receptor interaction. Given the role of the 25 kDa 
MOMP in virulence and in binding the organism to host cells, it is possible 
that this protein may serve as a useful moiety for the development of 
molecular vaccines against Legionnaires' disease.
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CHAPTER HI
CELLULAR MODELS OF INFECTION FOLLOWING OPSONIN- 
INDEPENDENT ADHERENCE OF LEGIONELLA PNEUMOPHILA
3.1 Abstract
Elucidating the specific interactions of Legionella pneumophila during 
infection requires the use of cell models in order to develop a thorough 
understanding of the bacteria-host cell relationship. A cell model of infection 
of U-937 cells, A549 cells and thioglycollate-elicited peritoneal macrophages 
from A /J mice by L. pneumophila was assessed and established. Previous 
investigations have shown that several cells support the replication of L. 
pneumophila in vitro. There is a need to delineate the interactions of L. 
pneumophila with its primary host cell during hum an infection. The 
alveolar macrophage, the target cell in Legionnaires' disease, is, however, 
difficult to obtain. Therefore, an alternative cell model that mimics L. 
pneumophila infection of alveolar macrophages is required. In addition, the 
interaction between L. pneumophila and other cell types, such as the 
epithelial pneumocyte-like A549 cell will help to define L. pneumophila's 
ability to sustain infection by replicating within cells other than alveolar
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macrophages thus prolonging its existence and possibly aiding in 
pathogenesis. Growth kinetics of L. pneumophila revealed that bacteria were 
able to attach to, penetrate and replicate w ithin U-937 cells, A549 cells and A/J 
peritoneal macrophages in an opsonin-independent fashion. Bacteria bound 
to host cells w ithin 1 h and replicated over a 36 h period at which time 
organisms were released from infected cells by lysis. This work demonstrates 
that L. pneumophila is able to replicate w ithin both professional phagocytes 
from humans and mice, in addition to hum an lung epithelial cells that are 
not professionally phagocytic.
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3.2 Introduction
L. pneumophila is a facultative intracellular bacterial pathogen that 
replicates in hum an monocytes and alveolar macrophages (188, 250). The 
role of these cells is to destroy foreign invading antigens. Legionnaires' 
disease is a severe and often fatal form of pneumonia. During Legionnaires' 
disease, the organism is able to circumvent the normal destructive processes 
of macrophages and not only survive but replicate within these cells that 
evolution "designed" to eradicate such agents as Legionella.
Following recognition of the organism in 1977 (233), Rodgers et al. (289) 
demonstrated by electron microscopy that L. pneumophila functioned as a 
facultative intracellular pathogen replicating within host lung cells. Horwitz 
and Silverstein (188) initially described the interaction of L. pneumophila 
with human peripheral blood monocytes and since then a variety of human 
and animal cells have been shown to support the intracellular replication of 
the pathogen (258, 267, 286, 370). However, L. pneumophila is unable to 
replicate within PMNLs (186, 258). The alveolar macrophage is the primary 
cell infected; therefore, macrophages serve as the logical target cell to 
investigate the pathogenesis of L. pneumophila infection at the cellular level. 
As alveolar macrophages are difficult to obtain from humans or mice, 
alternative cells are required to study the pathogenic processes at the cellular 
level.
For bacterial infection to proceed, pathogens must first bind to their
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host cells (24). In the opsonin-dependent system, organisms are pre-coated 
with specific antibody and bind to phagocytic cells through Fc receptors. Two 
mechanisms of attachment have been described for L. pneumophila; 
opsonin-dependent (26, 266) and opsonin-independent (155,154, 286). In 
opsonin-mediated adherence, complement fragments C3b and C3bi coat the 
organism prior to binding to the surfaces of monocytes via CR1 and CR3 
receptors (26). C3bi is deposited on the major outer membrane protein 
(MOMP) of L. pneumophila and the MOMP/C3bi complex binds to CR3 on 
human monocytes (26). The opsonin-independent mechanism of attachment 
does not involve specific antibody or complement and the MOMP may 
facilitate the attachment of L. pneumophila to U-937 cells in this system (see 
Section 2).
Complement-mediated binding is followed by internalization of 
Legionella organisms via a process termed coiling phagocytosis (182). 
Internalized organisms are contained within banded enclosures (258). 
Phagosomes containing organisms then become ribosome-lined and are in 
close association with mitochondria (179, 258). It is not understood why this 
organelle recruitment should occur, however it appears to be necessary for 
intracellular replication of L. pneumophila (179). The survival of L. 
pneumophila within mononuclear cells depends on the inhibition of 
phagosome-lysosome fusion and acidification of the phagosome (181, 185).
The precise mechanism of phagosome-lysosome inhibition has not been
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elucidated and is not well understood. However, recently, it has been shown 
that the dot (defective for organelle trafficking) Hem (intracellular 
multiplication) genes play a role in this process and are required for 
intracellular survival of L. pneumophila within the phagosome (297, 271). 
Through this inhibition, the normal degradative process that would follow to 
destroy foreign material is halted and unabated intracellular replication of the 
organism ensues. Following intracellular multiplication, L. pneumophila is 
released from the phagosome into the cytoplasm of the host cell and 
eventually escapes from the cell to the extracellular milieu to continue 
disease by infecting neighboring cells. The precise mechanism of escape has 
not been elucidated; however, cells rupture and are lysed with release of the 
bacteria. Gao et al. (143) have indicated that release of L. pneumophila may be 
preceded by macrophage apoptosis which results in lysis of infected cells. In 
addition, the major secretory protein of L. pneumophila may play a role in 
this process.
The terminal line in constitutive defense in the lung is the alveolar 
macrophage, the target cell of L. pneumophila. The intracellular nature of L. 
pneumophila in these cells aids organism survival by protecting it from the 
humoral branch of the immune system, thus, recovery from Legionnaires' 
disease relies on the cell-mediated branch of the immune system. The 
guinea-pig has been accepted as a model for human Legionnaires' disease; 
however, an ideal cell model for the study of legionellosis is not as readily
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available. Guinea pig alveolar macrophages, human peripheral monocytes, 
U-937 cells and HL-60 have all been used to investigate the microbiology and 
pathogenesis of L. pneumophila (102, 154, 190, 224, 267). In addition, these 
cells are not ideal as they only represent some of the normal activities of 
human alveolar macrophages in vivo; thus, it may be necessary to use more 
than one cell type to delineate the attachment and intracellular replication 
process for L. pneumophila. Early studies delineated the initial recognition of 
the bacteria by host cells in a complement-mediated receptor binding fashion 
(266). More recently, an attachment process that occurs in the absence of 
opsonins, a complement-independent mechanism, has been identified (155, 
286). The recognition event, whether opsonin-mediated or 
opsonin-independent may determine the intracellular fate of the organism.
It is possible that organisms entering macrophages via the complement route, 
trigger the norm al killing process of the cell as has been shown for many 
pathogens (82, 93, 322), while the opsonin-independent attachment 
mechanism previously described, may not stimulate the oxidative events that 
would normally lead to the organism's death. If this were the case then the 
result would be fulminant intracellular replication.
3.3 Material and Methods
Reagent formulations and preparation along with detailed procedures 
are given in Appendix 1.
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3.3.1 Bacterial Cultivation
L. pneumophila stain Nottingham  N7 was grown and maintained as 
previously described (see Section 2.3.1).
3.3.2 Eukaryotic Cell Growth and Maintenance
U-937 cells, A549 cells and thioglycollate-elicited A /J murine 
peritoneal macrophages were grown and maintained as previously described 
(see Section 2.3.2).
3.3.3 Intracellular Replication Assay
Intracellular replication and release of L. pneumophila was assessed in 
U-937, A549 and thioglycollate-elicited peritoneal macrophages from A/J 
mice. Monolayers of eukaryotic cells in 24-well plates were washed three 
times with HBSS to remove non-adherent cells. L. pneumophila (5xl07 
CFU/ml) in serum-free HBSS was added to these monolayers at a MOI of 100 
and were allowed to adhere to cells for 1 h at 37°C in 5 % COr  Following the
1 h organism-attachment period, supernatant fluids were removed and cells 
were washed three times w ith HBSS to remove unbound bacteria. The three 
washings along with the supem ates were collected and pooled for each cell 
type. Serial 10-fold dilutions of these pooled samples were made in 1 % (w/v)
peptone and duplicate samples of 25 |xl were plated on BCYE-a agar. A 1 ml
volume of either RPMI-1640 for U-937 cells and A /J peritoneal macrophages
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or H a m 's  FK12 for A549 cells supplemented with 10% heat-inactivated FBS 
was then added to all wells. At 6,12,24, 36,48 and 72 h  post-adherence cell 
monolayers were assessed by VBCC counts for both intracellular as well as 
extracellular bacteria.
3.3.4 Viable bacterial cell colony (VBCC) counts
Supernatant fluids were collected, cells were washed three times with 
HBSS and added to the supernatant fluids at which time 1 ml sterile water 
was added to cell monolayers for 20 min. Cell were lysed by vigorous 
aspiration and expulsion through a sterile pasteur pipette. A 100 pi aliquot 
from each of the supernatant fluids plus wash samples as well as each lysate 
were serially diluted 10-fold in 1 % (w /v) peptone and duplicate samples of 25 
pi were plated on BCYE-a agar to enumerate both intracellular and released 
legionellae from U-937, A549 and A /J thioglycollate-elicited peritoneal 
macrophages.
3.4 Results
L. pneumophila adhered readily to U-937 cells within 1 h. VBCC count 
data indicated that approximately 5x10s bacteria (approximately 1 % of the 
inoculum) had attached to U-937 cells during the 1 h incubation period, 
corresponding to 1 bacteria bound to each U-937 cell (Figure 3.1). This period 
was followed by one of rapid intracellular replication for 36 h. A 10-fold
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increase in the intracellular replication of L. pneumophila within U-937 cells 
was observed from 12 to 36 h. Lysis of U-937 cells between 36 and 48 h was 
seen microscopically and this lysis resulted in the release of progeny L. 
pneumophila. A similar profile of L. pneumophila replication was observed 
for A549 cells. Attachment of approximately 5.5x10s bacteria (approximately
1.1 % of the inoculum) occurred within 1 h resulting in a ratio of 1.1 bacteria 
bound to each A549 cell (Figure 3.2). Intracellular replication, from 24 to 36 h, 
resulted in a 10-fold increase in the numbers of L. pneumophila within A549 
cells. L. pneumophila growth in cells effected lysis of host cells between 36 
and 48 h releasing progeny as indicated by the rise in the numbers of 
extracellular bacteria present in supernatant fluids. Thioglycollate-elicited 
peritoneal macrophages from A /J mice supported the intracellular replication 
of L. pneumophila and resulted in a 12-fold increase in the numbers of 
bacteria within host cells from 12 to 36 h (Figure 3.3). Approximately 3.1X1CP 
bacteria (approximately 0.6 % of the inoculum) initially bound to host cells 
following the 1 h  incubation period, corresponding to 0.622 bacteria bound to 
each A /J peritoneal macrophage. Lysis occurred between 36 and 
48 h releasing bacteria into the extracellular milieu. VBCC counts of washed 
samples (extracellular bacteria) and cell lysates (intracellular bacteria) 
demonstrated maximal intracellular Legionella numbers at 36 h of infection 
for all cell types investigated (Figures 3.1, 3.2 and 3.3). As intracellular 
replication continued toward later stages of infection, an increase in the
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Figure 3.1: Attachment and intracellular replication of L. pneumophila 
within U-937 cells as assayed by VBCC counts. U-937 cells were seeded at 
5xl05 cells/well and infected at a multiplicity of infection of 100 for 1 h. 
Intracellular replication and release of L. pneumophila are shown. Results 
are expressed as means ± standard deviations from five separate experiments 
each of which were conducted in triplicate (i.e. 15 data points per column).
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Figure 3.2: Attachment and intracellular replication of L. pneumophila 
within A549 cells as assayed by VBCC counts. A549 cells were seeded at 5x105 
cells/well and infected at a multiplicity of infection of 100 for 1 h. 
Intracellular replication and release of L. pneumophila are shown. Results 
are expressed as means ± standard deviations from three separate 
experiments each of which were conducted in triplicate (i.e. 9 data points per 
column).
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Figure 3.3: Attachment and intracellular replication of L. pneumophila 
within thioglycollate-elicited peritoneal macrophages from A /J mice as 
assayed by VBCC counts. Macrophages were seeded at 5x105 cells/well and 
infected at a multiplicity of infection of 100 for 1 h. Intracellular replication 
and release of L. pneumophila are shown. Results are expressed as means ± 
standard deviations from three separate experiments each of which were 
conducted in triplicate (i.e. 9 data points per column).
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number of bacteria was found in the extracellular environment with a 
simultaneous decrease in the number of intracellular organisms. Further 
experiments dem onstrated that L. pneumophila d id  not replicate 
extracellularly in HBSS, RPMI-1640 with or without 10 % heat inactivated 
FBS or in HAM's FK12 with or without 10 % heat inactivated FBS either in 
the presence or absence of host cells.
3.5 Discussion
L. pneumophila infections constitute a significant medical problem 
especially among immunocompromised individuals. It is critical that 
representative cell models are developed to study the infectious process of L. 
pneumophila at the cellular level of infection. The antimicrobial agents, 
erythromycin, ciprofloxacin, tetracycline and rifampin singularly or in 
combination have been used with varying success to control Legionella 
infections; however, individuals often succumb to Legionnaires' disease 
despite aggressive antibacterial therapy and mortality rates as high as 40 % 
have been associated with Legionnaires' disease (131, 163). Defining the 
specific interactions between L. pneumophila and cells they infect is necessary 
for the development of alternative therapeutic strategies to augment current 
antimicrobial treatm ent and /o r prevention regimes.
The binding process of pathogen to host cell is complex and is most 
likely multifactorial. L. pneumophila organisms are able to bind to and
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replicate within alveolar macrophages; thus, they are protected from the 
host's humoral immune defenses. Therefore, mediating a cell-mediated 
immune response is critical to recovery. Several transformed cells have been 
proposed as potential cell models to study Legionella-host interactions but it 
is the U-937 cell that has been used most frequently for this purpose (1, 143, 
144,153,154, 217, 267, 269, 286). This is particularly relevant as these cells can 
be differentiated to macrophage-like cells expressing the complement 
receptors CR3 and CR4 at levels similar to alveolar macrophages.
In this study the ability of L. pneumophila to attach to and replicate 
within U-937 and A549 cells as well as in thioglycollate-elicited peritoneal 
macrophages from A /J mice was evaluated in an opsonin-independent 
system of infection. Since A549 cells are not professionally phagocytic and do 
not possess complement and Fc receptors normally found on the surface of 
mononuclear cells, L. pneumophila uses other mechanisms to attach to and 
infect these cells. Furthermore, in the environment, legionellae colonize and 
infect fresh water amoebae in the absence of opsonic components (18). In 
addition, Reynolds and Newball (277) have demonstrated that the distal 
bronchioles and the alveolar space of the human lung contain very low 
levels of complement. Thus, the study of L. pneumophila infection of host 
cells with and w ithout Fc and other mononuclear cell receptors both in the 
presence and in the absence of opsonins is of critical importance in 
developing a rationale for defining the initial recognition and colonization
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events of host cells by L. pneumophila.
Studies by Horwitz et al. (182) have demonstrated that L. pneumophila, 
in the presence of complement components, enters mononuclear cells by a 
process termed coiling phagocytosis in which long pseudopods coil around 
the organism as it is internalized. However, these workers also noted that 
not all L. pneumophila are taken up by this process, indicating either 
organism-based differences were occurring or alternatively two different 
mechanisms of uptake were taking place simultaneously. Once internalized, 
the organism resides within tight-fitting phagosomes that are lined with host 
cell ribosomes and mitochondria (179). Inhibition of phagosome-lysosome 
fusion is crucial to organism survival and subsequent intracellular 
replication within host cells (7,181,185, 258, 349).
In the present study L. pneumophila was able to adhere to and 
replicate within cells that are professionally phagocytic (U-937 and A/J 
macrophages) as well as in cells that are not (A549) in an opsonin- 
independent manner. The replication and lytic profiles were similar for all 
cell types investigated. Following organism attachment a decrease in 
numbers of L. pneumophila were noted for all cell types from initial 
attachment to 6 h  post-infection. This decrease in CFU/ml may represent 
initial organism killing by the host cells. It is possible that the pathogen was 
then able to overcome host cell defenses and replicate within these cells 
eventually leading to cell lysis between 36 to 48 post-infection.
103
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
This study demonstrates that opsonin-independent processes may be 
necessary for the initial interaction and establishment of cellular infection 
and that complement-mediated processes may follow only after cellular 
destruction and inflammation proceed. Furthermore, it has been 
demonstrated that complement, in the absence of specific antibody, does not 
promote the adherence of L. pneumophila to U-937 cells, guinea pig alveolar 
macrophages or J774 mouse macrophages (190). The work in the present 
study coupled with that of Husmann and Johnson (190) indicate that an 
opsonin-independent attachment mechanism may exist for Legionella and 
that this process may dictate the outcome of infection. In addition, the 
present work further demonstrates the usefulness of U-937 cells and 
peritoneal macrophages from A /J mice as models to study L pneumophila 
infections of cells in the host. A549 cells, which are characterized as type II 
pneumocytes, line the alveolus of the lung and may contribute to the overall 
pathogenesis of infection by supporting L. pneumophila growth in vivo in a 
manner similar to that in vitro. Further work to identify the interaction 
process of L. pneumophila with cells that reside in the lung, other than the 
alveolar macrophage, will aide in delineating specific and key pathogenic 
mechanisms for establishing disease. Once the host-bacteria relationship can 
be dissected it will facilitate the discovery of alternative therapies to assist in 
resolving Legionnaires7 disease. These three cells may prove crucial to that 
process.
104
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER IV
IN VITRO CYTOKINE PRODUCTION BY U-937 CELLS CHALLENGED WITH
LEGIONELLA PNEUMOPHILA
4.1 Abstract
Cytokines are immune modulating protein molecules of low 
molecular weight produced by various cells that regulate the intensity and 
duration of an immune response to an antigen. A major area of research that 
has received considerable attention is understanding the role cytokines play 
in modulating the immune system during infection with many obligate and 
facultative intracellular pathogens. There is limited information regarding 
the production of cytokines during infection w ith Legionella pneumophila.
In this study the production of the proinflammatory cytokines, interleukin 
(IL)-ip and tumor necrosis factor (TNF)-a, the chemokine, IL-8 and the
immune regulating cytokines IL-10, IL-12 and interferon (IFN)-y from
macrophage-like U-937 cells in response to L. pneumophila infection was 
investigated. Infection of U-937 cells, stimulated into the adherent 
macrophage-like form w ith phorbol esters, by L. pneumophila elicited the 
production of IL-ip and IL-8, while TNF-a, IL-12 and IFN-y were not
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stimulated during infection. Interestingly, U-937 cells challenged with L. 
pneumophila produced decreased levels of IL-10 as compared to uninfected 
controls. The effect of L. pneumophila viability on the induction of cytokines 
produced by U-937 cells was assessed by challenging the cells with either live, 
heat-killed or formalin-fixed L. pneumophila. Inoculation of U-937 cells 
with either heat killed or formalin fixed L. pneumophila elicited significantly 
greater levels of IL-8 and IL-10 as compared to cells infected with live L.
pneumophila; however, killed organisms failed to elicit IL-ip, TNF-a, IL-12
and IFN-y from U-937 cells. These results suggest that L. pneumophila 
infection elicits specific cytokines from affected cells, and that the normal 
cytokine response of macrophages is profoundly affected following Legionella 
infection.
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4.2 Introdnction
The facultative intracellular pathogen Legionella pneumophila is the 
causative agent of Legionnaires' disease, an acute multifocal necrotizing 
pneumonia. When the organism is inhaled by humans it descends into the 
lower respiratory tract and parasitizes alveolar macrophages (250). Studies 
have demonstrated the importance of the macrophage-L. pneumophila 
interaction that permits L. pneumophila to persist in the lung (34, 57, 86, 312, 
311) . Furthermore, it is widely accepted that a cell-mediated host response is 
crucial to the resolution of Legionnaires' disease (41,40, 77,137, 253, 315). 
Investigators have used a variety of in vitro models to study cell infection by 
L. pneumophila and those studied include cells of human and non-human 
origin as well as protozoa (2, 3,18,122,120, 258, 267, 370). Based on the nature 
of the disease process and the observation that L. pneumophila is an 
intracellular pathogen, investigations have begun to investigate the 
interactions of L. pneumophila with the host's immune system. In light of 
the high mortality rate associated with Legionnaires' disease and the lack of 
resolution often associated with appropriately treated disease, alternative 
therapeutic strategies are required. Vaccination, immunotherapy and 
cytokine therapy have been suggested to augment current antibiotic 
treatments. However, target bacterial molecules for use in vaccines and 
precise protocols for immunological intervention are not currently available. 
One potential avenue involves the use of naturally occurring host molecules
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or response systems, such as cytokines, to amplify the crucial host response to 
combat disease (140, 134,214,248). Cytokines are a class of soluble low 
molecular weight glycoproteins that mediate cell-to-cell communication 
during an immune response (10, 216). Membrane-bound forms have also 
been described for many cytokines. Cytokines comprise several groups of 
molecules including interleukins, lymphokines, monokines, interferons, 
colony-stimulating factors and a variety of other proteins (9,10, 81). Initially 
it was thought that these molecules were produced exclusively by leukocytes, 
lymphocytes, and monocytes; however, epithelial and endothelial cells can 
secrete a range of these as well (216). Cytokines exhibit synergistic, 
antagonistic, redundant and pleiotropic properties. Through these attributes, 
this diverse group o f molecules mediates, maintains, regulates and dictates 
the intensity and duration of the immune response in a coordinated, 
interactive fashion by  modulating the activity of immune effector cells (134, 
216). The effects of cytokines on target cells are exerted by binding to specific 
membrane bound cytokine receptors which function as ligand binding and 
signal transduction moieties (239). The cellular consequences of ligand 
binding are diverse and involve the induction of transcription of cytokine 
coding genes, as well as a diverse set of responses associated with cellular 
proliferation and differentiation (81, 239). It has been suggested that the 
sharing of receptor subunits may, in part, reflect the redundant functions of 
cytokines (216,239).
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Functions of immune cells are finely coordinated to ensure an 
adequate response to an antigenic stimulus, and part of this coordination is 
mediated by secreted cytokines. Cytokines regulate the immune response by 
stimulating or inhibiting the proliferation of various cells or by influencing 
the secretion of antibodies or other cytokines (81, 216). The development of 
an effective immune response involves lymphoid and inflammatory cells 
and other hematopoietic cells.
To date a detailed understanding of the host immune response to L. 
pneumophila has been hampered due to the lack of relevant systems to study 
infection. Several investigators have used in vitro systems to define the 
production of cytokines elicited by L. pneumophila or its component antigens 
during infection of cells in vitro. Increased levels have been described for 
mRNA specific for IL-l-a, IL-ip, IL-6, TNF-a and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) following L. pneumophila attachment to 
murine peritoneal macrophages (371, 367). In addition, binding of L. 
pneumophila to murine macrophages in vitro induces an increase in mRNA 
levels specific to the chemokines, macrophage inflammatory protein 
(MIP)-lp, MTP-2 and KC (367). Legionella, as well as purified antigens from
this organism, serve to induce the proinflammatory cytokine, IL-ip from 
murine peritoneal, splenic and pulm onary macrophages as well as from 
human peripheral blood monocytes (358). Matsiota et al. (230) showed that L.
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pneumophila infection of hum an monocytes resulted in a low level 
induction of TNF-a in vitro. Park and Skerrett (264) have shown that human 
monocytes infected w ith  L. pneumophila secrete higher levels of IL-10 than 
similarly infected alveolar macrophages in vitro. TNF-a and IFN-y are also 
produced by lymphocytes challenged with L. pneumophila in vitro (203).
It has been proposed that resolution of Legionella infections is 
facilitated by activation of macrophages and these subsequently resist 
Legionella infection. Initial reports indicated that treatment of monocytes
with IFN-y was able to limit intracellular replication of L. pneumophila in
human peripheral blood monocytes (31, 30, 65). This observation was 
subsequently confirmed using human alveolar macrophages (194, 250, 249).
IFN-y downregulates the function of complement receptors that mediate
phagocytosis of L. pneumophila; thus, activated mononuclear phagocytes 
inhibit L. pneumophila multiplication by phagocytozing 50 % fewer L. 
pneumophila (65, 186, 303). This restricts access of the bacteria to the 
intracellular milieu required for replication. In addition, IFN-y activated
monocytes and macrophages decrease the multiplication rate of L. 
pneumophila that are internalized by reducing iron availability. This 
bacteriostatic effect induced by IFN-y correlates w ith a 73 % down-regulation
of transferrin receptors (TfR) on the macrophage surface and an 83 % decrease 
in the concentration of intracellular ferritin (65). Hamilton et al. (161) also
110
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
found a threefold reduction in TfR binding sites in thioglycollate-elicited 
murine macrophages treated w ith IFN-y. The resultant net decrease in the 
concentration of intracellular iron restricts L. pneumophila growth within 
macrophages. Furthermore, it has been suggested that the mechanism of 
protection afforded by IFN-y pretreatment of macrophages is mediated, in 
part, by TNF-a. Indeed, pretreatment of human monocytes with IFN-y prior 
to L. pneumophila infection results in an increased TNF-a response (230).
Further studies suggest that the protection afforded by IFN-y treatment can be
overcome by subsequent exposure of alveolar macrophages or monocytes to 
the immunoinhibitory cytokine, IL-10, and this results in active intracellular 
replication of L. pneumophila (264). Data concerning the secretion of specific 
cytokines induced in cells by L. pneumophila infection are limited. A broad 
study has yet to be performed to investigate the ability of L. pneumophila to 
induce various cytokines during intracellular replication. Table 4.1 depictes 
the cytokines that were investigated in the present study and they comprise 
proinflamatory cytokines, a chemokine and immune-regulating cytokines. 
The present study serves to increase the current knowledge regarding the 
cytokines that may be crucial to disease development during L. pneumophila 
infection.
I l l
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4.3 Materials and Methods
Reagent formulations and preparation along with detailed procedures 
are given in Appendix 1.
4.3.1 Bacterial Cultivation
L. pneumophila stain Nottingham N7 was grown and maintained as 
previously described (see Section 2.3.1). L. pneumophila (5xl07 CFU/ml) were 
heat killed by boiling for 10 min in HBSS. In addition, aliquots of heat killed, 
bacteria were centrifuged for 10 min at 6,000 x g to obtain bacterial pellets and 
supernatant fluids. Bacterial pellets were washed three times by 
centrifugation with HBSS and resuspended in fresh HBSS prior to infection 
assays. The supernatant fluid was added directly to host cells. Further 
aliquots of L. pneumophila were fixed in 10% buffered formalin for 30 min. 
Bacteria were washed three times by centrifugation in HBSS to remove 
formalin. All viable bacterial inocula were confirmed by CFU/ml 
determination as assayed by VBCC counts. In addition, heat-killed and 
formalin fixed preparations were evaluated for viability by VBCC counts.
4.3.2 U-937 cell Growth and Maintenance
U-937 cells were grown, maintained and phorbol ester treated as 
previously described (see Section 2.3.2).
114
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4.3.3 I . pneumophila Infection of U-937 Cells
Monolayers of U-937 cells in 24-well plates were washed three times 
with HBSS to remove non-adherent cells and serum  components. Live L. 
pneumophila at 5xl07 CFU/ml or an identical num ber of heat killed or 
formalin fixed L. pneumophila in serum-free HBSS were added to the 
monolayers of U-937 cells (multiplicity of infection of 100) and allowed to 
adhere for 1 h at 37°C with 5% COz- Following the 1 h L. pneumophila-host
cell attachment period, culture supernatant fluids were collected, centrifuged 
and filtered through a 0.2 Jim filter to remove unbound bacteria and stored 
for cytokine analysis. L. pneumophila-infected U-937 cell monolayers were 
washed three times with HBSS to remove all unbound bacteria. Washing 
efficiency was determined by plating the final wash. A 1 ml volume of RPMI- 
1640 supplemented with 10 % heat-inactivated FBS was added to all wells and 
the U-937 cell monolayers were incubated at 37°C. At 6, 12, 24, 36 and 48 h 
post-adherence supernatant fluids were collected, centrifuged, filtered and 
stored frozen for cytokine analysis. In addition, bacterial burden in infected 
U-937 cells was determined by VBCC counts (see section 3.3.4). All collected 
supernatant fluids were centrifuged at 6,000 x g and stored at -70°C for assay 
using human cytokine-specific ELISA kits (Biosource International,
Camarillo, CA.).
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4.3.4 Determination of Cytokine Levels from U-937 Cell Cultures
Supernatant fluids from L. pneumophila challenged U-937 cells were
thawed and assayed for IL-1(3, TNF-a, IL-8, IL-10, IL-12 and IFN-y using
human cytokine-specific ELISA kits (Biosource International, Camarillo, CA.). 
ELISA was performed as per manufacture's instructions and optical densities 
were read on a Bio-Rad microplate reader at 450 run. The concentration of 
each cytokine in the culture preparations were calculated from standard 
curves generated during each assay.
4.3.5 Statistical Analysis
The nonparametric Mann-Whitney test was performed to analyze 
differences in levels of cytokines between control, uninoculated monolayers, 
and cells that had been exposed to viable or killed legionellae using the 
statistical analysis software, InStat (GraphPad Software Version 2.00, San 
Diego, CA.) on a Power Macintosh Performa 6214CD. A p value of less than 
0.05 was considered significant.
4.4 Results
Viable L. pneumophila adhered readily to U-937 cells and maximum 
binding was achieved within 1 h. This was followed by rapid intracellular 
replication over the following 36 h. Lysis of U-937 cells occurred between 36 
and 48 h and resulted in  the release of progeny L. pneumophila (see Figure
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3.1).
The production of IL-1|5, TNF-a, IL-8, IL-10, IL-12 and IFN-y from 
uninfected U-937 cells and from cells challenged with either live, heat-killed 
or formalin-fixed L. pneumophila w as investigated. The proinflammatory 
cytokine, IL-ip was induced by L. pneumophila infection and this reached 
maximum levels by 48 h post-infection (1004 ± 39 pg/m l) (Figure 4.1) while 
TNF-a was not elicited by L. pneumophila challenge of U-937 cells (Figure
4.2). IL-8, a chemokine primarily involved with neutrophil priming, was 
elicited at low levels during early infection (6 h) and increased steadily to 
maximum levels by 48 h (12,300 ± 430 pg /m l) (Figure 4.3). As seen in Figure 
4.5, U-937 cells infected with L. pneumophila showed a significant decrease in 
levels of IL-10 during early intracellular replication as compared with 
controls, indicating that infection m ay have resulted in down-regulation of 
IL-10 production. In this study minimum levels of IL-12 (Figure 4.7) and IFN-
y (Figure 4.8) were detected in supernatant fluids from either infected or
uninfected U-937 cells.
To determine whether the viability of L. pneumophila was critical for 
eliciting individual cytokine responses from Legionella-infected. U-937 
monolayers, cells were challenged w ith a similar inocula of either live, heat-
killed or formalin-fixed L. pneumophila. IL-ip (Figure 4.1) and TNF-a
(Figure 4.2) were not detected in supernatant fluids of U-937 cells following
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
challenge w ith either heat-killed or formalin-fixed L. pneumophila (p < 0.005 
as compared w ith live L. pneumophila challenge for IL-1P). Heat-killed L. 
pneumophila elicited high levels of IL-8 in the supernatant fluids from U-937 
cells within 6 h  and these levels were maintained to significantly higher 
levels than in those fluids from cells infected with live L. pneumophila (p < 
0.006 and 0.03) (Figure 4.3). To assess whether the molecule(s) responsible for 
the increased levels of IL-8 following treatment of cells with heat-killed L. 
pneumophila were located on the surface of the organisms or were being 
secreted by L. pneumophila, U-937 cells were challenged with either the 
bacterial pellet or the supernatant fluid of L. pneumophila preparations after 
heat inactivation. As shown in Figure 4.4 the bacterial pellet induced 
significantly greater levels of IL-8 as compared to the supernatant fluid. 
However, the supernatant fluid alone also resulted in a greater level of IL-8 
produced from U-937 cells as compared to live organism challenge.
Formalin- fixed L. pneumophila resulted in significantly higher levels of IL-8 
early during challenge and these levels remained steady over the 48 h period 
as compared to infection with live L. pneumophila (Figure 4.3). Culture of U- 
937 cells with either heat-killed or formalin-fixed L. pneumophila effected 
significantly higher levels of IL-10 detected in supernatant fluids compared 
with fluids from U-937 cells challenged with live L. pneumophila (p < 0.03 
and 0.008) (Figure 4.5). To define where the cytokine inducing molecule(s) 
were located on L. pneumophila organisms, similar studies to those
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Figure 4.1: Interleukin-1 [5 secretion from human macrophage-like U-937 cells 
challenged with live, heat-killed or formalin-fixed L. pneumophila. Control 
cultures did not receive L. pneumophila. Supernatant fluids were collected at 
the indicated time points during challenge and assayed for cytokine 
production by ELISA. Results are expressed as means ± standard deviations 
from three separate experiments each of which were conducted in triplicate (i. 
e. 9 values/data point). *p < 0.005. Data for control and following inoculation 
with heat-killed or formalin-fixed organisms remained at base- line levels.
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Figure 4.2: Tumor necrosis factor-a secretion from human macrophage-like 
U-937 cells challenged with live, heat-killed or formalin-fixed L. 
pneumophila. Control cultures d id  not receive L. pneumophila.
Supernatant fluids were collected at the indicated time points during 
challenge and assayed for cytokine production by ELISA. Results are from 
three separate experiments each of which were conducted in triplicate (i. e. 9 
values/data point). All figures remained at base-line levels throughout these 
experiments. Control positive assays and standard curves were normal.
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Figure 4.3: Interleukin-8 secretion from human macrophage-like U-937 cells 
challenged with live, heat-killed or formalin-fixed L. pneumophila. Control 
cultures did not receive L. pneumophila. Supernatant fluids were collected at 
the indicated time points during challenge and assayed for cytokine 
production by ELISA. Results are expressed as means ± standard deviations 
from three separate experiments each of which were conducted in triplicate (i. 
e. 9 values/data point). *p < 0.006, **p < 0.03.
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Figure 4.4: Interleukin-8 secretion from human macrophage-like U-937 cells 
challenged w ith live or heat-killed (supernatant fluid or bacterial pellet) L. 
pneumophila. Control cultures did not receive L. pneumophila.
Supernatant fluids were collected at the indicated points during challenge and 
assayed for cytokine production by ELISA. Results are expressed as means ± 
standard deviations from three separate experiments each of which were 
conducted in triplicate (i. e. 9 values/data point). *p = 0.0286.
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Figure 4.5: Interleukin-10 secretion from human macrophage-like U-937 cells 
challenged with live, heat-killed or formalin-fixed L. pneumophila. Control 
cultures did not receive L. pneumophila. Supernatant fluids were collected at 
the indicated time points during challenge and assayed for cytokine 
production by ELISA. Results are expressed as means ± standard deviations 
from three separate experiments each of which were conducted in triplicate (i. 
e. 9 values/data point). *p < 0.03, **p < 0.008.
123














Figure 4.6: Interleukin-10 secretion from hum an macrophage-like U-937 cells 
challenged with live or heat-killed (supernatant fluid or bacterial pellet) L. 
pneumophila. Control cultures did not receive L. pneumophila.
Supernatant fluids were collected at the indicated time points during 
challenge and assayed for cytokine production by ELISA. Results are 
expressed as means ± standard deviations from three separate experiments 
each of which were conducted in triplicate (i. e. 9 values/data point). *p = 
0.0286.
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Figure 4.7: Interleukin-12 secretion from human macrophage-like U-937 cells 
challenged w ith live, heat-killed or formalin-fixed L. pneumophila. Control 
cultures did not receive L. pneumophila. Supernatant fluids were collected at 
the indicated time points during challenge and assayed for cytokine 
production by ELISA. Results are expressed as means ± standard deviations 
from three separate experiments each of which were conducted in triplicate (i. 
e. 9 values/data point).
125












Figure 4.8: Interferon-y secretion from human macrophage-like U-937 cells 
challenged with live, heat-killed or formalin-fixed L. pneumophila. Control 
cultures did not receive L. pneumophila. Supernatant fluids were collected at 
the indicated time points during challenge and assayed for cytokine 
production by ELISA. Results are expressed as means ± standard deviations 
from three separate experiments each of which were conducted in triplicate (i. 
e. 9 values/data point).
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conducted for IL- 8  were performed for IL-10. Similar results were obtained
(Figure 4.6). Significant levels of IL-12 and IFN-y were not detected in
supernatant fluids from U-937 cells challenged with either heat-killed or 
formalin-fixed L. pneumophila (Figure 4.7 and 4.8 respectively).
4.5 Discussion
To date, there has been a concerted effort to better understand the host's 
immune response to infection with facultative intracellular bacterial 
pathogens such as L. pneumophila. However, in contrast to data available for 
cytokine responses to infection with M. tuberculosis, L. monocytogenes and 
other intracellular pathogens, the nature of the host immunologic response 
to L. pneumophila in terms of cytokine expression remains rudimentary. In 
vitro studies have focused on the importance of phagocytic cells parasitized by 
L. pneumophila and these have afforded much of our data on the 
intracellular replication of L. pneumophila (153, 250, 188, 370). Several
studies have suggested the importance of selected cytokines including IFN-y
and TNF-a as tools for suppression of intracellular replication of L. 
pneumophila in both monocytes and macrophages in vitro (11, 31, 65, 149, 23, 
249,313).
The macrophage-like U-937 cell represents a useful model for 
investigating cellular infection by L. pneumophila as has been shown in this
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report and by others (153,190,267,286). In the present study, intracellular 
replication of L. pneumophila in U-937 cells was shown to induce high levels
of the proinflammatory cytokine IL-lp. Historically, the production of IL-ip
and TNF-a by cells represents one of the first activation signals used by the
host to combat infection. Interestingly, conflicting data exist regarding TNF-a
production from cells in vitro. Matsiota et al. (230) showed that TNF-a levels 
in culture supernatant fluids from L. pneumophila infected hum an 
monocytes were low and were enhanced only after the addition of IFN-y. 
However, Blanchard et al. (38) demonstrated that Legionella-infected 
monocytes were found to produce TNF-a in a dose-dependent response to the
number of infecting bacteria, and the addition of recombinant IFN-y to
infected monocytes resulted in augmented production of TNF-a in a
synergistic manner. In this study TNF-a was not elicited following L.
pneumophila challenge in vitro. Furthermore, the viability of L. 
pneumophila appears to be relevant to the host response during infection, as 
U-937 cells cultured with heat-killed or formalin-fixed L. pneumophila failed
to elicit a potent IL-ip response suggesting that viable bacteria in some way 
actively modify or induce the production of some cytokines. It is unlikely 
that heat killing of L. pneumophila alone completely destroyed im portant 
surface epitopes on this organism since challenge of U-937 cells with
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formalin- fixed L. pneumophila resulted in similar cytokine profiles.
Macrophages readily support intracellular replication of L. 
pneumophila while polymorphonuclear leukocytes possess potent 
bacteriocidal activities for this organism (8 6 , 186). Based on this observation 
the ability of L. pneumophila to modify the production of IL-8 , a potent 
chemo-attractant and activator of neutrophils, by macrophages was examined. 
It was demonstrated in this study that IL- 8  is secreted from Legionella-infected 
cells. However, U-937 cells cultured with heat-killed Legionella produced 
significantly greater levels of IL-8  as compared to live organism challenge, at 
all time points investigated. Heat killing of L. pneumophila may result in the 
unmasking of cryptic epitopes that may be responsible for this observed effect. 
In addition, formalin fixation which maintains the structure of the outer 
surface of bacteria, indicates that the structure responsible for the increased 
levels of IL-8  may be located on the surface of the organism. Further studies 
were conducted to delineate whether the molecule(s) responsible for the 
increased levels of IL- 8  following heat killing of L. pneumophila were located 
on the surface of the organisms or were being secreted by L. pneumophila. 
These studies included challenging U-937 cells for their ability to induce 
cytokines with either the bacterial pellet or the wash fluids from L. 
pneumophila following heat inactivation. These results indicated that the 
pellet was able to induce significantly greater levels of IL-8  as compared to the 
supernatant fluid. However, the supernatant fluid alone also resulted in a
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greater level of IL- 8  produced from U-937 cells as compared to live organism 
challenge. Thus, preliminary data suggests that epitopes on the surface of the 
organism when heat-killed are in part responsible for the increased levels of 
IL-8  secreted from U-937 cells. That the supernatant wash fluid from heat- 
killed organisms resulted in a significantly greater level of IL- 8  than did live 
L. pneumophila suggested that the mechanism of IL-8  induction is a 
multifactorial process and both surface and secreted molecules may by 
responsible for the increased IL-8  response. That the molecule responsible for 
this cytokine induction is the MOMP of Legionella cannot be excluded. The 
significant difference in levels of IL- 8  secreted from U-937 cells treated with 
heat-killed L. pneumophila versus live L. pneumophila is interesting in that 
this chemokine is involved in neutrophil activation and recruitment in 
vivo. This m ay represent one mechanism by which Legionella limits 
neutrophil accumulation at the site of infection. In this fashion the local 
chemokine production is interrupted, thus allowing subsequent invasion of 
alveolar macrophages to precede. The importance of this observation cannot 
be overstated and requires further investigation in order to elucidate the 
importance of IL- 8  and other chemokines in the outcome of Legionnaires' 
disease.
Park et al. (264) showed that peripheral blood monocytes challenged in 
vitro with L. pneumophila produce IL-10. In contrast, in this study, infection 
of U-937 cells with L. pneumophila resulted in a down-regulation of IL-10 as
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compared to uninfected controls. In these studies, IL-10 was constitutively 
expressed from phorbol ester treated U-937 cells. Challenge of U-937 cells 
with viable L. pneumophila suppressed IL-10 levels in culture supernatant 
fluids even below those levels expressed by uninfected cells. Interestingly, 
U-937 cells challenged with either heat-killed or formalin-fixed L. 
pneumophila produced significantly greater levels of IL-10 than did cells 
infected with live L. pneumophila or control cultures indicating that viable L 
pneumophila suppresses IL-10 production. To assess where the cytokine 
inducing molecules were located on L. pneumophila, similar studies to those 
conducted for IL- 8  were performed for IL-10 and similar results were obtained 
Indeed, like IL-8 , the results for IL-10 indicated that the molecule(s) 
responsible for the increased level of this cytokine were located on the 
bacterial surface; however, this molecule(s) may also be secreted from the 
bacterial surface. Again, the MOMP of Legionella is a likely candidate 
molecule. Work by Blander and Horwitz (43, 42, 41) have shown that the 
metalloprotease and outer membrane material of L. pneumophila, elicit 
cellular immune responses in guinea pigs. It is known that IL-10 is a potent 
down-regulator of host immune response (118, 147, 148, 199, 309). Previous 
studies have addressed the importance of IL-10 during L. pneumophila 
infection of cells by administering exogenous IL-10 to human alveolar 
macrophages and monocytes and suggest that treatment of alveolar 
macrophages w ith IL-10 exacerbated Legionella infection (264). Thus, based
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on these results it w as expected that IL-10 would be produced from U-937 cells 
following challenge w ith a permissive infection. Interestingly, this was not 
what was observed. This would suggest that the interaction of L. 
pneumophila with U-937 cells resulted in decreased levels of IL-10 and this 
led to a permissive cellular infection.
It is widely accepted that a potent host imm une response is required for 
resolution of Legionnaires' disease. Therefore, it was expected that cells 
infected with L. pneumophila would produce high levels of those cytokines 
well recognized to be important mediators of cell-mediated host immune 
response. However, the in vitro studies did not detect appreciable levels of
IL-12 or EFN-y in culture supernatant fluids. These results may offer one
reason why U-937 cells infected with L. pneumophila are readily destroyed. 
This may represent a limitation of in vitro studies that use a single cell type 
in monoculture. That exogenous EFN-y treatment of monocytes resulted in 
down-regulation of host cell infection further supports the suggestion that 
the source of EFN-y may not come from macrophages but from another cell 
type (31, 249). The importance of this observation for the establishment and 
progression of Legionnaires' disease requires further study to better 
understand which cells in the lungs produce EFN-y during infection. In 
addition, the complex interactions of specific cytokines in response to L. 
pneumophila infection need to be addressed if a rationale is to be developed
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so that the host's response may be manipulated to combat disease. In this 
study, the host response to L. pneumophila was characterized by investigating 
several classes of cytokines produced during L. pneumophila challenge.
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CHAPTER V
IN  VIVO ANIMAL MODEL OF EXPERIMENTAL LEGIONNAIRES' DISEASE
5.1 Abstract
An experimental model of Legionnaires' disease was established in the 
A /J mouse using Legionella pneumophila strain Nottingham 7. Initially, an 
effective dose 50 (ED5Q) was established with this strain and mouse lungs were
harvested for both gross pathology and histopathology. An ED5Q was defined
as the inoculum of L. pneumohila that resulted in 50 % of the infected mice 
becoming mouribund at which point it was determined that they would not 
recover from infection and were euthanized. Following the ED5Q study, a
sublethal infection of L. pneumophila was used to investigate the replication 
of bacteria and the pathology of the resultant pneumonic changes induced in 
the lungs of mice over time. The ED50 was calculated to be 4.63xl06.
Pathological and histopathological changes were evident when challenges of 
106 to 109 organisms were used. To better characterize the 
immunostimulatory effect of L. pneumophila in vivo, A /J mice were 
infected intratracheally with a sublethal dose (lxlO6 CFU) of either live or 
heat-killed L. pneumophila. Live challenge resulted in an initial 8 -fold
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increase in the numbers of L. pneumophila in the lungs within an initial 
24 h period and this was followed with gradual clearing of the organism by 
120 h. Gross pathologic and histopathologic evaluations revealed a 
progression of diseased state. Bronchoalveolar lavage (BAL) fluids, lung 
homogenates and sera were collected from mice challenged with live or heat- 
killed L. pneumophila and were tested for the presence of various cytokines 
in response to Legionella infection. BAL fluids and homogenates of lung 
tissue from L. pneumophila-infected mice contained significantly higher
levels of IL-ip, TNF-a, macrophage inflammatory protein 2 (MIP-2), IL-12 
(p40 and p70), and IFN-y as compared to uninfected animals. Serum cytokine 
levels demonstrated a systemic rise in IL-1|5, MIP-2, IL-12 (p40 and p70) and
IFN-y from L. pneumophila-infected A /J mice. TNF-a was not detected in
the sera of A /J mice challenged with L. pneumophila. IL-10 was not detected 
in any samples from either infected or control mice. A /J mice challenged 
with heat-killed L. pneumophila did not develop gross pathologic or 
histopathologic changes and failed to elicit significant levels of cytokines in 
BAL fluids, lung homogenates or sera. These results suggest that L. 
pneumophila elicited a potent yet specific cytokine response in A /J mice.
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5.2 Introduction
The use of single cell systems is critical to understanding how 
individual cell types respond to challenge with L. pneumophila. However, 
these systems provide limited insight into the complex interactions involved 
in the infection of an animal host. Historically, the guinea pig (132, 120, 87), 
rat (315) and ham ster (263) models have been used to study the progression of 
Legionnaires' disease, but have not been useful for studying the host immune 
response to L. pneumophila infection, in part, due to the lack of specific 
immunologic reagents available for these species. The use of animal models, 
primarily the guinea pig, have yielded insight into the under lying processes 
that occur following inhalation of L. pneumophila into the lung and have 
confirmed the host cellular response to L. pneumophila challenge.
Yamamoto et al. (370) established that peritoneal macrophages of A /J mice 
supported L. pneumophila replication, while peritoneal macrophages from 
other mouse strains, including BALB/c, BDF1, C3H/HeN, C57BL/6 and 
DBA/2, were resistant to Legionella infection. Prior to these studies it was 
believed that mice were uniformly resistant to L. pneumophila infection and 
thus represented a poor model for studying this condition.
Recently, there has been a recrudescence in the interest to better 
understand the host's immune response, particularly to elucidate any role 
that cytokines may play in regulating infection systemically. To date there is 
limited information regarding the production of cytokines during L.
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pneumophila infection in animal models. Brieland et al. (55) developed a 
surgical model of Legionnaires' disease pneumonia using A /J mice and this 
has been shown to closely mimic the progression of hum an disease in many 
respects. A major advantage of this development is the abundance of 
immunologic reagents available for the mouse and this has allowed for a 
more intense study of the immune response following pneumonic infection
with Legionella. IFN-y, TNF-a and IL-12, as well as nitric oxide, have been 
detected in lung homogenate fluids of A /J mice challenged with L. 
pneumophila (55, 58, 59). Recently, Brieland et al. (59) showed that mice 
depleted of IL-12 by treatment with an IL-12 specific blocking monoclonal 
antibody, developed an increase in L. pneumophila replication with 
exacerbated pneumonic changes in the lungs of mice following challenge. 
Although not characterized definitively, it was suggested by these workers, 
that inhibition of IL-12 was presumably functioning through the modulation
of TNF-a.
To develop a better understanding of the complex immunologic 
response to L. pneumophila, in vivo studies were conducted using A /J mice, 
to study experimental Legionnaires' disease. Both gross pathology and 
histopathology were documented during infection with live or inoculation 
with heat-killed L. pneumophila. In addition, the production of several 
classes of cytokines in response to L. pneumophila infection were 
investigated.
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5.3 Materials and Methods
Reagent formulations and preparation along with detailed procedures are 
given in Appendix 2.
5.3.1 Bacterial Cultivation
L. pneumophila serogroup 1, strain Nottingham N7 was grown and 
maintained as previously described (see Section 2.3.1). Following 24 h of
growth in 5 ml of BYE-a media, 1 ml of L. pneumophila was placed in sterile
Eppendorf tubes and centrifuged at 6,000 x g for 5 min. Supernatant fluid was 
removed and the bacterial pellet was washed three times with pyrogen-free 
Dulbecco's phosphate buffered saline (DPBS ) (Cellgro). Bacteria were then 
resuspended in 1 ml fresh DPBS and diluted to give a series of inocula of 
lxlO5 to lxlO9 CFU for animal effective dose ^  (ED 5Q) studies. Subsequent
sublethal challenge experiments used inocula of lxlO6 CFU. For heat-kill 
studies, L. pneumophila (lxlO6 CFU) in DPBS was boiled for 10 min. Heat 
killing was confirmed by plating organisms on BCYE-a. In addition, all 
bacterial inocula used for ED5Q and sublethal experiments were serially
diluted and plated on BCYE-a to determine CFU/ml of L. pneumophila.
5.3.2 Intratracheal Inoculation of Mice
A colony of A /J mice was established at the University of New
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Hampshire animal facility by breeding siblings from the same liter (Jackson 
Laboratories, Bar Harbor, Maine). Mice received food and water ad libitum 
and were housed, cared for and bred in accordance with NIH and University 
of New Hampshire Animal Care and Use Committee (ACUC) guidelines 
under protocol # 960905. Male or female inbred A /J mice 6  to 8  weeks old 
were placed into six groups each of 5 mice and anesthetized with 0.1 ml of a 10 
m g/m l solution of ketamine and xyaline. The skin of the ventral neck was 
shaved, swabbed with a tincture of iodine and an incision made through the 
skin of the ventral neck and the trachea isolated. For ED ^  studies, a 40 |il
volume of various doses (1x10s to lxlO9 CFU) of L. pneumophila in pyrogen- 
free DPBS was injected into the trachea of different groups of mice using a 1 
ml syringe with a 27-gauge needle (Plate 5.1). For sublethal challenge studies 
an inoculum of lxlO6 CFU of L. pneumophila was used for each mouse. The 
bacterial challenge inoculum was followed by 10 jil of air. Control animals 
received DPBS only. Three 4-0 absorbable subcuticular sutures were used to 
close the incision. Following challenge mice were placed in HEPA filter top 
cages and their behavior and eating patterns were observed six times daily 
over a period of 1 2  days. This included failure to groom, loss of mobility, 
failure to show normal patterns of activity and abnormal resting postures in 
which the animal appeared to be sleeping or was hunched up. Moribund 
mice were sacrificed by COz asphyxiation. The ED50 value was determined by
the method of Reed and Meunch.
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Plate 5.1. Intratracheal inoculation of L. pneumophila into an A /J mouse that 
has been anesthetized with ketamine and xyaline.
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5.33 Gross Pathology and Histopathologv
Following challenge with either live or heat-killed L. pneumophila, 
mice were euthanized by C02 asphyxiation and lungs were removed and
photographed for gross pathologic purposes. For histopathologic preparation, 
the trachea of euthanized mice was isolated, tied off and the lungs were 
perfused with 1 ml of a 10 % neutral buffered formalin solution. After 1 min, 
lungs were removed and stored in the same solution for processing by 
histologic procedures (Appendix 2). Briefly, lung samples were placed into 
histology embedding cassettes and washed overnight in water. Tissues were 
dehydrated in an ethanol series (70-100 %), placed in the clearing agent, 
Histoclear II (National diagnostics, Atlanta, GA.) and embedded in paraffin 
wax using a Shandon Citadel Tissue Processor (Shandon Lipshaw, Pittsburg, 
PA.). Six micron thick sections were cut using an American Optical 
Microtome and sections were deparaffinized, stained with Harris' Alum 
Hematoxylin and 0.1 % eosin (Appendix 2) and examined histopathologicallv 
using an Olympus optical microscope. Duplicate samples were stained with 
Steiner's stain (Appendix 2) for organism detection.
5.3.4 Replication of L. pneumophila in  Lungs of A/I Mice and Detection of 
Cytokine Production
Time course studies were performed to characterize the replication of 
L. pneumophila N 7 in the lungs of mice following sublethal challenge.
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Initially following surgery as well as at 12,24,48,72, 96 and 120 h post­
infection groups of animals (n = 5) were humanly euthanized by C 0 2,
according to ACUC protocol # 960905, and the lungs from challenged and 
control mice were aseptically harvested, weighed and homogenized for 5 min 
on ice in 10 ml sterile pyrogen-free DPBS in an electric Omni homogenizer.
A 100 |xl aliquot of each homogenate was serially diluted 10-fold and duplicate
25 pi samples of each dilution were plated on BCYE-a selective agar 
containing polymyxin B, anisomycin and cefamandole (BCYE + PAC, Becton- 
Dickinson, Cockeysville, MD). Legionella colonies were enumerated after 72 
h growth and the concentration of L. pneumophila were expressed as CFU per 
gram of lung tissue. To determine the levels of cytokines elicited following L. 
pneumophila infection, A /J mice were challenged with either a sublethal 
dose of live L. pneumophila or an equivalent number of heat-killed L. 
pneumophila as determined by previous growth curve studies conducted for 
the organism. At similar time points, BAL fluids and serum samples were 
collected from A /J mice (n = 5 per group). To collect BAL fluids, the trachea 
of sacrificed animals was tied off and the lungs lavaged with 1 ml pyrogen- 
free DPBS using a syringe with a 27-gauge needle. All lavages yielded similar 
volumes, with approximately 90 % recovery. BAL fluids were centrifuged at 
6 ,0 0 0  x g for 1 0  min, filtered through a 0 .2  pm filter, transferred to sterile 
Eppendorf tubes and stored frozen at -70"C until assayed for cytokine levels 
using murine cytokine-specific ELISA kits (R & D systems, Minneapolis,
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Minn.). Blood was collected from the dorsal aorta using a 1 ml syringe with a 
27-gauge needle, placed into sterile tubes, allowed to clot for 4 h at 4°C, then 
centrifuged at 1,000 x g for 10 min. Sera were collected, placed into sterile 
Eppendorf tubes and stored frozen at -70°C until assayed for levels of 
cytokines.
In separate experiments, lung homogenates were collected from 
similarly infected A /J mice. Lungs were harvested and homogenized and a 1 
ml sample of lung homogenate from challenged (live or heat-killed L. 
pneumophila) or control mice was centrifuged at 6,000 x g for 10 min. The 
supernatant fluid was filtered, transferred to sterile Eppendorf tubes and 
stored frozen at -70°C until assayed for cytokines. The non-parametric 
Mann-Whitney test was performed as described in section 4.3.5 to analyze 
differences in cytokine levels from BAL fluids, lung homogenates and sera of 
A /J mice that received DPBS, viable or killed legionellae.
5.4 Results
5.4.1 Pathogenesis and pathology. The ED5Q value for L. pneumophila
strain Nottingham 7 infection of A /J mice was determined and is illustrated 
in Table 5.1. The ED50 was calculated mathematically by the Reed and
Meunch method to be 4.63xl06 CFU/mouse. Gross and histopathological 
lesions induced in A /J mice after inoculation intratracheally with L. 
pneumophila were evident in the lungs and distributed throughout both
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Table 5.1. Effective dose ^  study administering L. pneumophila N7 to A/J 
mice via intratracheal challenge
Challenge
CFU L. pneumophila Alive animals /  Challenged animals
1x10s 5 / 5
lxlO6 5 / 5
lxlO7 1 / 5
lxlO8 0 / 5
1x109 0 / 5
Five mice were inoculated with each dilution of L. pneumophila and the 
ED50 was calculated mathematically from duplicate experiments to be 
4.63xl06 CFU. Control mice were injected w ith Dulbeccos phosphate buffered 
saline (DPBS) and in this group no deaths occured up to twelve days post­
challenge.
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right and left lobes. Plate 5.2 depicts lungs harvested from A/J mice that had 
received 1x10s to lxlO9 CFU of L. pneumophila. Control animals received 
DPBS. At lxlO7 CFU, A /J  mouse lungs were pale in color indicative of 
necrosis, while at lxlO8  and lxlO9 CFU severe hemorrhaging was observed.
Histopathological examination revealed pathological changes in the 
lungs of infected mice receiving lxlO5 to 1x109 CFU. At lx l 05 CFU the 
alveolar septa appeared thickened as compared to control sections, with the 
presence of congestion and possibly hemorrhage within the septa (Plate 5.3). 
Lung sections from animals that had received lxlO6 CFU exhibited an 
increase in cellular infiltrate and this consisted of PMNLs and mononuclear 
cells as detected at higher magnifications (Plate 5.4). In addition, edema was 
present and appeared as lightly pink staining areas while congestion of blood
r j
vessels was evident. At 1x10 CFU, the perivascular space was thickened and 
showed an increased presence of red blood cells when compared with controls 
(Plate 5.4). Dilation of capillaries and hemorrhaging within the alveolar septa 
were notable and indicated lysis of capillaries. Both cellular and protein-rich 
exudate were evident in addition to a reduction in the number of alveoli as 
compared to control lungs. As shown in Plate 5.5, at lxlO8 CFU, hemorrhage 
into the alveoli occurred as a result of disruption of blood vessel walls and 
this resulted in an overall loss of lung architecture. Animals receiving lxlO9 
CFU presented with severe congestion of blood vessels and hemorrhaging
145
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Plate 5.2. Lung gross pathology of A /J mice inoculated intratracheally with L. 
pneumophila during ED50 study.
A) From left to right; control lung from A /J mouse inoculated intratracheally 
with Dulbeccos phosphate buffered saline (DPBS), A /J mouse lungs infected 
with 105 and 106 CFU of L. pneumophila respectively. B) From left to right; 
A /J mouse lungs infected with 107, 108, and 109 CFU of L. pneumophila. At 
1 0 7 CFU, A /J  mouse lung is pale indicative of necrosis and at 108 and 109 CFU 
hemorrhaging is observed.
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Plate 5.3. Histological sections of lung tissue from A /J  mice inoculated 
intratracheally w ith  L. pneumophila during ED50 study. Hematoxylin and 
eosin stain.
A) Control lung inoculated intratracheally with DPBS (X 255). B) A/J mouse 
lung infected w ith  105 CFU of L. pneumophila. Note thickened alveolar septa 
with increased presence of red blood cells (RBCs) as compared to control lungs 
(X 255).
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Plate 5.4. Histological sections of lung tissue from A /J mice inoculated 
intratracheally w ith  L. pneumophila during ED50 study. Hematoxylin and 
eosin stain.
A) A /J mouse lung infected with 106  CFU of L. pneumophila. Note increase 
in cellular infiltrate (X 255). B) A /J mouse lung infected with 107 CFU of L. 
pneumophila. Note congestion of blood vessels, thickened alveolar septa, 
fibrin strands present as light pink staining areas and the presence of both 
cellular and protein-rich exudate (X 294).
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Plate 5.5. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with L. pneumophila during ED50 study. Hematoxylin and 
eosin stain.
A) A /J mouse lung infected with 108 CFU of L. pneumophila. N ote 
hemorrhage into alveoli (X 255). B) A /J mouse lung infected with 109 CFU of 
L. pneumophila. Note congestion of blood vessels and hemorrhaging, and 
bronchioles filled with protein-rich material (X 128).
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Plate 5.6. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with 108 CFU of L. pneumophila during ED50 study. Steiner's 
stain. Note organisms within lung alveoli (X 1277).
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(Plate 5.5). In addition, bronchioles were filled with protein-rich material, 
indicative of a dysfunctional lung. As shown in Plate 5.6, L. pneumophila 
was visulalized during the ED50 study by using the silver nitrate based
Steiner's stain.
5.4.2 Sublethal infection. Following the ED^ study, a sublethal dose
(lxlO6 CFU) was chosen to investigate the in vivo replication of L. 
pneumophila with time. In addition, gross pathology and histopathology 
coinciding with bacteriologic replication were evaluated. L. pneumophila 
strain Nottingham 7 was able to replicate within the lungs of A /J mice and 
this resulted in both gross and histopathological changes. There was an 8 -fold 
increase in L. pneumophila replication 12 to 24 h after intratracheal 
inoculation (Figure 5.1). Over the next 12 h (between 24 to 36 h), growth of L. 
pneumophila in the lung plateaued and at 48 to 120 h L. pneumophila was 
gradually cleared from the lungs, although low numbers of bacteria were still 
detected in lung homogenates of mice five days post infection.
During the course of L. pneumophila infection gross and 
histopathological evidence of infection were demonstrated in mice 
inoculated with lxlO6 CFU. At 24 h  post-infection, changes in lung 
appearance were evident as compared to controls (Plate 5.7). Changes were 
observed during the course of infection and at 72 h and 96 h post-challenge,
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Figure 5.1: Replication of L. pneumophila in the lungs of A /J mice over time. 
L  pneumophila was administered (1x106 bacteria per mouse) to A/J mice 
intratracheally, animals were euthanised at the indicated time points and 
lungs were removed and homogenized. Tissue homogenates were diluted 
and plated onto BCYE-PAC plates and colonies were counted after 72 h.
Results are expressed as means ± standard deviations from five separate 
experiments each using five mice per time point. Data are calculated as CFU/ 
gram lung tissue.
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hemorrhagic necrosis was present in the right and left lobes of the lung (Plate 
5.8 and 5.9). At 120 h  post-infection, the lobes of the lung were often dark in 
color due to hemorrhage and the lungs appeared pale as compared to controls 
which were pink and healthy looking (Plate 5.9). Histopathological changes 
were documented over time during the course of L. pneumophila infection. 
Plates 5.10 through 5.17 illustrate the progression of infection during 
replication of L. pneumophila within A/J mouse lungs. Histopathological 
changes were evident by 24 h post-infection (Plate 5.12) and were present 
throughout the course of the infection including at 120 h  post-challenge (Plate 
5.17), when, according to VBCC counts (Figure 5.1), only low number of L. 
pneumophila were present. These changes included increased cellular and 
proteinaceous exudate, extreme thickening of the interalveolar septa, a 
reduction in the number and structure of opened alveoli and an increased 
presence of red blood cells as compared to control sections (Plate 5.11-5.15). 
Throughout the course of infection alveolar wall thickening was observed 
and fibrin deposits in the alveoli were present by 72 h post-infection (Plate 
5.15). Bronchi and bronchioles were essentially normal in appearance, except 
at later time points (Plate 5.16). Edema with scattered PMNLs were noted in 
perivascular spaces during infection (Plates 5.15 and 5.16). In addition, to 
characterize the effect of L. pneumophila viability on the organism 's ability to 
induce pathologic and histopathologic changes in vivo, A /J mice were 
challenged intratracheally with a sublethal dose (lxlO6 CFU) of heat-killed L.
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Plate 5.7. Lung gross pathology of A /J mice inoculated intratracheally with a 
sublethal dose (106 CFU) of L. pneumophila. A /J mice were challenged with 
either live or heat-killed L. pneumophila.
A) Control lung from A /J mouse inoculated intratracheally with DPBS. B) 
A /J mouse lung challenged w ith heat-killed L. pneumophila 6 h post­
challenge. C) A /J mouse lung infected with live L. pneumophila 6 h post­
challenge. D) A /J mouse lung challenged with heat-killed L. pneumophila 
24 h post-challenge. E) A /J mouse lung infected with live L. pneumophila 24 
h post-challenge.
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Plate 5.8. Lung gross pathology of A /J mice inoculated intratracheally with a 
sublethal dose (106 CFU) of L. pneumophila. A /J mice were challenged with 
either live or heat-killed L. pneumophila.
A) A /J mouse lung challenged with heat-killed L. pneumophila 48 h post­
challenge. B) A /J mouse lung infected with live L. pneumophila 48 h post­
challenge. C) A /J mouse lung challenged with heat-killed L. pneumophila 
72 h post-challenge. D) A /J mouse lung infected with live L. pneumophila 
72 h post-challenge. Note hemorrhagic necrosis in upper left and lower right 
lobes of lung.
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Plate 5.9. Lung gross pathology of A /J mice inoculated intratracheally with a 
sublethal dose (106 CFU) of L. pneumophila. A /J  mice were challenged with 
either live or heat-killed L. pneumophila.
A) A /J mouse lung challenged with heat-killed L. pneumophila 96 h post­
challenge. B) A /J mouse lung infected with live L. pneumophila 96 h post­
challenge. Note hemorrhagic necrosis in both lobes of lung. C) A/J mouse 
lung challenged with heat-killed L. pneumophila 120h post-challenge. D) 
A /J mouse lung infected with live L. pneumophila 120 h post-challenge. 
Note hemorragic necrosis in upper left lobe of lung.
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Plate 5.10. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 6 h post­
challenge. A /J mice were challenged with either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A /J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J  mouse lung infected with live L. pneumophila (X 255).
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Plate 5.11. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 12 h post­
challenge. A /J mice were challenged with either live or heat killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A /J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note RBCs and few 
inflammatory cells within blood vessel (X 255).
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Plate 5.12. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CPU) of L. pneumophila 24 h post­
challenge. A /J mice were challenged w ith either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A /J mouse lung challenged w ith heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note thickened 
interalveolar septa and increase of inflammatory cells (X 255).
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Plate 5.13. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 36 h post­
challenge. A /J mice were challenged with either live or heat killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J  mouse inoculated intratracheally with DPBS (X 
255). B) A /J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note thickened 
interalveolar septa and increase of inflammatory cells and limited number of 
opened alveoli (X 255).
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Plate 5.14. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 48 h post­
challenge. A /J mice were challenged with either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A/J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note thickened 
interalveolar septa and increased presence of RBCs (X 255).
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Plate 5.15. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 72 h post­
challenge. A /J mice were challenged with either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A/J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected w ith live L. pneumophila. Note marked 
increase of inflammatory cells, thickened interalveolar septa, limited number 
of opened alveoli, fibrin deposits and increased presence of RBCs. Both 
cellular and protein-rich exudate are present (X 255).
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Plate 5.16. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 96 h post­
challenge. A/J mice were challenged with either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A/J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note marked 
increase of inflammatory cells, thickened interalveolar septa, limited number 
of opened alveoli, fibrin deposits and increased presence of RBCs. Both 
cellular and protein-rich exudate are present. Terminal bronchioles are filled 
with cellular exudate (X 255).
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Plate 5.17. Histological sections of lung tissue from A /J mice inoculated 
intratracheally with a sublethal dose (106 CFU) of L. pneumophila 120 h post­
challenge. A /J mice were challenged with either live or heat-killed L. 
pneumophila. Hematoxylin and eosin stain.
A) Control lung from A /J mouse inoculated intratracheally with DPBS (X 
255). B) A /J mouse lung challenged with heat-killed L. pneumophila (X 255). 
C) A /J mouse lung infected with live L. pneumophila. Note increase of 
inflammatory cells, thickened interalveolar septa, limited number of opened 
alveoli, and increased presence of RBCs. Both cellular and protein-rich 
exudate are present (X 255).
174
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
175
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission
pneumophila. Plates 5.7 through 5.9 depict the gross pathology associated 
with lungs of A /J mice treated with heat killed L. pneumophila while plates 
5.10 to 5.17 show the histopathological appearance of lungs. There was 
relatively no pathological or histopathological changes associated with 
challenge of A /J mice with heat-killed L. pneumophila.
5.4.3 Cytokine determination from murine specimens following 
sublethal challenge. The profiles of IL-lp ,TNF-a, MIP-2, IL-10, IL-12 (p40 and
p70) and IFN-y from BAL fluids and lung homogenates of A /J mice were 
examined immediately following sublethal intratracheal challenge with L. 
pneumophila N7 as well as at 12, 24, 48, 72 and 96 h post-infection. The 
proinflammatory cytokines IL-ip and TNF-a were detected in both BAL fluids 
and lung homogenates at 12 h post-challenge with live L. pneumophila. 
Levels of IL-ip were maximal in BAL fluids at 48 h post-infection (402 ± 86 
pg/ml) (Figure 5.2) while maximum levels in lung homogenates were 
detected at 72 h post-infection (4029 ± 1688 pg/m l) (Figure 5.3). Maximal 
levels of TNF-a were detected at 48 h in both BAL fluids (Figure 5.5) and lung
homogenates (Figure 5.6) (1973 ± 238 pg /m l and 4422 ± 1677 pg/m l 
respectively). The C-X-C chemokine, MIP-2, a potent activator of neutrophil 
activation and a potent neutrophil attractant, reached maximum levels in 
BAL fluids at 24 h post-challenge (331 ± 69 pg/ml) (Figure 5.8) and in lung
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homogenates at 48 h  (2800 ± 267 pg/m l) (Figure 5.9). As IL-12 is an important 
mediator of cell-mediated host responses, the ability of A /J mice to produce 
localized IL-12 during L. pneumophila infection was evaluated. IL-12 p40 
reached maximum levels in BAL fluids 72 h post-infection (824 ± 64 pg/ml) 
(Figure 5.11) and in lung homogenates by 48 h post-challenge (3868 ± 2208 
pg/ml) (Figure 5.12). In addition, the heterodimeric, biologically active form 
of IL-12, p70 protein, reached maximum levels in BAL fluids (Figure 5.14) and 
in lung homogenates (Figure 5.15) at 48 h post-challenge (415 ± 136 pg/m l and 
958 ± 583 pg/m l respectively). IFN-y reached peak levels at 72 h post-infection
in both BAL fluids (2345 ± 555 pg/m l) (Figure 5.17) and lung homogenates 
(1579 ± 432 pg/ml) (Figure 5.18). IL-10 was not detected in either BAL fluids or 
lung homogenates following L. pneumophila challenged (Figure 5.20 and 5.21 
respectively)
In contrast, the levels of cytokines detected in serum differed from 
those detected in BAL fluids or lung homogenates. Although IL-lp was 
induced by L. pneumophila infection, it was detected only at low levels and 
reached a peak at 48 h post-infection (64 ± 20 pg/ml) (Figure 5.4).
Furthermore, very low levels of TNF-a were detected in sera of infected A/J 
mice (Figure 5.7). A significant rise in the levels of IL-12 p40 and IL-12 p70 
(Figures 5.13 and 5.16 respectively) were detected in sera from Legionella- 
infected mice as compared to uninfected animals. IL-12 p40 was detected
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Figure 5.2: Interleukin-1 p production from bronchoalveolar lavage fluids of 
A/J mice challenged with either live or heat-killed L. pneumophila. A/J 
mice were inoculated intratracheally with L. pneumophila (lxlO6 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 ml sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p < 
0.0001 (live vs. heat-killed and control).
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Figure 5.3: Interleukin-1(5 production from lung homogenates of A /J mice 
challenged with either live or heat-killed L. pneumophila. A /J mice were 
inoculated intratracheally with L. pneumophila (lxlO6 bacteria per mouse), 
mice were sacrificed at the indicated time points and lungs were removed and 
homogenized and assayed for cytokine production by ELISA. Results are 
expressed as means ± standard deviations from three separate experiments 
each consisting of five mice per group at each time point. *p < 0.0001 (live vs. 
heat-killed and control).
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Figure 5.4: Interleukin-1 P production from sera of A /J mice challenged with 
either live or heat-killed L. pneumophila. A /J mice were inoculated 
intratracheally w ith L. pneumophila (lxlO6 bacteria per mouse), mice were 
sacrificed at the indicated time points, serum was collected and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p < 0.03, **p = 0.0022 (live vs. heat-killed and 
control).
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Figure 5.5: Tumor necrosis factor-a production from bronchoalveolar lavage 
fluids of A /J mice challenged with either live or heat-killed L. pneumophila. 
A /J mice were inoculated intratracheally with L. pneumophila (lxlO6 bacteria 
per mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 m l sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p < 
0.0006, **p < 0.03 (live vs. heat-killed and control).
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Figure 5.6: Tumor necrosis factor-a production from lung homogenates of 
A /J mice challenged w ith either live or heat-killed L. pneumophila. A/J 
mice were inoculated intratracheally with L. pneumophila (1x106 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
removed and homogenized and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p < 
0.0001 (live vs. heat-killed and control).
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Figure 5.7: Tumor necrosis factor-a production from sera of A /J mice 
challenged with either live or heat-killed L. pneumophila. A /J mice were 
inoculated intratracheally with L. pneumophila (lxlO6 bacteria per mouse), 
mice were sacrificed at the indicated time points, serum was collected and 
assayed for cytokine production by ELISA. Results are expressed as means ± 
standard deviations from three separate experiments each consisting of four 
mice per group at each time point.
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Figure 5.8: Macrophage inflammatory protein-2 production from 
bronchoalveolar lavage fluids of A /J mice challenged with either live or heat- 
killed L. pneumophila. A /J mice were inoculated intratracheally with L. 
pneumophila (lxlO6 bacteria per mouse), mice were sacrificed at the indicated 
time points and lungs were lavaged with 1 ml sterile DPBS and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p = 0.0002, **p = 0.0207 (live vs. heat-killed and 
control).
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Figure 5.9: Macrophage inflammatory protein-2 production from lung 
homogenates of A /J  mice challenged with either live or heat-killed L. 
pneumophila. A /J mice were inoculated intratracheally with L. 
pneumophila (lxlO6 bacteria per mouse), mice were sacrificed at the indicated 
time points and lungs were removed and homogenized and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p < 0.0001, **p = 0.002 (live vs. heat-killed and 
control).
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Figure 5.10: Macrophage inflammatory protein-2 production from sera of A/J 
mice challenged w ith either live or heat-killed L. pneumophila. A /J mice 
were inoculated intratracheally with L. pneumophila (lxlO6 bacteria per 
mouse), mice were sacrificed at the indicated time points, serum was collected 
and assayed for cytokine production by ELISA. Results are expressed as means 
± standard deviations from three separate experiments each consisting of 
three mice per group at each time point. *p < 0.0001 (live vs. heat-killed and 
control).
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Figure 5.11: Interleukin-12 p40 production from bronchoalveolar lavage 
fluids of A /J mice challenged with either live or heat-killed L. pneumophila. 
A /J mice were inoculated intratracheally with L. pneumophila (lxlO6 bacteria 
per mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 ml sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p < 
0.0001, **p = 0.008 (live vs. heat-killed and control).
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Figure 5.12: Interleukin-12 p40 production from lung homogenates of A/J 
mice challenged with either live or heat-killed L. pneumophila. A /J mice 
were inoculated intratracheally with L. pneumophila (lxlO6 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
removed and homogenized and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p < 
0.0001 (live vs. heat-killed and control).
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Figure 5.13: Interleukin-12 p40 production from sera of A /J mice challenged 
with either live or heat-killed L. pneumophila. A /J mice were inoculated 
intratracheally with L. pneumophila (1x106 bacteria per mouse), mice were 
sacrificed at the indicated time points, serum was collected and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p < 0.0002, **p < 0.03 (live vs. heat-killed and 
control).
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Figure 5.14: Interleukin-12 p70 production from bronchoalveolar lavage 
fluids of A /J mice challenged w ith either live or heat-killed L. pneumophila. 
A /J mice were inoculated intratracheally w ith L. pneumophila (lxlO6 bacteria 
per mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 ml sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p = 
0.0002 (live vs. heat-killed and control).
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Figure 5.15: Interleukin-12 p70 production from lung homogenates of A/J 
mice challenged w ith either live or heat-killed L. pneumophila. A /J mice 
were inoculated intratracheally with L. pneumophila (lxlO6 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
removed and homogenized and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p = 
0.0022, **p = 0.0095 (live vs. heat-killed and control).
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Figure 5.16: Interleukin-12 p70 production from sera of A /J mice challenged 
with either live or heat-killed L. pneumophila. A /J mice were inoculated 
intratracheally w ith L. pneumophila (lxlO6 bacteria per mouse), mice were 
sacrificed at the indicated time points, serum was collected and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p < 0.0001 (live vs. heat-killed and control).
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Figure 5.17: Interferon-y production from bronchoalveolar lavage fluids of 
A /J mice challenged with either live or heat-killed L. pneumophila. A/J 
mice were inoculated intratracheally with L. pneumophila (lxlO6 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 ml sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means ± standard deviations from three separate 
experiments each consisting of five mice per group at each time point. *p <
0.008, **p < 0.0001 (live vs. heat-killed and control).
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Figure 5.18: Interferon-y production from lung homogenates of A /J mice 
challenged w ith  either live or heat-killed L. pneumophila. A /J mice were 
inoculated intratracheally with L. pneumophila (1x106 bacteria per mouse), 
mice were sacrificed at the indicated time points and lungs were removed and 
homogenized and assayed for cytokine production by ELISA. Results are 
expressed as means ± standard deviations from three separate experiments 
each consisting of five mice per group at each time point. *p < 0.0001 (live vs. 
heat-killed and control).
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Figure 5.19: Interferon-y production from sera of A /J mice challenged with 
either live or heat-killed L. pneumophila. A /J mice were inoculated 
intratracheally with L. pneumophila (1x106 bacteria per mouse), mice were 
sacrificed at the indicated time points, serum was collected and assayed for 
cytokine production by ELISA. Results are expressed as means ± standard 
deviations from three separate experiments each consisting of four mice per 
group at each time point. *p < 0.0001, **p = 0.0022 (live vs. heat-killed and 
control).
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Figure 5.20: Interleukin-10 production from bronchoalveolar lavage fluids of 
A /J mice challenged with either live or heat-killed L. pneumophila. A/J 
mice were inoculated intratracheally with L. pneumophila (1x106 bacteria per 
mouse), mice were sacrificed at the indicated time points and lungs were 
lavaged with 1 ml sterile DPBS and assayed for cytokine production by ELISA. 
Results are expressed as means from three separate experiments each 
consisting of three mice per group a t each time point.
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Figure 5.21: Interleukin-10 production from lung homogenates of A /J mice 
challenged with either live or heat-killed L. pneumophila. A /J mice were 
inoculated intratracheally with L. pneumophila (lxlO6 bacteria per mouse), 
mice were sacrificed at the indicated time points and lungs were removed and 
homogenized and assayed for cytokine production by ELISA. Results are 
expressed as means from three separate experiments each consisting of four 
mice per group at each time point.
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Figure 5.22: Interleukin-10 production from sera of A /J mice challenged with 
either live or heat-killed L. pneumophila. A /J mice were inoculated 
intratracheally with L. pneumophila (lxlO6 bacteria per mouse), mice were 
sacrificed at the indicated time points, serum was collected and assayed for 
cytokine production by ELISA. Results are expressed as means from three 
separate experiments each consisting of four mice per group at each time 
point.
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immediately after surgery. Levels declined during the next 12 h then rose 
steadily to reach maximum levels 48 h post-infection (201 ± 58 pg/m l). For IL- 
12 p70, peak levels were also detected at 48 h post-infection (125 ± 33 pg/ml).
EFN-y levels in the sera of mice were initially detected at 12 h post-infection 
and these rose steadily to reach peak levels at 72 h post-infection (337 ±31 
pg/ml) (Figure 5.19). IL-10 was not detected in the sera from either infected or 
uninfected mice (Figure 5.22). A /J mice challenged with heat-killed L. 
pneumophila did not produce detectable levels of any of the tested cytokines 
from BAL fluids, lung homogenates or serum.
5.5 Discussion
These in vivo studies have confirmed that L. pneumophila is able to 
replicate within the lungs of A /J mice. Intratracheal administration of a 
sublethal dose of L. pneumophila resulted in evident gross pathologic as well 
as histopathologic changes in the lung. Microscopic evaluation of lung tissue 
from L. pneumophila-infected mice presented with thickening of 
interalveolar septa, an increase in red blood cells present and evidence of both 
cellular and protein-rich exudate that extended to the terminal bronchioles 
during later time points. Despite the ability of A /J mice to resolve a sublethal 
L. pneumophila infection, pathology was associated with lung specimens 
even after organism clearance. During human disease L. pneumophila is 
atypical among pneumonic pathogens in that a slow rate of radiographic
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resolution is shown (110). This frequently lags behind clinical recovery; thus, 
the observation that there was pathology seen in mouse lungs even after 
organism clearance may be typical for L. pneumophila infections in this 
mouse model and in humans.
During L. pneumophila infection, A /J mice were able to mount a 
protective response to eradicate four orders of magnitude less than the 
maximum level of L. pneumophila in the lung. This was evidenced by the 
observation that L. pneumophila was cleared from lungs during later stages 
of infection. Therefore, this model provides insight into an 
immunocompetent host response, in which a protective immune response 
"naturally" develops in A /J  mice and allows resolution of infection. The 
mechanism of the response which allows for the development of L. 
pneumophila specific immune responses in vivo is unknown. Therefore, 
the focus of this study was to further investigate the production of the diverse 
classes of cytokine molecules in the A /J mouse model of Legionnaires7 
disease. L. pneumophila induced production of the proinflammatory 
cytokines IL-ip and TNF-a and these cytokines were detected in both BAL
fluids and lung homogenates during intracellular replication of L. 
pneumophila. Challenge of mice with heat-killed organisms failed to evoke
a potent IL-1(3 or TNF-a response as induced cytokine levels were similar to 
those of uninfected control animals. It is well known that IL-1(3 and TNF-a
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are crudal to host immunity. One important role for these molecules is to 
influence the localization of the inflammatory response to the site of 
infection by facilitating cell infiltration and up-regulation of cell adhesion 
molecules, thus setting the stage for immune cell migration into infected 
tissue (112, 216, 81). In this study the highest concentration of IL-ip and
TNF-a were observed in BAL fluids and lung homogenates indicating that 
the primary source of these molecules was from this site while, the serum 
levels of IL-lp and TNF-a were low. Similar observations by Yu et al. (372)
were made for site-specific elevated levels of TNF-a in the lungs of mice 
following repeated respiratory challenge w ith Pseudomonas aeruginosa while 
low levels of TNF-a were detected in the sera of mice. It has been observed in
vitro that TNF-a appears to play an important role in limiting L.
pneumophila infection (37, 314). The data suggest that the process by which
A /J mice resolve infection may be related, in part, to a potent TNF-a
response. However, the precise mechanisms by which these animals produce
TNF-a in response to live L. pneumophila and the role this cytokine plays in
infection require further study.
A potent cellular infiltrate was evident in the lung tissue of Legionella- 
infected A /J mice. In light of this observation, the production of MIP-2 in the 
A /J mouse model was investigated so that the role of those chemokines
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induced during experimental Legionnaires' disease might be elucidated. MIP- 
2 has been described as the mouse equivalent of human IL-8, a C-X-C 
chemokine (159, 304). This molecule is a potent regulator of neutrophil 
activation (81). MIP-2 was detected in lung homogenates of A /J mice infected 
with live L. pneumophila; however, when mice were challenged with heat 
killed organisms MIP-2 was not detected. Because this model represents an 
infection that may spontaneously resolve, it is possible that a critical antigen 
dose of L. pneumophila may be im portant to stimulate alveolar macrophages 
to secrete cytokines. This secretion threshold was not achieved by injection of 
lxlO6 heat-killed L. pneumophila. Further studies are necessary to resolve 
these differences.
In agreement with the work of Brieland et al., (59) data from this study 
suggested that IL-10 was not induced by L. pneumophila infection in vivo. 
This result may offer one reason why it is that A /J mice are eventually able to 
clear infection with sublethal inocula of L. pneumophila. Indeed, IL-10 has 
been shown to down-regulate and impair host defenses against a variety of 
pathogenic bacteria (118,199,147). In contrast, the presence of IL-12 has been 
shown to be critical to the induction of host resistance to intracellular 
pathogens and this may be a result of up-regulating the host cellular immune 
response (69,129,189, 343). In addition, it has been suggested that IL-12 plays a 
role in the host response to L. pneumophila (59). In this study, replication of 
L. pneumophila within the lungs of A /J mice stimulated the production of
202
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
both p40 and pTO components of IL-12 and this cytokine was detected in BAL 
fluids, lung homogenates and sera. IL-12 p40 levels were 10-fold higher than 
the biologically active heterodimer IL-12 p70 in limg homogenates of infected 
mice. It has been documented that cells producing IL-12 in vitro or in vivo 
secrete a 10 to 100-fold excess of p40 over the biologically active p70 
heterodimer (208, 321). Since the murine IL-12 p40 subunit can act as an IL-12 
receptor antagonist by binding to the IL-12 p i receptor subunit which results 
in blocking the binding of the IL-12 heterodimer, it may be that this represents 
an important process for controlling IL-12 activity. Because IL-12 can induce 
IFN-y gene transcription, it has the capacity to induce cytokine production,
predominantly IFN-y (67, 205). In this study IL-12 (p40 and p70) production
preceded the appearance of IFN-y in BAL fluids and this suggested that IL-12
may be influencing the production of IFN-y in A /J mice following L.
pneumophila infection. IFN-y was detected in lung homogenates and in sera
of A /J mice challenged with L. pneumophila. The importance of IFN-y has 
been addressed in numerous reports during infection with a number of 
intracellular pathogens (46, 84,89,128,196, 231, 247, 332). Host resistance to 
intracellular bacterial pathogens depends on cell-mediated immunity and
activation of macrophages by DFN-y. The administration of recombinant 
IFN-y was shown to protect mice against L. monocytogenes and lethal M.
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tuberculosis infection, while neutralization w ith anti-EFN-y antibodies 
markedly exacerbated these diseases (71,128). In addition, IFN-y has been 
shown to inhibit L. pneumophila replication in vitro (31, 38, 65, 149, 249). 
IFN-y in combination with other cytokines in vivo including, IL-12 and 
TNF-a, may serve to facilitate the elimination of L. pneumophila for mice
and may aid in subsequent recovery.
This study demonstrated that L. pneumophila was capable of inducing 
the production of several important groups of cytokines in the lungs and sera 
of A /J mice during L. pneumophila infection. A better understanding of the 
immune mechanisms involved in host protection are of utmost importance 
so that the potential for alternative therapeutic strategies for Legionnaires' 
disease may be realized. These may include cytokine therapy and 
modulation.
This study provides new insight into the interaction of L. 
pneumophila with the host using the in vivo mouse model. This study 
further demonstrates the usefulness of the A /J mouse strain to study the 
pathogenesis as well as the host's specific immune response during L. 
pneumophila infection and should be an invaluable model to aide in 
elucidating the specific host-bacterial interactions during L. pneumophila 
infection. In addition, this model may be used to investigate alternative 
therapeutic strategies to combat Legionnaries' disease.
204
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER VI
CONCLUSIONS
Legionnaires' disease is a severe and potentially fatal form of sporadic 
and epidemic pneum onia in humans. The causative agent, Legionella 
pneumophila, is a facultative intracellular bacterium that parasitizes alveolar 
macrophages and monocytes (188, 250). The organism is widely distributed in 
the environment and infection occurs through inhalation of contaminated 
aerosolized water droplets that descend into the lower respiratory tract 
leading to disease (90, 361). Attachment of this facultative intracellular 
pathogen to host cells forms the prelude to infection. Many such agents 
possess pili, fimbriae, capsular mucopolysaccharide, flagella, lectin-like 
molecules, and OMPs, all of which have been implicated as putative bacterial 
ashesins for parasitism of host cells (152, 24, 282,123, 317). It has been 
demonstrated that complement receptors, CR1 and CR3 on human 
monocytes are one mechanism by which L. pneumophila mediates 
phagocytosis in an opsonin-dependent system (266). Bellinger-Kawahara et 
al. (26) demonstrated that complement component C3 fixes
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exclusively to the MOMP of L. pneumophila via the alternative pathway of 
complement activation. Recently an opsonin-independent mechanism has 
been proposed (155, 154) in which L.pneumophila enters cells in the absence 
of opsonic components; however, this mechanism is less well understood. 
Gibson et al. (154) demonstrated that complement receptors were not essential 
for L. pneumophila attachment to host cells. Indeed, blocking studies using 
monoclonal antibodies specific for CR1, CR3, CR4 or their subunits did not 
inhibit bacterial binding and did not prevent the intracellular replication of L. 
pneumophila.
In the first part of this study, the role of the MOMP as an adhesin for 
binding L. pneumophila to macrophage-like U-937 cells was assessed in an 
environment devoid of antibody and complement. Previous work in our 
laboratory by High et al. (170) involved cloning and sequencing the 25 kDa 
MOMP of L. pneumophila. The gene encoding the 25 kDa MOMP of L. 
pneumophila was transformed into E. coli JM 83 and the resultant E. coli LP 
116 clone was shown to express the Legionella-MOMP in E. coli by Western 
blot analysis and immunofluorescence assay using both anti-L. pneumophila 
antiserum and Legionella-MOMP-specific MAb. The parent E. coli JM 83, and 
the genetically m utated E. coli JM 83 clone LP 116 were evaluated for 
attachment to macrophage-like U-937 cells. Comparison of E. coli JM 83 and 
LP 116 showed that the expression of the protein of the Legionella-MOMP 
gene facilitated organism binding to cells in the absence of opsonins. LP 116
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was 5 times more adherent than the parent E. coli strain by both VBCC counts 
and IFA. These results suggest that the MOMP of L. pneumophila was, in 
part, responsible for this opsonin-independent attachment to U-937 cells. As 
a facultative intracellular pathogen, L. pneumophila interacts with the cell 
membranes of alveolar macrophages prior to phagocytosis and, as a result, 
surface-located antigens are crucial to disease induction. It is postulated that 
an opsonin-independent mechanism of binding is central to the initial 
establishment of cell infection in the human lung. This is especially 
pertinent as it has been shown that the lung is essentially devoid of 
complement (277). The identification of the MOMP of L. pneumophila as an 
adhesive molecule which facilitates attachment of this organism to host cells 
may merit further investigation for the potential development of useful 
anti-adherence vaccines. Indeed, the use of this surface protein from L. 
pneumophila may prove useful for the prevention of Legionnaires' disease. 
Such vaccines could be of major importance for preventing infection and 
reducing mortality from Legionnaires' disease especially among high risk 
patients.
Resistance to and survival from legionellosis likely requires an active 
cellular immune response; however, the role of host immune responses in 
the pathogenesis of Legionnaires' disease is incompletely understood. In this 
study, a biphasic approach was taken, using both in vitro and in vivo models 
of experimental Legionnaires' disease to elucidate the production of various
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classes of cytokines during infection; thus, gaining a better understanding of 
the host response during L. pneumophila infection. Replication of L.
pneumophila w ithin adherent U-937 cells elicited the production of IL-ip and
IL-8, while expressed levels of TNF-a, IL-12 and IFN-y were not affected. 
Interestingly, U-937 cells challenged with L. pneumophila produced decreased 
levels of IL-10 as compared to uninfected controls. U-937 cells cultured with 
heat killed Legionella produced significantly greater levels of IL-8 and IL-10 as 
compared to live organism challenge. Heat kill of L. pneumophila may result 
in the unmasking of cryptic epitopes that may be responsible for this observed 
effect. In addition, formalin fixation which maintains the structure of the 
outer surface of bacteria, indicated that the molecule(s) responsible for the 
increased levels of IL-8 and IL-10 are located on the surface of the organism. 
Preliminary data suggests that epitope(s) on the surface of heat-killed 
organisms, are in part responsible for the increased levels of IL-8 and IL-10 
secreted from U-937 cells. These results suggest that L. pneumophila 
organisms elicit specific cytokines in macrophage-like cells in vitro, and also 
downregulates the ability of these cells to produce specific cytokine types 
following infection.
A murine m odel of L. pneumophila lung infection was established by 
injecting L. pneumophila into the trachea of A /J  mice. Following the 
acquisition of initial ED50 data, a sublethal infection was established. L.
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pneumophila actively replicated within lungs of A /J mice over time and 
produced pathologic and histopathologic evidence of the progression of 
disease. During pneumonic infection, L. pneumophila induced the 
production of the proinflammatory cytokines, IL-ip and TNF-a, of the
immune-regulating cytokines, IL-12 and IFN-y and of the chemokine MIP-2 as
detected in BAL fluids, lung homogenates and the sera of mice. Viable 
organisms were necessary to stimulate a detectable host cytokine response, 
indicating that L. pneumophila modulated cytokine production in A/J mice 
by an as yet unknown mechanism. Animals were able to resolve infection 
indicated by clearance of L. pneumophila from the lungs of infected mice.
The profile of cytokines produced during infection may have contributed to
resolution of infection. IFN-y and TNF-a have previously been shown to
activate alveolar macrophages in vitro to inhibit the intracellular growth of L. 
pneumophila (249). In addition, IL-12 produced by monocytes, macrophages 
and neutrophils is required for a Thl type (cell-mediated) host cytokine 
response. The cytokine profile produced in the A /J mice following L. 
pneumophila challenge would suggest the induction of a Thl response
indicated specifically by the production of IL-12 and IFN-y with a paucity of 
IL-10. This type of host immune response should assist in resolving L. 
pneumophila infection as portrayed in the A /J mouse.
Alternatively, when the U-937 cell was used as a model of macrophage
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infection, there was no production of either IL-12 or IFN-y. Although IL-10 
was detected during L. pneumophila infection, lower levels were produced as 
compared to uninfected cells. In the in vitro system, U-937 cells were not able 
to combat infection and were eventually lysed. Striking differences were 
noted between in vitro and in vivo models and it is stressed that any 
comparisons between the two systems should be evaluated with care. It is our 
belief that the use of both systems provide invaluable information to yield a 
better understanding of the host response to L. pneumophila infection. Such 
studies may lead to the development of novel therapeutic strategies such as 
the use of cytokine therapy to assist in resolving clinical Legionnaires' disease. 
Recovery from legionellosis is associated w ith the development of cell- 
mediated immunity and patient susceptibility to Legionnaires' disease is 
linked to deficiencies in cellular immune responses. It is generally accepted 
that the failure to control or resolve infectious disease often results from 
inappropriate rather than insufficient immune responses. Therefore, 
development of a successful immune response with minimal pathology to an 
infectious agent is the desired goal of immunotherapy. The clinical 
implications of the findings from this study with regard to therapy or 
prophylaxis of Legionnaires' disease are manifold. Cytokines such as IL-12 
and IFN-y, that are important in the cell-mediated immune response may be
a useful adjuvant in cytokine therapy, while exogenous administration of 
cytokines may enhance protective memory responses or compensate for the
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loss of a major cellular source of endogenous cytokines. In contrast, the use 
of cytokine antagonists active against immunosuppressive cytokines such as 
IL-10, could be helpful when endogenous, "inappropriate" cytokine 
expression sustains immunopathology and disease. In addition to these 
therapeutic perspectives, already supported by a considerable amount of data 
in experimental models of infection (199, 248, 292, 329), several possibilities 
can be envisioned that may carry the exploitation of the action of specific 
cytokines one step further than the simple administration or neutralization 
of specific cytokines. As noted during the present in vitro cytokine studies, 
microbial products located on the surface of the organisms are in part 
responsible for cytokine production. Studies by Blander and Horwitz have 
shown that the metalloprotease (43) and outer membrane material (41) elicit 
cellular immune responses in guinea pigs, thus, the MOMP, located on the 
surface of L. pneumophila may be, in part, responsible for the observed 
cytokine responses seen in the present study. A better understanding of the 
host response to L. pneumophila infection is central to the development of 
novel immunotherapeutic strategies. Furthermore, it would prove 
beneficial, to define those antigens of L. pneumophila that trigger protective 
cytokine production. Once the chemical nature of such microbial products 
has been established they could be molded artificially and possibly used as 
adjuvants for enhancing a potent L. pneumophila cell-mediated immune 
response. This approach has been used to test the ability of a recombinant
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adenovirus vector-expressing IL-12 to skew the immune response in a Thl 
direction and prevent leishmaniasis, a disease caused by an intracellular 
protozoal pathogen, in susceptible BALB/c mice (140). These investigators 
suggested the potential use of recombinant adenoviruses expressing cytokines 
as potent immuno-modulatory agents for the generation of protective 
immune responses against intracellular pathogens. In addition, the potential 
vaccine properties of potentially protective antigens encoded for by genes in 
the Mycobacterium tuberculosis genome were evaluated for immunogenicitv 
and protective efficacy against challenge with M. tuberculosis (331). Mice 
injected with plasmid DNA encoding proteins from M. tuberculosis resulted 
in significant levels of the Thl-type cytokines, IL-2 and IFN-y. Mice
"vaccinated" with DNA demonstrated significant and sustained reduction in 
bacterial CFU numbers in spleen and lungs. Thus, DNA vaccination may 
prove to be a powerful and easy method for comparative screening of 
potentially protective antigens from intracellular pathogens, such as L. 
pneumophila. The fine tuning and specific modulation of cytokines by 
cytokine therapy or by using potentially protective antigens for subunit 
vaccines, such as the MOMP, to provide an appropriate immune response 
may prove to be extremely beneficial to combating Legionnaires' disease.
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CHAPTER VH
FUTURE STUDIES
A multifaceted approach to investigating the interaction of Legionella 
pneumophila with the host both in vitro and in vivo was implemented in 
this study. The role of the MOMP as an adhesin for L. pneumophila 
attachment to host cells was evaluated in vitro. In addition, the complex 
cytokine host response during L. pneumophila infection was investigated 
using both in vitro and  in vivo infection models. Throughout these studies 
many interesting lines of work developed which would merit further 
investigation
1. Isogenic m utants of L. pneumophila that do not express the MOMP could 
be constructed and evaluated in binding studies to elucidate attachment 
potential of these m utants to host cells. If these mutants are still able to bind 
to cells then additional bacterial adhesins may be involved in the complex 
event of organism attachment. L. pneumophila outer membrane 
preparations may be added to host cells in binding assays, and evaluated by gel 
electrophoresis to identify additional adhesins. In addition, the host cell 
receptor responsible for MOMP attachment should be defined. Once
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elucidated both adhesin and host cell receptor blocking studies could be 
executed as a preliminary step to developing anti-adhesin and /o r anti­
receptor vaccines to assist in controlling Legionnaires' disease.
2. To assess the role of the MOMP, in addition to other L. pneumophila 
antigens as immunostimulatory molecules capable of eliciting an immune 
response, purified MOMP or additional antigen structures may be used in 
both in vitro and in vivo assays. Initially, purified MOMP may be added to 
host cells and the cytokine response evaluated. Furthermore, the host 
cytokine response in mice may be defined following MOMP challenge. In 
addition, if the host response is protective, the possibility exists for using the 
MOMP or other antigens as adjuvants to develop a vaccine which is capable 
of mounting a protective immune response.
3. To address the role that specific cytokines play during L. pneumophila 
infection, several approaches may be implemented. 1) By using an effective 
dose 50 model in mice, various cytokines may be screened in both dose and
time-dependent studies for their protective capabilities following L. 
pneumophila challenge. 2) Monoclonal antibodies can be administered to 
mice to deplete specific cytokines, that have shown protective abilities, prior 
to L. pneumophila infection. 3) Cytokine therapy can be employed by
214
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administering a particular cytokine to address pathology and outcome of 
infection during L. pneumophila challenge. To begin to address this point,
A /J mice were administered either interferon-y, IL-ip or IL-12, 
intraperitoneally prior to intratracheal challenge with 106 CFU of L. 
pneumophila to assess the ability of these cytokines to reduce bacterial 
numbers in mouse lungs.
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Figure 7.1. Exogenous cytokine treatment of A /J mice with 5 ng of interferon- 
y. Recombinant IFN-y was purchased from R & D systems and reconstituted 
as per manufacture's instructions. IFN-y was administered intraperitoneally 
(0.1 ml) 24 h  prior to L. pneumophila challenge. Animals were anesthetized 
and challenged intratracheally with 106 CFU of L. pneumophila as described 
in section 5.3.2. Animals were euthanized at specified time points and lungs 
were aseptically harvested, homogenized, serially 10-fold diluted and plated 
onto BCYE-PAC agar as described in section 5.3.4. Legionella colonies were 
enumerated after 72 h grow th and the concentration of L. pneumophila was 
expressed as CFU per gram of lung tissue. The non-parametric Mann- 
Whitney test was performed to analyze differences between untreated and 
cytokine treated mice. Controls are mice that have been challenged with L. 
pneumophila and not pre-treated with cytokine. *p < 0.0014, **p <0.0004.
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Figure 7.2. Exogenous cytokine treatment of A /J mice with 0.5 jig of 
interleukin-1 p. Recombinant IL-ip was purchased from R & D systems and 
reconstituted as per manufacture's instructions. IL-ip was administered 
intraperitoneally (0.1 ml) 24 h  prior to L. pneumophila challenge. Animals 
were anesthetized and challenged intratracheally with 106 CFU of L. 
pneumophila as described in section 5.3.2. Animals were euthanized at 
specified time points and lungs were aseptically harvested, homogenized, 
serially 10-fold diluted and plated onto BCYE-PAC agar as described in section
5.3.4. Legionella colonies were enum erated after 72 h growth and the 
concentration of L. pneumophila was expressed as CFU per gram of lung 
tissue. The non-parametric Mann-Whitney test was performed to analyze 
differences between untreated and cytokine treated mice. Controls are mice 
that have been challenged w ith L. pneumophila and not pre-treated with 
cytokine. *p < 0.03, **p <0.002.
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Figure 7.3. Exogenous cytokine treatment of A /J mice with 1 jig of 
interleukin-12. Recombinant IL-12 was purchased from R & D systems and 
reconstituted as per manufacture's instructions. IL-12 was administered 
intraperitoneally (0.1 ml) 24 h prior to L. pneumophila challenge. Animals 
were anesthetized and challenged intratracheally with 106 CFU of L. 
pneumophila as described in section 5.3.2. Animals were euthanized at 
specified time points and lungs were aseptically harvested, homogenized, 
serially 10-fold diluted and plated onto BCYE-PAC agar as described in section
5.3.4. Legionella colonies were enumerated after 72 h growth and the 
concentration of L. pneumophila was expressed as CFU per gram of lung 
tissue. The non-parametrie Mann-Whitney test was performed to analyze 
differences between untreated and cytokine treated mice. Controls are mice 
that have been challenged with L. pneumophila and not pre-treated with 
cytokine. *p < 0.0059.
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4. To elucidate the immunization capabilities of L. pneumophila in vivo, 
mice may be challenged with heat-killed organisms or purified antigens prior 
to infection with viable L. pneumophila and the ability of the host to resolve 
infection may be investigated. In addition, the host cytokine response may be 
determined and pathology studies conducted to further define the 
mechanism of protection.
5. Additional work is required to define the role of cell-mediated immunity 
and the part that T cells play during L. pneumophila infection. Mice may 
either be depleted of specific T cell subsets (CD4 or CD8) using monoclonal 
antibodies or transgenic mice devoid of a particular subset can be challenged 
with L. pneumophila to define the cytokine profiles during challenge. In 
addition, the pathology and outcome of infection could be evaluated under 
these conditions.
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APPENDICES
Appendix 1: Media used in biological
A. Bacterial cultivation
1.1. Storage of Bacterial Cultures. Legionella pneumophila serogroup 1 
strain Nottingham 7 (N7) is a virulent clinical isolate from a fatal case of 
Legionnaires' disease. Bacteria were stored frozen in 1 % serum, 10 % sorbitol 
at -70°C throughout this study. Thawed aliquots were plated onto buffered
charcoal yeast extract agar (BCYE-a) and grown at 37°C in a humid
environment for 72 h.
Escherichia coli JM 83 and E. coli JM 83 clone LP 116 were stored frozen 
in 10 % glycerol at -70°C. Thawed aliquots were plated onto nutrient agar and 
grown at 37°C for 24 h. Frozen aliquots and all media used for E. coli JM 83 
clone LP 116 were supplemented with 50 (ig/m l ampicillin (Sigma, St. Louis, 
MO.).
1.2. Buffered charcoal yeast extract agar (BCYE-a). This media was
purchased in dehydrated form from Becton Dickinson (Cockeyesville, MD.) 
and was resuspended in deionized water. The formulation of this agar is as 
follows:
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37 g of BCYE-a was added to 800 ml of fresh deionized water and mixed 
until dissolved. The pH of the m edium was adjusted to 6.9 by adding 10N 
KOH dropwise. The final volume was adjusted to 1 liter by adding deionized 
water. The agar was sterilized by autoclave using 121°C at 12 psi for 20 min 
and the media was allowed to cool to 52°C. Four ml of a 10 % L-cysteine 
solution in deionized water that was filter sterilized was aseptically added to 
each liter, evenly distributed throughout the media and poured into plates. 
Agar was allowed to solidify and plates were sterility checked in a 37°C 
incubator for 24 h and then stored at 4°C.
1.3. Buffered Yeast Extract Broth (BYE-a). BYE-a broth was used to 
grow L. pneumophila from plate grown cultures. This media was the 
standard broth for L. pneumophila cultivation and was not supplemented 
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The above components were added to 800 ml deionized water. 
The pH  of the broth was adjusted to 6.9 with the dropwise addition of ION 
KOH and the total volume was adjusted to 1 liter w ith fresh deionized water.
The BYE-a broth was filtered through a 0.45 pm  filter and then through a 
sterile 0.22 pm filter. Four ml of a 10 % solution of L-cysteine in deionized 
water was aseptically added per liter and the broth was aliquot into 5 ml 
batches, sterility checked in a 37°C incubator for 24 h and then stored at 4°C.
1.4. Nutrient agar or nutrient broth. This media was purchased in 
dehydrated form from DIFCO laboratories (Detroit, MI) and was resuspended 
in deionized water. The formulation of this agar is as follows:
23 g of dehydrated media was added to 800 ml deionized water. The 
total volume was adjusted to 1 liter with fresh deionized water. Both the agar 
and broth were sterilized by autoclave using 121°C at 12 psi for 20 min and the 
media was allowed to cool to 52°C. Agar was poured into plates and allowed 
to solidify and plates were sterility checked in a 37°C incubator for 24 h and 
then stored at 4°C. Broth was aliquot into 5 ml batches and sterility checked 
in a 37°C incubator for 24 h  and then stored at 4°C. All media used to grow E. 
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1.5. 1 % Peptone. 1 g of peptone (DIFCO) was dissolved in 100 ml of 
deionized water. The solution was sterilized by autoclaving (121 °C at 12 psi 
for 20 min) and then aliquot in 0.9 ml volumes with a Cornwall syringe into 
sterilized standard type dilution blank test tubes. These 0.9 ml dilutions were 
sterility checked and stored at 4°C.
B. Cell Culture
1.6. Hank's Balanced Salt Solution (HBSS) w ith or without Ca'*'* and 
Mg**. Sterile batches of 500 ml IX HBSS supplemented with phenol red 
were purchased from Cellgro (Cellgro, Hendon, VA.). Bottles were stored at 
4°C until needed.
1.7. Fetal Bovine Serum. Sterile fetal bovine serum  was purchased 
from Sigma in 500 ml batches. The contents of each bottle was thawed and 
aliquot into 50 ml batches in 50 ml sterile conical tubes and stored at -20°C 
until needed. FBS was heat inactivated by placing conical tube into a 56°C 
water bath for 30 min.
1.8. Sodium pyruvate. HEPES. NEAA and L-Glutamine. Above were 
purchased in sterile 100 ml batches (Cellgro). Sodium pyruvate was at a 
concentration of 100 mM (100 X) and was stored at 4°C. HEPES buffer was at a 
1 M concentration and was stored at 4°C. NEAA was at 100 X and was stored
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at 4°C. L-Glutamine was at a concentration of 200 mM and stored at -20°C 
until needed.
1.9. RPMI-1640. U-937 cells and peritoneal macrophages from A/J mice 
were cultured in RPMI-1640 without antibiotics. Sterile batches of 500 ml IX 
RPMI supplemented with phenol red was purchased from Cellgro. 70 ml was 
removed and the following components were added:
Component A m ount
Heat inactivated
Fetal bovine serum (FBS) 50 ml




* Non-essential amino acids
1.10. HAM's FK12. A549 cells were cultured in HAM's FK 12 medium 
without antibiotics. Sterile batches of 500 ml IX HAM's FK12 supplemented 
with phenol red was purchased from Biofluids. 70 ml was removed and the 
following components were added:
Component A m ount
Heat inactivated
Fetal bovine serum (FBS) 50 ml
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1.11. Trvpsin-EDTA. Tryspin-EDTA was purchased as sterile 100 ml 
batches from Cellgro, aliquoted into 25 ml batches in sterile 50 ml conical 
tubes and stored frozen at -20°C.
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Appendix 2: Production of polyclonal antisera
2.1. Rabbits
W hite New Zealand rabbits were purchased from Charles River 
Laboratory and pre-bled to assess pre-immunization levels of antibodies 
against L. pneumophila and E. coli JM 83.
2.2. Antigen preparation
Whole cells of L. pneumophila, E. coli JM 83 and E. coli JM 83 clone LP 
116 were grown on appropriate media ( see Appendix 1.1) and formalin fixed 
for 1 h w ith 1 % formaldehyde (VWR) in IX PBS to yield lxlO9 CFU/ml. 
Bacteria were washed 10 times with IX PBS. Following the last wash, 1 ml 
bacterial suspensions were mixed with 1 ml Freund's incomplete adjuvant 
(VWR). Rabbits were subcutaneously administered 0.2 m l of the bacterial 
solutions on the right and left sides of their backs.
2.3. Bleeding procedure
2.3.1. Ear bleed. Rabbits used for both L. pneumophila and £. coli JM 83 
were treated in the same manner. Samples of blood were aseptically obtained 
from the central artery of one of the rabbit's ears for antibody titer analysis 
following the immunization schedule. The rabbit's artery was vasodilated by 
warming the ear with a 15 watt bulb of a portable lamp. The ear was swabbed
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with alcohol and a 21-gauge needle was inserted into the artery to retrieve 
approximately 5 ml of blood into a sterile 15 ml conical tube. The ear was 
swabbed again with alcohol.
2.3.2. Cardiac puncture. Once the antibody titer had reached a suitable 
level, the final volume of blood was collected by cardiac puncture and 
exsanguination of the rabbit. An injection of Nembutal into the peripheral 
vein of the rabbit's ear was used to anesthetize the animal. Blood was drawn 
by inserting an 18-gauge needle through the chest into the heart. The rabbit 
was humanely exsanguinated with a final Nembutal injection into the heart. 
Blood collected was allowed to clot overnight at 4°C. Serum was collected by 
centrifugation at 300 x g and stored in 1 ml aliquots at -70°C. An antibody titer 
assay was performed on each rabbit.
2.4. Antibody titer assay
An indirect immunofluorescence assay was performed to assess titer of 
sera drawn from rabbits. L. pneumophila or E. coli JM 83 were fixed in 1 % 
formalin for 30 min., added to glass slides and allowed to dry. Sera were 
diluted in IX PBS and added to the bacteria and incubated at 37°C for 1 h. 
Slides were washed three times with IX PBS and goat anti-rabbit FITC 
conjugated serum was added to the bacteria on the glass slides and incubated 
at 37°C for 1 h. Slides were then washed three times with IX PBS and viewed
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with a BH-2 Olympus microscope in the fluorescence mode. The most 
diluted serum sample from rabbits that exhibited a positive result was 
selected as the titer.
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Appendix 3: Reagents and Procedures used in Histological Studies
3.1. Harris/ Alum Hematoxylin
The formulation of the solution was as follow:
Com ponent A m ount
Hematoxylin crystals 5.0 g
Absolute alcohol 50.0 ml
Aluminum ammonium sulfate 100.0 g
Distilled water 1000.0 ml
Mercuric oxide 2.5 g
Hematoxylin crystals and the alum am monium sulfate were dissolved 
in the alcohol and distilled water respectively by the aid of heat. The two 
solutions were removed from heat and mixed together and rapidly brought to 
a boil. Mercuric oxide was then added slowly and the mixture was reheated 
for 15-20 min. until a purple color was observed. The solution was quickly 
removed from heat and placed into a basin of cold water. The addition of 3.5 
ml glacial acetic acid per 100 ml of solution increases the precision of the 
nuclear stain. The solution was filtered before use.
3.2. Stock 1 % Aqueous Eosin Solution
The formulation of the solution was as follow:
Com ponent A m ount
Water soluble Eosin Y 5.0 g
Distilled water 500.0 ml
Glacial acetic add  1.0 ml
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A working stock was made by adding 100 ml of the stock Eosin to 780 
ml 95 % ethanol, 10 ml of a 1 % solution of aqueous phloxine B and 4 ml of 
glacial acetic add.
3.3. Acid Alcohol
This was made by mixing 1000 ml of a 70 % alcohol solution ( 737 ml of 
95 % alcohol with 263 ml distilled water) with 10 ml of concentrated 
hydrochloric add.
3.4. Saturated Lithium Carbonate
This solution was made by adding 4.5 g of lithium carbonate was to 450 
ml of distilled water.
3.5. Buffered formalin solution
A 10 % solution of formaldehyde (VWR) was made by adding 135 ml c ( 
a 37 % formaldehyde stock to 365 ml of IX phosphate buffered saline (Cellgro). 
Aliquots of 40 ml were kept at room temperature.
3.6. Preparation of histological sections
A /J mice were euthanized by C 0 2 (ACUC protocol # 960905) and the
trachea isolated and tied. Lungs were perfused with 1 ml of a 10 % buffered 
formalin solution for 1 min. Lungs were excised and placed in 10 % buffered
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formalin until processed.
3.7. Histological processing of tissue samples
Lungs were cut and placed into embedding cassettes and washed 
overnight in water. Samples were placed into a Shandon Citadel Tissue 
Processor and the following cycle was used without the use of a vacuum or 
heat:
Treatm ent Tim?
70 % ethanol 1.5 h
80 % ethanol 1.0 h
(95 % ethanol) X 2 1.0 h
(100 % ethanol) X 3 1.0 h
Histoclear 1.15 h
(Histoclear) X 2 1.5 h
Hot paraffin 2.15 h
H ot paraffin 2.5 h
Tissue samples were embedded in hot paraffin and allowed to harden 
at -20°C for 10 min. A facing knife was used to cut the excess paraffin and the 
tissues were then cut 6 pm thick using an American Optical Microtome. The 
sections were floated in a 45°C water that contained gelatin and allowed to 
drip dry. Samples were placed on a hot plate at 45°C for 15 min to dry and 
then in a 55°C incubator for 20 min. Samples were then stained with 
hematoxylin and eosin.
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3 .8 . Hematoxylin and e o s in  s ta in in g  procedure
The following staining procedure was used:
Treatm ent Tim e
(Histoclear) X 3 2 min.
(100 % ethanol) X 2 1 min.
100 % ethanol 2 min.
(95 % ethanol) X 2 1 min.
Distilled water 15 dips
Harris' Hematoxylin 12 min.
Running tap water 2 min.
Acid alcohol 3 dips
Distilled water 10 dips
Lithium carbonate 7 dips
Running tap water 10 min.
Eosin 5 min.
95 % ethanol 10 dips
(100 % ethanol) X 3 1 min.
(Histoclear) X 4 2 min.
3.9. Steiners' stain
3.9.1. Solutions
0.1 % uranyl nitrate. 0.05 g uranyl nitrate (BDH Chemicals Ltd, 
England) was dissolved in 30 ml distilled water.
0.1 % silver nitrate. 0.5 g silver nitrate (Fisher Scientific) was dissolved 
in 30 ml distilled water. Silver nitrate was preheated in a 70°C waterbath for 5 
min. before use.
2.5 % gum mastic. 2.5 g gum mastic (MCB Manufacturing Chemists 
Inc., OH.) was dissolved in 100 ml absolute ethanol and filtered before use.
H ydroquinone. 0.25 g hydroquinone (Sigma) was dissolved in 25 ml 
distilled water.
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Developing solution. 15 ml gum mastic, 25 ml hydroquinone and 0.1 
% silver nitrate were combined.
3.9.2. Procedure
Sections were deparaffinized, hydrated with distilled water and treated 
with 0.1 % uranyl nitrate. Sections were rinsed twice in distilled water and 
placed into 0.1 % preheated silver nitrate. Sections were rinsed twice in 
distilled water and dehydrated in 95 %, followed by absolute ethanol for 2 
changes. Sections were treated with 2.5 % filtered gum mastic for 3 min., 
dried for 1 min. and then placed into preheated developing solution a 70°C 
waterbath with agitation for 10 min. Sections were rinsed in distilled water 
for 3 changes and dehydrated and cleared as follows:
Treatm ent 
95 % ethanol 







Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
%w
IMAGE EVALUATION 












1.25 1-4 Hill 1.6
150mm
A P P L IE D  ^  IIWIGE . Inc
  1653 East Main S treet
- Rochester. NY 14609 USA 
—  Phone: 716/482-0300 
-= = ~  Fax: 716/288-5989
0 1993. Applied Image. Inc.. All Rights Reserved
permission of the copyright owner. Further reproduction prohibited without permission.
